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Abstract 
Background. Necator americanus is one of the major causes of human 
hookworm infection, affecting over 800 million people worldwide. Hookworm 
infections cause gastro-intestinal bleeding, anaemia and iron deficiency, and 
are associated with high rates of morbidity, especially in children. Although 
chemotherapy has proven effective, high rates of reinfection are reported in 
socioeconomically developing countries, possibly due to the short-term 
efficacy of anthelmintic drugs in addition to individual predisposition to these 
infections, raising interests in developing suitable alternatives to chemotherapy 
which are capable of providing complete, long-term protection against 
hookworms. Understanding of the molecular mechanisms used by Necator 
americanus larvae to penetrate the human skin and the vasculature would 
therefore aid the development of effective vaccines against this important 
pathogen. 
 
Methods. First, Necator americanus larval exsheathing fluid (EF) and 
excretory/secretory products (ES) were profiled using gel electrophoresis and 
enzyme assays. Protease inhibitors against the main protease classes were used 
to determine which proteases are present in larval products. Second, the 
interaction of larval EF and ES products with human skin and extracellular 
matrix (ECM) macromolecules including collagens I, III, IV and V, fibronectin 
and laminin was investigated using western blots and protein separation by gel 
electrophoresis. Third, the impact of Necator americanus larval EF and ES on 
the endothelial barrier was examined using human umbilical vein endothelial 
cells (HUVEC). Permeability, an essential endothelial barrier function, was 
 ii 
assessed during treatment with larval products, using transendothelial electrical 
resistance (TEER), and post-treatment using albumin-tracer flux. Finally, at the 
cellular level, responses to treatment with larval products were assessed by 
investigating molecular changes at cell-cell vascular endothelial (VE)-cadherin 
junctions and actin filaments, and by determining levels of secreted 
inflammatory cytokines, IL-6 and IL-8, and vascular endothelial growth factor 
(VEGF) in the culture medium.  
 
Results. It would appear that a repertoire of larval proteases, including serine, 
cysteine, aspartyl and metalloprotinases, caused partial degradation of skin 
macromolecules, collagens I, III, IV and laminin while fibronectin was fully 
degraded. Proteolysis of skin- and ECM macromolecules was related to the 
characteristic presence of proteolytic enzymes in larval products. The presence 
of transglutaminase activity was confirmed in both EF and ES products.  
 
Larval proteases caused a dose related increase in endothelial permeability, 
characterised by a decrease in monolayer resistance (TEER) with increased 
permeation of albumin tracer, which was minimal in the presence of a cocktail 
of protease inhibitors. These barrier changes were associated with disruption of 
junctional VE-cadherin and F-actin, the formation of intercellular gaps and an 
increase in endothelial secretion of IL-6 and IL-8. 
 
Conclusions. Necator americanus larvae produce a repertoire of proteolytic 
enzymes which could play an important role in negotiating the skin and 
EUHDFKLQJWKHHQGRWKHOLXPWRJDLQDFFHVVWRWKHKRVW¶VEORRGFLUFXODWLRQ 
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1. General Introduction 
The interest in studying the journey of Necator americanus larvae through the 
skin and the underlying vasculature necessitates a deep understanding of 
Necator americanus infection and the structure of the skin and the vascular 
endothelium WKH WZR PDMRU EDUULHUV FRQWUROOLQJ ODUYDO HQWU\ LQWR WKH KRVW¶V
microcirculation. 
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1.1 Necator americanus 
Human hookworm infection is one of the most devastating gastro-intestinal 
infections, affecting over 800 million people worldwide (Haas et al, 2005; 
Bethony et al, 2006). The two main species that account for almost all human 
infections, Ancylostoma duodenale and Necator americanus, are among the 
most prevalent nematodes (Williamson et al, 2003) and occur in most warm-
temperature regions with Necator americanus largely thriving in sub-Saharan 
Africa, Southeast Asia, Melanesia, and Latin America (Hoagland and Schad, 
1978; Loukas and Prociv, 2001) and Ancylostoma duodenale favouring cooler 
and drier, tropical regions of the world (Albonico et al, 1998). Hookworms are 
highly host specific, obligate blood-feeders (Williamson et al, 2003a), causing 
gastro-intestinal bleeding, anaemia and iron deficiency in most chronic 
infections (Hotez and Pritchard, 1995; Albonico et al, 1998; Devaney, 2005). 
The severity of these outstanding features can lead to retardation of growth as 
well as physical and cognitive impairment in children with chronic conditions 
depending on the intensity and prevalence of infection (Crompton, 2000; 
Williamson et al, 2003a), which in turn is influenced by the susceptibility of 
individuals at all ages to hookworm infections (Timothy and Behnke, 1993; 
Bethony et al, 2002). Since hookworms do not replicate in the human host, the 
intensity of Necator americanus infection is estimated using a quantitative 
faecal egg count as a practical marker for worm burden (Hotez et al, 2005). 
Hookworm infections are defined by the World Health Organization (WHO) to 
be moderate in individuals producing 2,000 to 3,999 eggs per gram of faeces 
(epg) while heavily infected individuals produce over 4,000 epg.  
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At high intensity, hookworm infections can cause significant morbidity and 
mortality (Hotez and Pritchard, 1995). However, there is increasing evidence 
suggesting that a tolerated Necator americanus infection (at ~ 50 epg), as 
described by Mortimer et al (2006), might be associated with therapeutic 
benefits to autoimmune conditions such as CURKQ¶VGLsease (Reddy and Fried, 
2007; Reddy and Fried, 2009), allergic disorders including asthma (Pritchard et 
al, 1995; Quinnell et al, 2004; Falcone and Pritchard, 2005) and atopic 
dermatitis (Cooper et al, 2003; Wordemann et al, 2008; Flohr et al, 2009). 
Despite being of major importance to humankind, little is actually known about 
parasite-host interactions, parasite invasion strategies and the importance of the 
generated immune responses in terms of host protection and/ or parasite 
survival (Loukas and Prociv, 2001).  
1.1.1 Life cycle of Necator americanus 
Necator americanus is an obligate skin-penetrating hookworm (Hawdon et al, 
1993) which resides in the jejunum and duodenum (Pritchard et al, 1990). 
Following sexual pairing between adult worms, female worms start producing 
eggs by days 42²49 post-infection (Jian et al, 2003, Bethony et al, 2006), 
which undergo several cell divisions prior to being passed out in host faeces 
(Pritchard et al, 1990; Loukas and Prociv, 2001). Under humidified and warm 
(25²28°C) conditions (Schad et al, 1973), the embryonated eggs hatch within 
1 to 2 days. The hatched first-stage larvae (L1) feed on organic debris and 
faecal microflora to grow and develop as shown in Figure 1.1 (Pritchard et al, 
1990; Bethony et al, 2006), moulting twice to form the infective non-feeding 
third-stage (L3) larvae, ensheathed in a loose outer cuticle left over from the 
second moult (Loukas and Prociv, 2001; Brooker et al, 2004; Bethony et al, 
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2006). In the presence of appropriate conditions such as moisture, warmth and 
shade (Schad et al, 1973; Hotez and Pritchard, 1995), infective L3 larvae will 
crawl onto vegetation, soil particles and rocks to maximize their chances of 
contacting a new host, the so-called 'questing behaviour' (Hotez and Pritchard, 
1995; Hotez et al, 2004). 
 
Upon contact with infective L3 larvae, key molecules in the skin can provide a 
trigger to the invading larvae, allowing them to actively penetrate the skin and 
reach the bloodstream, mainly through the vasculature (Hotez and Pritchard, 
1995) and/ or possibly through the lymphatic system (Pritchard et al, 1990). 
Infective L3 larvae migrate to the lungs, through the vasculature, where they 
break out into the alveolar spaces and migrate up the trachea mostly by 
coughing (Hawdon et al, 1993; Devaney, 2005). Finally, L3 larvae are 
swallowed, arriving in the small intestine where maturation to the L4 stage 
takes place (Devaney, 2005). During the larval stages, Necator americanus 
encounter the endothelium in the skin, as they penetrate into the blood 
circulation and as they migrate out into the lungs.  
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Figure 1.1 Life cycle of Necator americanus.  
 Eggs are passed in the stool.  Larvae hatch in 1 to 2 days, and grow in 
the faeces and or the soil, to become infective (third-stage) larvae  within 
5 to 10 days.  On contact with the human host, the larvae penetrate the 
skin and are carried through the blood vessels to the heart and then to the 
lungs.  They penetrate into the pulmonary alveoli, ascend the bronchial 
tree to the pharynx, and are swallowed.  Once they reach the small 
intestine, larvae reside and mature into adults.  Adult worms attach to the 
intestinal wall and feed on intestinal mucosa and blood. Female worms 
then start laying eggs.  
From http://www.dpd.cdc.gov/dpdx/HTML/Hookworm.htm.   
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The L4 larvae are characterised by a false buccal cavity which is shed 
following the final moult to the adult worm stage (Behnke et al, 1986; 
Pritchard et al, 1990). Within six weeks post-infection, adult worms reach 
sexual maturity and are easily distinguished as adult males show a rounded 
posterior end in addition to a copulatory bursa while females have a sharp, 
needle-like tail and a vulva located anterior to the middle of the body 
(Pritchard et al, 1990; Jian et al, 2003). Adult worms then mate and females 
start laying eggs, completing the life cycle of Necator americanus.  
1.1.2 The course of Necator americanus infection 
Human hookworm infection is usually stimulated by ecological factors at the 
transmission sites (Haas et al, 2005). Necator americanus larvae often adopt a 
motionless resting posture, also known as developmental arrest (Hotez et al, 
2004), to minimise unnecessary energy expenditures in the soil. Stimuli 
including humidity (Haas et al, 2005), radiating warmth from hosts, and lights 
(Haas et al, 2005a) contribute to the 'ambushing strategy' as infective, non-
feeding L3 larvae position themselves on top of soil particles and blades of 
grass and wait for the appropriate host. L3 larvae are then activated to the 
searching (in which larvae raise their anterior ends and move in all directions) 
and waving (in which one third of the larval body is erected) behaviours which 
are essential for these species to locate and reach the appropriate host. Other 
factors such as vibration, carbon dioxide and chemical gradients seem to cause 
little to no activation of larvae (Sasa et al, 1960; Sciacca et al, 2002), which is 
regarded as a beneficial way for saving energy during the frequent contact with 
soil-living habitats (Schad, 1991). 
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Although thin, the outer layer of human skin is considered a highly efficient 
barrier to the majority of infective parasites including human hookworms 
(Matthews, 1982). In the presence of a thin water-film, Necator americanus 
infective larvae crawl on the surface and penetrate the human skin by pressing 
their anterior ends vertically on the skin and 'nictating' or 'waving' their 
elevated neck laterally (Haas et al, 2005), a process that is largely stimulated in 
the presence of chloroform soluble lipids of human skin surface (Matthews, 
1982; Salafsky et al, 1990). Initial invasion, which is believed to be totally 
mechanical (possibly driven by surface lipids), occurs as fast as 5 minutes and 
is often accomplished in 1 to 2 hours after being exposed to the skin 
(Matthews, 1982). Exsheathment, described as the loss of the loose sheath of 
infective L3 larvae, is apparently not essential during larval invasion as 
ensheathed L3 larvae were also capable of penetrating the skin (Figure 1.2) 
(Kumar and Pritchard, 1992). Necator americanus larvae remain in the skin for 
48 to 72 hours post-infection (Behnke et al, 1986; Hawdon et al, 1993), a 
period that is required to resume larval feeding and reactivate developmental 
changes to facilitate the parasitic infection in mice (Hawdon et al, 1993; 
Hawdon and Hotez, 1996). Activated L3 larvae negotiate through the lower 
epidermal and dermal layers, using a repertoire of enzymatic secretions 
(Matthews, 1975; Matthews, 1982; Kumar and Pritchard, 1992a; Loukas and 
Prociv, 2001; Williamson et al, 2004), and enter the capillaries to be carried to 
the lungs via the blood circulation. Parasitic developmental changes are usually 
observed a few hours after arrival in the lungs including acquiring pigments in 
the parasitic intestine and the rounding of their anterior end (Jian et al, 2003), 
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and are indicative of the obligatory lung mediated phase in Necator 
americanus infection (Hoagland and Schad, 1978; Behnke et al, 1986).  
 
   
 
Figure 1.2 Micrographs of Necator americanus L3 (a) ensheathed, and 
(b) exsheathed larvae under phase contrast microscopy.   
 
Necator americanus larvae enter the gastrointestinal tract, finally arriving in 
the small intestine where they mature into adult worms (Hawdon and Schad, 
1990). Migration of Necator americanus larvae either from the skin to the 
lungs or from the lungs to the small intestine is believed to occur in response to 
local triggers (Timothy and Behnke, 1993; Zhan et al, 2002; Hawdon and Datu, 
2003). At this stage, maturation into juvenile adult worms is usually 
accomplished and worms exhibit a full buccal cavity, a pharynx connecting this 
cavity to the intestine (Jian et al, 2003), a dorsal pair of ventral cutting plates 
(Figure 1.3), a concave median tooth and a pair of sub-ventral lancets 
(Pritchard et al, 1990). Adult worms attach to the intestinal wall and feed on 
intestinal mucosa and blood and are estimated to cause a blood loss of 
approximately 40 µL per day per single worm (Devaney, 2005). Despite being 
mechanical, attachment to the intestinal wall and degradation of host tissue is 
also explained by the enzymatic activity of these worms, allowing the release 
(a) 
(b) 
50 µm 50 µm 
Sheath 
    ź 
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of nourishing components of the wall through a cascade of haemoglobinases 
(Williamson et al, 2004) and other proteolytic enzymes (Williamson et al, 
2003).  
 
 
 
Figure 1.3 Two faces of Necator americanus. (a) Micrograph showing 
the buccal cavity (B) and plates (P) used for attachment and feeding in the 
gut. Micrograph courtesy of Bernard Matthews. (b) Necator americanus 
attached to the intestinal mucosa, stained with haematoxylin and eosin. 
Host tissue (HT) is drawn into the buccal cavity prior to digestion in the 
oesophagus (OG). In addition, parasite-protective molecules are secreted 
at the site of attachment (Adapted from Pritchard and Brown, 2001). 
 
1.1.3 Necator americanus secreted products 
According to Loukas and Prociv (2001), secretions of Necator americanus are 
believed to come into contact with the human host not only anatomically 
during penetration and feeding, but also physiologically during immune 
responses. These secretions are supposed to boost hookworm infection by 
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revealed numerous larval and adult proteins with potential antigenic and 
immunoevasive properties (Carr and Pritchard, 1986; Loukas and Prociv, 
2001). Antioxidants are functional molecules which might provide some 
protection to cuticle-exposed antigens including neutralizing host free radicals 
such as superoxide dismutases (SOD) and counteracting the effects of lipid 
hydroperoxides such as glutathione-S-transferases (GST) (Hotez and Pritchard, 
1995; Brophy et al, 1995; Loukas and Prociv, 2001). Parasite derived C type 
lectins, which are present in serum and on surface of immune effector cells, 
could be responsible for switching off the local inflammatory responses to 
feeding in the small intestine as they compete with host lectins to bind to 
immune cells (Loukas and Prociv, 2001). Furthermore, the secretion of a 
neutrophil inhibitory factor (NIF), which blocks the adhesion of activated 
human neutrophils to vascular endothelial cells at feeding sites, have been 
reported in adult Necator americanus but its functional properties are yet to be 
investigated (Daub et al, 2000). This factor was said to antagonize naturally 
occurring CR3 receptors and affect the migration of monocytes to the 
inflammatory sites, hence providing a mechanism for immune evasion (Asojo 
et al, 2005). Calreticulin, an extracellular calcium binding protein with lectin 
like features, has been purified from Necator americanus secreted products. 
Calreticulin, which shows an association with the complement system (Cq1) as 
well as integrins (Reilly et al, 2004), is also believed to act as an immune 
modulator during the parasitic infection (Hotez and Pritchard, 1995; Kasper et 
al, 2001). Necator americanus adult worms are also known to secrete 
acetylcholinesterase (Pritchard et al, 1991), possibly to degrade acetylcholine 
produced in the intestinal wall, as well as anti-coagulant (Rogers and 
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Sommerville, 1963; Schad, 1991) and anti-platelet (Zhan et al, 2005) proteins 
at the site of attachment in the small intestine, which would delay the formation 
of blood clot and enhance the blood loss. 
 
Evidence suggests that Necator americanus larvae are capable of releasing a 
wide range of pre-synthesized proteolytic enzymes at any stage of their 
development (Sasa et al, 1960; Matthews, 1975; Williamson et al, 2004). 
These enzymes are believed to be stored in secretory granules, present within 
the oesophageal glands of these parasites (Smith, 1976), and contribute to 
parasitic developmental processes. To date, the infective larvae of Necator 
americanus were shown to facilitate skin penetration, larval migration and 
intestinal attachment (Matthews, 1982; Brown et al, 1999; Williamson et al, 
2003) by secreting a mixture of proteolytic enzymes including aspartyl, 
metalloproteases, serine and cysteine proteases (Kumar and Pritchard, 1992; 
Kumar and Pritchard, 1992a; Brown et al, 1999; Quinnell et al, 2004). Most of 
these proteases are gelatinolytic in nature (Kumar and Pritchard, 1992a) and 
have an ability to degrade a number of skin macromolecules such as collagens 
I²V, fibronectin and laminin (Brown et al, 1999), and host haemoglobin 
(Williamson et al, 2003). In addition, cysteine proteases including Ancylostoma 
secreted proteins (ASP-1 and ASP-2) are very immunogenic and play different 
roles in the biology of Necator americanus including tissue invasion and 
immune evasion (Hawdon and Hotez, 1996; Bin et al, 1999; Loukas et al, 
2000). Furthermore, aspartic proteases, which are expressed at all 
developmental stages of Necator americanus such as Na-APR-1 and -2 (Brown 
et al, 1999; Bethony et al, 2005), are also capable of hydrolyzing human 
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haemoglobin and serum proteins in a multi-protease cascade (Williamson et al, 
2002; Williamson et al, 2003).  
 
Proteases are also known to cause the most ubiquitous effects on the immune 
system than all other Necator americanus secreted proteins. As such, 
metalloproteases have been shown to specifically cleave the chemo-attractant 
eotaxin-1 (Culley et al, 2000), therefore interfering with the role of eosinophils 
at all inflammatory sites of feeding while cysteine proteases can selectively 
cleave CD23, a host lectin, from the surface of B-cells and are therefore 
responsible for the enhanced IgE synthesis (i.e. Hypersensitivity type I), 
observed in Necator americanus infection (Hewitt et al, 1995; Loukas and 
Prociv, 2001).  
1.1.4 Immunogenicity of Necator americanus 
Necator americanus larval entry is often associated with mild clinical 
inflammatory responses such as static ground itch lesions, migratory creeping 
eruption and skin redness, which could last for a few weeks post-infection 
(Hotez et al, 2004, Wright and Bickle, 2005). Upon arrival into the lungs, 
Necator americanus larvae can cause central haemorrhagic and inflammatory 
lesions, which may be evident clinically depending on the intensity of the 
hookworm infection, possibly with cough and sore throat (Hotez et al, 2004). 
Following migration to the small intestine, occasional mild nausea and 
moderate abdominal pain could be experienced, in addition to weight loss and 
intestinal bleeding, the main pathological effects of hookworm infection. Less 
commonly occurring features include oedema in both feet and the right arm as 
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previously stated by Wright and Bickle (2005). These symptoms are less likely 
to occur on the second infection with the exception of the skin irritation.          
 
During their life cycles, Necator americanus are in close contact with the 
immune system as they circulate in the vasculature (Hotez and Pritchard, 
1995), offering the parasite and host several opportunities to interact at the 
cellular level. The skin, lungs and gut are considered as critical obstacles to 
these parasites, where most immune activation and immune modulation is 
likely to happen (Loukas and Prociv, 2001; Pritchard and Brown, 2001). 
Antigenic stimulation of the KRVW¶V immune system may afford a degree of 
early protection in pre-exposed hosts, especially during the skin invasive phase 
(Kumar and Pritchard, 1992). Although hookworm antigenic expression is 
stage-specific, antibodies developed in individuals infected with Necator 
americanus failed to recognize exsheathed L3, but succeeded to detect antigens 
on the surface of ensheathed L3 larvae (Pritchard et al, 1990). These 
observations would explain the diversionary role of larval surface antigens in 
bypassing the immune response in the skin and allowing the defenceless, 
exsheathed parasite to remain unrecognized (Kumar and Pritchard, 1992; 
Loukas and Prociv, 2001). 
1.1.4.1 Immune responses to Necator americanus infection 
Necator americanus infection elicit a strong, stage-specific, Th2 response 
which is characterized by increased activation of CD19+ B-cells and CD3+ and 
CD4+ T-cells corresponding to elevated levels of total and antigen-specific 
immunoglobulin, particularly IgGs, IgM and IgE (Pritchard and Walsh, 1995; 
Loukas and Prociv, 2001; Quinnell et al, 2004; Geiger et al, 2007). Some 
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antibody responses, such as IgG4 and IgE, are more species-specific and 
appear to correlate with the intensity of hookworm infection (Pritchard and 
Walsh, 1995; Palmer et al, 1996; Loukas et al, 1996; Xue et al, 1999) while 
down-regulation of others, such as IgA, is possibly due to the proteolytic 
breakdown of this antibody (Behnke, 1991; Pritchard, 1995). Infections are 
also associated with a mixed Th1/Th2 cytokine response in which both Th1 
(gamma interferon (INF-Ȗ) and IL-12) and Th2 (IL-4, IL-5 and IL-13) are 
produced (Pit et al, 2001; Quinnell et al, 2004a), emphasising the significance 
of a mixed Th1/Th2 cell response to Necator americanus infection intensity. In 
addition, Necator americanus infection is accompanied by an increase in the 
levels of IL-10, an anti-inflammatory cytokine with a regulatory role to play in 
the immune response, and a down-regulation of cellular reactivity (Geiger et 
al, 2004; Bethony et al, 2006; Geiger et al, 2007). However, Wright and Bickle 
(2005) reported a transient elevation in IL-5 and IL-13 production in infected 
individuals but no IFN-ȖRU,/-10 mediated responses were observed.  
 
Eosinophilia, a characteristic response to Necator americanus infection (Culley 
et al, 2002; Wright and Bickle, 2005), is known to predominate the 
inflammatory response to larval and adult parasites (Behnke, 1991; Loukas and 
Prociv, 2001; Quinnell et al, 2004). In a self infection study, an increase in 
eosinophil counts was recorded as early as day 3 post-infection, implicating the 
involvement of non-specific responses, and was shown to persist for up to 2 
years post-infection (Wright and Bickle, 2005). Evidence suggests that 
eosinophils bind to Necator americanus larvae in the presence of the 
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complement system (Desakorn et al, 1987), thus being able to eliminate these 
parasites only at the larval stage (Meeusen and Balic, 2000).  
1.1.4.2 Immune modulation in Necator americanus infection  
Necator americanus is known to survive in the human host, mainly as adult 
worms, for an average of 5 to 7 years with recent evidence showing the 
intensity of hookworm infection to increase with age (Beaver et al, 1984; 
Bethony et al, 2002). Necator americanus species, which live in close contact 
with the host immune system, secrete a number of stage-specific molecules 
such as eotaxin metalloproteinase, calreticulin, antioxidants and neutrophil 
inhibitory factor (NIF), with immuno-modulatory properties capable of 
redirecting the immune response during hookworm infection (Kumar and 
Pritchard, 1992a; Quinnell et al, 2004a; Loukas et al, 2005). 
 
Immuno-modulation of the host immune system, reported to date, include 
parasite-mediated suppression of antigen-specific immune responses, 
divergence of the host immune responses from protective against these 
parasites to non-protective, and inactivation of immune effector mechanisms 
which are mainly responsible for expulsion of these parasites (Quinnell et al, 
2004a). Immuno-suppression was supported by the increase in immune 
responsiveness following chemotherapy-induced removal of parasites. This is 
described by a decline in antigen-specific antibody responses, including IgGs 
and IgE, and eosinophilia to pre-infection levels while a significant increase in 
anti-adult IgD (Pritchard et al, 1992) and anti-larval IgA was observed (Kumar 
et al, 1980; Quinnell et al, 2004a). 
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During Necator americanus establishment in the gut, natural killer (NK) cells 
are attracted to the site of infection by protein secretions from adult worms 
(Hsieh et al, 2004). NK cells selectively bind to excretory/secretory (ES) 
products which cause these cells to become activated and secrete INF-ȖORFDOO\
a mechanism that is likely to modulate host immune responses and contribute 
to the longevity of infection (Teixeira-Carvalho et al, 2008). In addition, the 
high levels of IL-10 and regulatory Treg cells are believed to play a pivotal role 
in the down-regulation of cellular reactivity and the inhibition of protective 
immune responses against these parasites (Taylor et al, 2005; Geiger et al, 
2007). Cellular reactivity, which is reduced during the adult-phase of 
hookworm infection, is probably induced by adult ES proteins to inhibit killing 
of incoming L3 and L4 larvae, therefore prolonging the survival of Necator 
americanus in the human host (Croese et al, 2006). 
1.1.5 Treatments for Necator americanus infection     
The World Health Organization has approved four anthelmintic drugs for 
morbidity control against soil transmitted infections (STI) including 
albendazole, mebendazole, levamisole, and pyrantel pamoate (WHO, 1997). 
These drugs have demonstrated a broad spectrum of activity and have been 
used effectively for more than 30 years (Keiser and Utzinger, 2008). 
Albendazole and mebendazole, which are derivatives of the benzimidazole 
class, are associated with a cure rate of 66% in patients treated with a 400 mg 
single dose of albendazole (Cline et al, 1984) and about 31% cure rates in 
Mafia Island, following treatment with a 500 mg single oral dose of 
mebendazole (Albonico et al, 2002). A recent study investigating the efficacy 
of albendazole, pyrantel pamoate and tribendimidine against Necator 
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americanus infection, in hamsters, demonstrated an equal activity of all drugs 
at doses as high as 100 mg/kg (Xue et al, 2005). In clinical trials, 
tribendimidine exhibited a safe, broad spectrum of activity with a promising 
effect against Necator americanus. A 400 mg single oral dose of 
tribendimidine and albendazole, which was administered to patients infected 
with Necator americanus, resulted in cure rates of about 86% and 66% 
respectively, indicating that tribendimidine may become the drug of choice 
(Xiao et al, 2005; Wu et al, 2006). Unlike ivermectin (Campbell et al, 1984), 
the only macrocyclic lactone anthelmintic approved for human use, drugs such 
as nitazoxanide and amidantel have revealed no activity against Necator 
americanus despite being effective against other human intestinal protozoa and 
nematodes (Xiao et al, 2005). 
 
Because of their high efficacy, low costs and ease of use, albendazole and 
mebendazole are widely used in control programmes for intestinal nematode 
infections, raising concerns about potential emergence of drug resistance. The 
likelihood of developing drug resistance among intestinal parasites is greater 
than all other parasites as the density of sexual stages resides in the small 
intestine. To date, resistance to mebendazole and pyrantel pamoate has been 
reported in human hookworm infection in Australia and Africa (Horton, 2003; 
Albonico et al, 2003). Since anthelmintic drugs do not provide complete and 
long-lasting protection, naturally acquired immunity is not common in 
individuals with a history of Necator americanus infection, possibly 
accounting for the high rates of reinfection within 4 to 12 months post-
infection (Quinnell et al, 1993; Albonico et al, 1995). Additional factors, 
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including individual predisposition (Hotez et al, 2004) and the geo-distribution 
of hookworm infections in socioeconomically developing countries (Loukas 
and Prociv, 2001; Hotez et al, 2007), may also increase the potential for 
reinfection.  
1.1.6 Vaccines 
Although anthelmintic treatments are widely used to control human intestinal 
infections, the prevalence of hookworm infection remains of major concern 
from a public health standpoint. Therefore, developing an effective vaccine 
against hookworm infections is a suitable alternative to chemotherapy and 
provide early protection against these parasites. Vaccination with irradiated 
Necator americanus larvae resulted in almost complete protective immunity 
against challenge infection (i.e. Th2 response associated with high IgG, IgE 
and IL-5), and reduced the pathology associated with hookworm infections in 
mice (Brown, 2000; Culley et al, 2001). Although immunization with 
irradiated larvae was effective and supported the feasibility of hookworm 
vaccination, an ideal vaccine would mimic the effect of live, attenuated larvae 
with larval-derived antigens, which could be genetically engineered on a large 
scale.  
 
Since Necator americanus antigens are stage-specific (Pritchard et al, 1990; 
Williamson et al, 2004), the ultimate hookworm vaccine should consist of at 
least two different antigens, one that targets penetrating and migrating larvae to 
reduce the number of larvae entering the gastrointestinal tract, and the other 
targeting adult stage to interrupt blood feeding and hence minimize the 
pathology associated with hookworms (Girod et al, 2003; Loukas et al, 2005a). 
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Based on this theory, larval proteins such as ASPs (Loukas and Prociv, 2001; 
Goud et al, 2005; Bower et al, 2008), metalloproteases (Hotez et al, 2003; 
Goud et al, 2005) and calreticulin (Winter et al, 2005) appear to be attractive as 
larval vaccines while adult haemoglobinases (Daub et al, 2000; Pearson et al, 
2009), and glutathione-S-transferase (GST) (Zhan et al, 2005) have shown 
great promise as adult vaccine candidates.  
 
According to Bethony et al (2005), vaccination against the aspartic protease 
Na-ASP-2 elicited a strong antibody response in rats including IgG1, IgG2a 
and IgM levels, which were durable and easily boosted with a single dose of as 
low as 50 micrograms. Na-ASP-2 vaccines also reduced the worm burden 
(Xiao et al, 2008), and was therefore selected to undergo process development 
in clinical trials (Bethony et al, 2006; Bower et al, 2008). Calreticulin, another 
lead vaccine candidate which was selected based on its role as an immune 
evasion protein, induced a strong Th2 response, characterised by high levels of 
specific IgE (Winter et al, 2005). Free calreticulin vaccine also provided great 
protection against Necator americanus infection with reduced worm burdens in 
the lungs of vaccinated mice. Unlike encapsulated calreticulin, lower levels of 
eosinophlia, IgG1, IgG2a and IgE were observed following free calreticulin 
vaccines, indicating that these findings require further investigations to identify 
the nature of protection generated by free calreticulin vaccines (Winter et al, 
2005). 
 
Ac-GST-1, an enzyme that is involved in the detoxification of host-generated 
free radicals during haemoglobin digestion, presents a promising vaccine 
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candidate to prevent the establishment of Necator americanus larvae in the 
small intestine (Zhan et al, 2005; Devaney, 2005). Ac-GST-1 vaccine induced 
strong antibody responses (IgG1 and IgG2) and elevated levels of IFN-Ȗand 
IL-4 responses, characteristic of a mixed Th1/Th2 response (Zhan et al, 2005; 
Pearson et al, 2009). Na-APR-1, an aspartic protease responsible for initiating 
the cascade of haemoglobin digestion (Williamson et al, 2002), is another 
vaccine candidate with high potentials to target the adult stage of these 
parasites (Loukas et al, 2005; Pearson et al, 2009). Immunisation with 
recombinant Na-APR-1 was associated with a significant protection against 
blood loss and low worm burdens and egg counts in dogs (Loukas et al, 2005). 
Immunisation with anti-adult Na-APR-1 was reported to partially inhibit 
Necator americanus larvae from passage through skin (16- 26%) while anti-
larval Na-APR-2 vaccines caused over 50% inhibition of larval migration 
through the skin (Williamson et al, 2003), signifying that stage-specificity of 
these antigens possibly accounts for their potentials to inhibit Necator 
americanus infection at different stage. 
1.1.7 Overviews 
Understanding the molecular biology of hookworms represents an excellent 
opportunity for studying the fundamental, parasite-specific processes in the 
host, including the entry of Necator americanus larvae into the host¶V blood 
circulation. Migration of hookworm larvae through the skin has been described 
in some detail in the literature. The skin, the major barrier that protects the host 
against hookworms and all other parasites, is introduced and the available 
knowledge of the parasitic mechanisms to negotiate the skin is discussed.  
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1.2 The Skin 
The skin is the largest, outermost organ of the human body, accounting for 
approximately 15% of the total body weight in adults. It acts as a 
multifunctional barrier between the body and the environment, mainly to 
protect the human body against external physical, chemical and biological 
factors. By serving as an anatomical barrier, the skin prevents pathogenic 
invasion of the body, controls the loss of fluids, absorbs the harmful, ultraviolet 
(UV) radiation from the sun, and has an immunological role in host defences. It 
also contributes to the thermo-regulation of the human body through radiation, 
convection and evaporation and plays a role in sensation to incoming stimuli of 
touch, pain, pressure, heat and cold and others. 
 
The skin is organised into two major compartments, the epidermis and the 
dermis, separated by the dermal-epidermal junction. Below the dermis is a fatty 
layer, known as the hypodermis, which attaches the skin to the rest of the body. 
This introduction focuses on the structure and the major components of the 
skin and briefly highlights the available knowledge with concerns to the 
interaction of hookworms and the skin. 
1.2.1 The epidermis 
The epidermis is the outermost layer of the skin which consists of terminally 
differentiated, stratified epithelium (Figure 1.4). The major cells, making up to 
95% of the total epidermal structure, are the keratinocytes in which keratin 
filaments form the cytoskeleton (Wolff and Schreiner, 1968; Mackenzie, 1975; 
Sun and Green, 1978). Based on the arrangement of epidermal cells, the 
epidermis can be divided into four morphologically distinct layers (Holbrook 
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and Odland, 1975; McGrath et al, 2008), comprising from the inside to the 
outside: 
 
- The basal layer, also known as the stratum basale, which is 
characterised by small and cubical cells with large, dark nuclei, dense 
cytoplasm and tono-filament keratin bundles. The basal cells, mainly 
keratinocytes and stem cells, form a single layer by aligning perpendicularly to 
the underlying basement membrane to which they attach through the 
hemidesmosomes. Hemidesmosomes are asymmetrical cellular structures 
capable of anchoring cells to the underlying extracellular matrix through 
integrin adhesion proteins (Shienvold and Kelly, 1976). Epithelial cells are 
generated at the basal layer by mitotic divisions, and new cells migrate 
outwards to form the prickle cell layer (Yasuno et al, 1980).  
- The prickle cell layer, also known as the stratum spinosum, is a 
multilayered region (5 to 15 layers) which contains larger, polygonal 
keratinocytes with eosiniphilic cytoplasm and vesicular nuclei (Staiano-Coico 
et al, 1986). 
- The granular layer, also known as the stratum granulosum, which is 
characterised by flattened keratinocytes with dense, keratohyalin granules 
made of histidine-rich proteins (such as profilaggrin) and keratin (Lavker and 
Matoltsy, 1971). Lamellar bodies, which migrate to the periphery of cells in the 
granular layer, are involved in the desquamation process as they discharge of 
their lipid components into the intercellular space which contributes to the 
formation of the cornified envelope (Odland and Holbrook, 1981; Odland, 
1991). 
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- The horny layer, also known as the stratum corneum, is the outermost 
layer of the epidermis where cells, now flattened corneocytes, are devoid of 
nucleus and cytoplasmic organelles. The cornified envelope, which is made of 
cross-linked proteins from the keratohyalin granules, contributes to the barrier 
properties of the skin (Lynley and Dale, 1983; Ishida-Yamamoto and Iizuka, 
1998).  
 
The cellular diversity within the epidermis represents 5 to 10% of the total, 
with each type playing a role in the skin. Langerhans cells are mobile, dendritic 
antigen presenting cells which originate from the bone marrow. These cells are 
capable of accumulating foreign antigens and presenting them to naïve T-cells, 
in the basal layer, and therefore are thought to play a role in recognition and 
defence against foreign pathogens (Kiistala and Mustakallio, 1968; Girolomoni 
et al, 2002). In addition, the epidermis contains melanocytes which produce 
melanin and donate pigment to the keratinocytes (Szabo, 1954; Jimbow et al, 
1976), and Merkel cells which form synaptic junctions with dermal sensory 
axons and seem to serve as mechano-receptors (Kidd et al, 1971; Lacour et al, 
1991).  
1.2.2 The dermal-epidermal junction 
The epidermis is anchored to the underlying dermis through the dermal-
epidermal junction, also known as the basement membrane, which is 
synthesised by basal keratinocytes and dermal fibroblasts. The junction 
provides mechanical support for epidermis and plays an additional role during 
wound healing and inflammatory processes by regulating the exchange of large 
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molecules and cell trafficking (Heaphy and Winkelmann, 1977; Schechter, 
1989). 
The dermal-epidermal junction is composed primarily of laminin and collagen 
IV, the structural scaffolds of all basement membranes, which align in four 
distinct layers comprising, the cell membrane through which basal 
keratinocytes attach to the underlying layers, the lamina lucida, the lamina 
densa, and the sub-basal lamina which is directly connected to the dermis. 
Anchoring filaments, made of either collagen XVII or collagen VII, connect 
these layers and maintain the integrity of the junction (Ghohestani et al, 2001). 
1.2.3 The dermis 
The dermis is a dense connective tissue layer which originates from the dermal 
fibroblast and contains the vascular network, glands i.e. sweat and sebaceous, 
and the hair follicles (Figure 1.4). The main structural macromolecules of the 
dermis are collagens, elastin, fibronectin and laminin, arranged in the 
extracellular matrix, primarily contributing to the structural complexity and 
multifunctional nature of the skin (Pearce, 1968; Swanson and Helwig, 1968). 
The dermis provides a mechanical support for the overlaying epidermis and is 
structurally divided into two main areas (Briggaman and Wheeler, 1968; 
Rodrigo and Cotta-Pereira, 1979): 
 
- A superficial, papillary region, connected to the epidermis through the 
dermal-epidermal junction. The layer is composed of collagen fibres arranged 
in loose bundles and of thin elastic fibres anchored to the junction. 
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- A deep, reticular region, made of coarser collagen bundles and thicker 
elastin fibres and accounting for the strength, extensibility, and elasticity of the 
dermis.  
 
The dermis has a rich vascular network which plays a key role in thermo-
regulation, wound healing, and immunological defences. Cutaneous vessels, 
which originate from the underlying muscle vasculature, traverse the dermis 
vertically forming a superficial plexus at the interface between the papillary 
and reticular layers, and a deep plexus lying close to the hypodermis and 
providing nutritional supply to sweat glands and hair follicles (Yen and 
Braverman, 1976; Braverman, 2000). The dermis also contains a lymphatic 
system with an active role in the protection of the body against invasive 
pathogens. The major cellular constituents of the dermis are fibroblasts, which 
mainly reside in the papillary region and are responsible for the synthesis of all 
types of fibres in the connective tissue (Saalbach et al, 1996). Other cells in the 
dermis are associated with immunological functions and include dermal 
dendrocytes (Narvaez et al, 1996), Langerhans cells, mast cells, microphages 
and T-cells (Bos and Kapsenberg, 1995). 
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Figure 1.4 Micrograph showing the histology of the skin. 
From http://faculty.irsc.edu/FACULTY/TFischer/Default.htm.  
 
1.2.4 Extracellular matrix 
The extracellular matrix (ECM) is the fundamental element of all connective 
tissues which is composed of structural fibres, embedded in an interlocking 
mesh, known as the ground substance. The latter consists mainly of water, for 
communication and transport purposes between tissues, and a complex of 
glycosaminoglycans (GAGs), such as heparin sulfate, which forms 
proteoglycans when attached to matrix proteins particularly, perlecan and 
collagen XVIII (Del Forno et al, 1978). The ground substance also comprises 
hyaluronic acid, a non-proteoglycan polysaccharide which serves as cell to cell 
adhesion bridges and regulates cell behaviour during healing, inflammation and 
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tumor development (Miyake et al, 1990). In this context, Necator americanus 
have been shown to secrete a wide range of proteolytic enzymes capable of 
degrading the main fibrous and non fibrous components of the dermis (Hotez et 
al, 1990; Kumar and Pritchard, 1992a; Brown et al, 1999), including: 
1.2.4.1 Collagen 
Collagen is the most abundant constituent of the extracellular matrix, 
accounting for about 98% of the total mass of the dried dermis. To date, the 
skin has been associated with the largest diversity of collagens, with over ten 
types divided based on their structure and function into two main subgroups 
(Garrone et al, 1997): fibril and FACIT, fibril-associated collagens with 
interrupted helices (Gordon and Olsen, 1990).  
 
Fibril collagens, including types I, III and V, are characterised by a long central 
triple helical domains with a periodicity of 64²67 nm and Glycine-X-Y 
repeating sequences (Garrone et al, 1997; Ruggiero et al, 2005). Collagens I 
and III, being the major constituents of the dermis, co-exist as individually 
banded fibrils that are loose in the papillary region and become thicker in the 
reticular region of the dermis, hence accounting for their resistance to 
proteolytic degradation and maintaining the stability of the skin. Collagens V, 
VI and VII have also been shown to occur in the form of fibrils and serve as 
molecular bridges with a role to play in anchoring principal fibres to the 
surrounding matrix components and cells (Fichard et al, 1997). Collagen V has 
been detected in the dermis, forming heterotypic fibrils with collagens I and III, 
and occasionally in the dermal-epidermal junction with a potential function 
during cell migration to the epidermis (Ruggiero et al, 1994; Garrone et al, 
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1997). Although less abundant, collagen VI is believed to play an important 
role in bridging elements in the dermis such as cells and proteoglycans 
(Bonaldo et al, 1990; Tillet et al, 1994), while the presence of collagen VII at 
the dermal-epidermal junction is involved in anchoring fibril components of 
the junction (Ruggiero et al, 2005).   
 
Unlike other types of collagen, collagen IV is a non fibrillar molecule, from the 
FACIT group which forms the framework of the dermal-epidermal junction 
and basement membranes around blood vessels, nerves and dermal appendages 
(Timpl, 1996). Collagen IV is primarily involved in securing the basement 
membrane and dermal cells into the dermis and maintaining the integrity of the 
dermal-epidermal junction. The FACIT group also include collagens XII and 
XIV (Van der Rest and Garrone, 1991) and collagen XVI (Ruggiero et al, 
2005). These collagens are preferentially distributed in tissues containing 
banded collagen I fibrils, including the dermis, and are believed to mediate 
interactions of collagenous fibrils and possibly mediate cell-matrix adhesion 
during development (Brown et al, 1993; Nishiyama et al, 1994). 
1.2.4.2 Elastin 
Elastin, a component of the connective tissue, is responsible for retractile 
properties of the dermis and provides elasticity to the skin, lungs, tendons and 
blood vessels. Elastin is synthesised by dermal fibroblasts as proelastin which, 
upon proteolytic degradation, leads to the formation of tropoelastin, the 
monomer of elastin fibres (Smith and Wood, 1991). Tropoelastins are then 
deaminated, upon contact with a mature elastin fibre, allowing these molecules 
to be cross-linked to the elastin strand (Plopper, 2007). Elastin fibres, which 
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are thin in the papillary dermis become thicker in the reticular dermis and 
interweave between collagen fibres to prevent overstretching and subsequent 
damage to the skin structure.    
1.2.4.3 Fibronectin 
The extracellular matrix is rich in fibronectin, a multifunctional glycoprotein 
with a major role in cellular adhesion (Ruoslahti, 1988), growth and wound 
healing (Peltonen et al, 1989) and cross-linking of the matrix fibres. It consists 
of two similar polypeptide chains, which by enfolding in several domains, 
mediate binding to cell surface receptor molecules from the integrin family 
(Yamada, 1988) and collagen fibres (Timpl and Martin, 1997). By binding to 
collagens and cell surface integrins, fibronectin facilitates cell movement 
during tissue injury and wound healing by triggering reorganisation of the 
cellular cytoskeleton.  
1.2.4.4 Laminin 
Laminin, a non-collagenous glycoprotein, is an essential constituent of all 
basement membranes which promotes a variety of biological functions 
including cell adhesion, cross-linking of extracellular molecules (Terranova et 
al, 1980; Sollberg et al, 1992; Timpl and Brown, 1996), proliferation and 
differentiation, as well as neurite outgrowth (Martin and Timpl, 1987). 
Laminin, synthesised by keratinocytes and dermal fibroblasts, is capable of 
interacting with collagen IV, nidogen and heparin sulfate proteoglycan through 
the multi-domain structure of this protein which also have high affinity for 
some cell types such as endothelial and epithelial cells (Marinkovich et al, 
1992; Nishiyama et al, 2000). Hence, laminin plays an essential role in 
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anchoring the dermal-epidermal junction to the surrounding tissue and 
stabilising the skin layers.  
1.2.5 Necator americanus and the human skin    
Necator americanus larvae penetrate the skin using mechanical forces and 
enzymatic activities to migrate through the different layers and gain access to 
WKH KRVW¶V PLFURFLUFXODWLRQ 0DWWKHZV ; Kumar and Pritchard, 1992). 
Larvae have been shown to remain in the skin of mice for up to 48 hours post-
infection (Figure 1.5) (Behnke et al, 1986; Hawdon et al, 1993), during which 
time they resume larval feeding and reactivate developmental changes to 
facilitate the parasitic invasion of the host (Hawdon et al, 1993; Hawdon and 
Hotez, 1996). Necator americanus secrete a repertoire of proteolytic enzymes 
which allow them to degrade collagens I to V, elastin, laminin and fibronectin, 
the main components of the extracellular matrix and all basement membranes 
(Hotez et al, 1990; Kumar and Pritchard, 1992a; Brown et al, 1999; Loukas 
and Prociv, 2001; Williamson et al, 2006) and reach the dermal blood vessels.  
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Figure 1.5 Necator americanus larvae residing in the hamster skin. 
 
The skin is rich in vascular capillaries which consist of a single layer of 
endothelial cells, surrounded by a simple vascular basement membrane while 
the post-capillary venules have a similar structure with a multilayered 
basement membrane, allowing the later to accommodate inflammatory 
responses (Ruggiero et al, 2005). Entry into the blood circulation necessitates 
Necator americanus larvae to pass through the vascular basement membrane 
and negotiate the endothelium, the innermost lining of all blood vessels and 
dermal capillaries which plays a major role in regulating the vascular 
permeability. In order to understand the work presented in this thesis, the 
reader is introduced to the endothelium and vascular permeability.  
ŻLarvae 
Epidermis  
Dermis 
50 µm 
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1.3 The endothelium 
The endothelium is the innermost cellular lining of the vasculature and the 
lymphatic vessels. As a selective, semi-permeable barrier, the endothelium 
plays an important role in maintaining vascular homeostasis (Stevens et al, 
2000; Aurrand-Lions et al, 2002) and regulating other physiological functions 
including permeability and cellular trafficking (Ruffer et al, 2004; Aird, 2007; 
Vandenbroucke et al, 2008), cell polarity (Bazzoni and Dejana, 2004), and 
signal transduction (Mehta and Malik, 2006).  
 
Endothelial cells express a considerable heterogeneity which is characterised 
by structural diversity across the vascular tree (Kumar et al, 1987; Garlanda 
and Dejana, 1997; Simionescu, 2000; Ruffer et al, 2004). The vasculature is 
lined with continuous, non-fenestrated endothelium, rich in tight junctions, in 
organs with a strict control of permeability between the blood and surrounding 
tissues, such as the brain, skin and heart, whereas fenestrated continuous 
endothelium is characteristic of vascular beds with increased transendothelial 
transport such as the pancreas, kidney, exocrine and endocrine glands and 
intestinal mucosa. The endothelium can also be sinusoidal, or discontinuous, 
which is found in vascular beds with selective filtration properties such as the 
liver, spleen and bone marrow (Rubin and Staddon, 1999; Aird, 2007). 
Endothelial heterogeneity is also evident within the microcirculation, where 
endothelial junctions are more restrictive in arterioles, therefore maintaining 
the laminar blood flow, compared with capillaries, the main site of molecular 
exchange, and less mature in post-capillary venules (Leach, 2002; Bazzoni and 
Dejana, 2004; Aird, 2007a). The latter, containing simple intercellular junction, 
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are therefore considered as the preferred site for cellular transport during 
inflammation (Muro et al, 2004; Miyasaka and Tanaka, 2004; Aird, 2007a), in 
response to permeability-increasing agents (Bazzoni and Dejana, 2004) and 
possibly during parasitic invasion. However, proteolytic activity of Necator 
americanus secretions is likely to mediate disruption of endothelial integrity at 
the molecular level, possibly allowing larvae to breach the endothelium at the 
capillary plexus. The structure of the endothelium and its role in regulating the 
vascular permeability are introduced here. 
1.3.1 Vascular permeability    
The endothelium is a semi-permeable, physical barrier which regulates the 
exchange of fluids, solutes, plasma proteins and macromolecules between the 
blood and the interstitial space, in a process known as vascular permeability. 
This is a continuous process that occurs at the microcirculation site, the 
capillaries, in two pathways, that is the transcellular and paracellular pathway 
(Lum and Malik, 1994; Leach, 2002). 
1.3.1.1 Transcellular permeability 
Transcellular transport or transcytosis, is a route by which macromolecules 
(less than 3 nm in diameter) and plasma proteins, such as albumin, are shuttled 
across the endothelium (Simionescu et al, 1978). Based on the physical 
properties of the transported molecules, transcytosis can be mediated by special 
structures, including caveolae (Predescu and Palade, 1993; Minshall et al, 
2002) and vesiculo-vacuolar organelles (VVOs). Caveolae, 70 nm membrane-
bound vesicles, are particularly prevalent in capillaries and transport molecules 
from the luminal space either by non-specific fluid-phase uptake (Vogel et al, 
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2001; Schubert et al, 2001) or via receptor-dependent binding to the molecule 
(Dejana et al, 1999; Minshall et al, 2002; Aird, 2007). Albumin, for instance, 
has been shown to bind to a 60 kDa endothelial cell surface glycoprotein, gp60, 
which is believed to initiate transcytosis (Minshall et al, 2002). Caveolae, 
which pinch off and shuttle across the cytoplasm, merge with the membrane 
and liberate their content on the abluminal side of the endothelium. VVOs, on 
the other hand, are specifically present in venular endothelial cells and consist 
of groups of vesicles, possibly arising from the fusion of individual caveolae to 
allow transport across the much thicker cytoplasm of venular endothelium 
compared with capillaries (Dvorak and Feng, 2001; Aird, 2007). Transcellular 
channels may also be involved in transport of amino acids, glucose and other 
ions including nitric oxide and prostacyclin (Bazzoni, 2006). 
 
 
Figure 1.6 Permeability pathways through the vascular endothelium.  
A) Capillaries mediate transfer of solutes and fluids between blood and 
underlying tissue. Water and small solutes pass through the intercellular 
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cleft, whereas larger solutes pass through endothelial cells either via 
transendothelial channels or transcytosis which is primarily mediated by 
caveolae. B) In response to inflammation, post-capillary venules 
accommodate inducible transfer of water and solutes through the 
paracellular route which involves formation of gaps between endothelial 
cells (I), and/or the transcellular route (II) through VVO-mediated 
formation of transcellular channels ( Adapted from Aird, 2007).  
    
1.3.1.2 Paracellular permeability 
The paracellular pathway is a structural equivalent of the 'small pore' theory, 
which explains transport of hydrophilic solutes through the endothelium 
(Pappenheimer et al, 1951). Paracellular transport was first reported by Majno 
and Palade (1961) and supported through tracer studies by Williams et al 
(1975). Anatomically, paracellular channels made of an intercellular junction 
complex, are located between adjacent endothelial cells and act as a regulated 
barrier for passive diffusion of fluids and small, hydrophilic solutes as well as 
cell trafficking through the paracellular space (Bazzoni and Dejana, 2004; 
Aird, 2007). Adhesion of endothelial cells, through the paracellular junctions, 
also mediates cellular communications and cross-talking which maintains the 
homeostatic balance and regulates other physiological functions in the 
endothelium such as proliferation and survival (Hordijk et al, 1999; Edens and 
Parkos, 2000; Taddei et al, 2008; Vandenbroucke et al, 2008). Paracellular 
permeability is therefore an essential measure to evaluate the integrity of the 
endothelium and its physiological importance as an active barrier between the 
blood and the surrounding tissues.    
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Techniques used to analyse paracellular permeability are based on the 
biophysical properties of the endothelium and include the transendothelial 
electrical resistance (TEER) and tracer flux across the endothelial layer 
(Spring, 1998; Bazzoni and Dejana, 2004). Resistance, which is calculated 
XVLQJ 2KP¶V ODZ is based on the ability of ionic currents in the aqueous 
medium to carry a pulse of an electrical current across the endothelial 
monolayer, and is measured as the change in voltage between the apical and 
basal compartments of the cell layer (Rutten et al, 1987). Tracer flux, however, 
is used to determine the flow of non-electrolyte, tracers which usually are not 
transported by the paracellular routes. Fluorescent albumin or dextrans, of 
known molecular weight, are the most common tracers used to determine the 
size of the paracellular pathways as a function of their molecular size and 
radius (Huxley and Curry, 1991; Balda et al, 1996; Minshall et al, 2002). 
TEER and tracer fluxes are often inversely related, and used as indicative of 
the integrity of the paracellular junctions and the barrier properties of the 
endothelium (Bazzoni and Dejana, 2004).  
1.3.2 The molecular organisation of the endothelial cell to cell junctions 
Inter-endothelial cell junctions are specialised regions of the endothelial 
membrane, where cells come into close contact to establish structural integrity 
and regulate endothelial permeability (Leach and Firth, 1995; Vestweber, 
2000; Dejana et al, 2000; Dejana et al, 2008). Permeability, which is regulated 
by the dynamic opening and closing of these adhesive structures, is mediated 
by adhesion molecules which are primarily organised into two classical groups, 
adherens and tight junctions (Karnovsky, 1967; Karnovsky, 1968; Dejana et al, 
1995). Adhesion, in both junctions, is mediated by transmembrane proteins 
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which promote homophilic interactions between adjacent cells as well as 
promoting stabilisation and dynamic control of these junctions by binding to 
cellular cytoskeleton (Gonzalez-Mariscal et al, 2008; Dejana et al, 2009). Gap 
junctions, which are also present in the endothelium, are not involved in the 
control of permeability (Dejana et al, 2009) and will not be addressed here.  
1.3.2.1 Adherens junctions 
Adherens junctions (AJs), representing the majority of junctions within the 
endothelial barrier, are cellular membrane contacts formed by transmembrane 
glycoproteins of the cadherin family (Dejana et al, 1995; Ruffer et al, 2004; 
Villasante et al, 2007). Cadherins are single-chain transmembrane proteins 
which mediate homophilic, calcium dependent adhesion and are able to form 
multimeric complexes with cytoplasmic binding proteins (Bazzoni and Dejana, 
2004; Villasante et al, 2007). Vascular endothelial (VE) cadherin, the major 
constituent of AJs in the vascular endothelium, is expressed in essentially all 
vessels (Lampugnani et al, 1992; Ayalon et al, 1994; Bazzoni and Dejana, 
2004), whereas neuronal (N) cadherin is distributed diffusely over the cell 
surface, possibly maintaining endothelial integrity by anchoring endothelial 
cells to other cell types expressing N-cadherin (such as pericytes), and 
therefore has no major role to play in regulating endothelial permeability 
(Lampugnani and Dejana, 1997, Hordijk et al, 1999).  
 
VE-cadherin, also known as cadherin-5 or CD144, is structured in an 
extracellular domain, consisting of five calcium binding repeats that associate 
homophilically with VE-cadherin on the adjacent cell (Lampugnani et al, 1995; 
Hordijk et al, 1999; Vandenbroucke et al, 2008). The cytoplasmic tail of VE-
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cadherin comprises a C-terminal domain (CTD) which forms complexes with 
ȕ-catenin and plakoglobin Ȗ-catenin), linking VE-FDGKHULQWRĮ-catenin, which 
in turn is anchored with the actin cytoskeleton to promote stabilisation of the 
junctional complex (Lampugnani et al, 1995; Dejana et al, 2000) while the 
juxtamembrane domain (JMD) binds p120-catenin to further stabilise AJs by 
anchoring VE-cadherin with endothelial microtubules, known as kinesin 
(Lampugnani et al, 1995). Dynamic interactions between the AJs proteins and 
the actin cytoskeleton are believed to maintain the stability of AJs and regulate 
junctional permeability while microtubules are believed to ensure the stability 
of the cytoskeleton by connecting actin filaments to other cellular components 
and mediating dynamic cellular processes including the opening and closing of 
these junctions (Figure 1.7) (Dejana et al, 2008; Vandenbroucke et al, 2008). 
The association of VE-cadherin with desmosomal proteins including 
desmoplakin and vimentin is mediated by plakoglobin, forming desmosomal-
like structures at the membrane which are known as complexus adherentes 
(Kowalczyk et al, 1998; Schmelz et al, 1994). These structures are specific for 
endothelial cells mostly in the lymphatic vessels (Girard and Springer, 1995), 
and therefore will not be addressed in this work. 
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Figure 1.7 Molecular structure of endothelial cell to cell junctions 
(Adapted from Leach et al, 2009). 
 
Besides VE-cadherin, nectin-afadin complex which binds to the actin 
F\WRVNHOHWRQ WKURXJK Į-catenin, co-localises with cadherins and may be 
involved in the assembly of AJs (Bazzoni and Dejana, 2004). Other junctional 
proteins such as VE-cadherin-2, which shows similar homology and adhesive 
properties to the cadherin family, has been identified at the AJs but had no 
ability to modulate vascular permeability or interact with cellular signalling 
pathways (Telo et al, 1998).  
1.3.2.2 Tight junctions 
Tight junctions (TJs), or zonula occludens, form a very close contact between 
adjacent endothelial cells representing around 20% of total inter-endothelial 
junctional complexes (Mehta and Malik, 2006). The density of TJs is believed 
to account for unique barrier properties within different vascular beds (Harhaj 
and Antonetti, 2004; Aird, 2007). For instance, the blood brain barrier and 
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arteries, which require a strict control of permeability, are rich in well 
organised TJs, whereas these junctions are poorly developed in post-capillary 
venules, which accommodate the dynamic transport of immune cells and 
plasma proteins during inflammation (Bazzoni et al, 1999; Bazzoni and 
Dejana, 2004).  
 
Structural organisation of TJs comprises two principal groups; the tetrahelical 
molecules including occludin (Furuse et al, 1993) and claudins (Furuse et al, 
1998), and the immunoglobulin gene superfamily involving junctional 
adhesion molecules (JAMs) (Dejana et al, 2000; Aurrand-Lions et al, 2002). 
While occludin is considered as an accessory junctional protein (Furuse et al, 
1993; Leach, 2002; Harhaj and Antonetti, 2004), claudins (especially claudin-
5) are a large family of transmembrane proteins which form the building units 
of tight junctional strands (Furuse et al, 1998; Bazzoni, 2006). Both occludin 
and claudins are structured in four membrane-spanning domains (Jiang et al, 
1998), two extracellular loops through which they interact homophilically and 
heterophilically, therefore contributing to the assembly of endothelial TJs 
(Mehta and Malik, 2006), and two cytoplasmic termini which are capable of 
interacting with the zonula occludens ZO-1 and other actin binding proteins 
(Figure 1.7) (Furuse et al, 1994; Ruffer et al, 2004). Through their interaction 
with ZOs and actin cytoskeleton, both occludin and claudins establish an 
essential role in promoting better stability of inter-endothelial junctions and in 
regulating paracellular permeability (Bazzoni and Dejana, 2004; Bazzoni, 
2006; Vandenbroucke et al, 2008). Junction adhesion molecules (JAMs), 
mono-spanning membrane proteins with two extracellular immunoglobulin 
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domains and a short cytoplasmic tail, represent the third class of TJs associated 
integral proteins (Bazzoni and Dejana, 2004; Weber et al, 2007). To date, four 
members of the JAM family have been identified in endothelial cells (JAM 1²
3 and endothelial cell-selective adhesion molecule, ESAM), all capable of 
establishing homophilic and heterophilic interactions (Bazzoni and Dejana, 
2004; Dejana et al, 2009), which is likely to be involved in TJs assembly as 
well as in regulation of paracellular permeability and cellular trafficking 
(Mehta and Malik, 2006). 
1.3.2.3 Intracellular and non-junctional proteins 
Endothelial cells express different proteins with adhesive properties which are 
localised either outside the junctions or in the cytoplasm. Two proteins, which 
have been extensively studied, are reviewed here. However, it is worth noting 
that a set of other proteins including actin polymerising formin (Goode and 
Eck, 2007), vasodilator-stimulated phosphoprotein, VASP (Huttelmaier et al, 
1999), vinculin (Wilkins and Lin, 1986) and cingulin (Cordenonsi et al, 1999) 
which are localised outside the AJs and TJs, form connections between actin 
cytoskeleton and junctional molecules to provide mechanical stability of inter-
endothelial junctions and maintain the integrity of the endothelium (Mehta and 
Malik, 2006). 
 
Platelet endothelial cell adhesion molecule (PECAM-1 or CD31) is a member 
of the immunoglobulin superfamily, which plays a major role in leukocyte 
transendothelial migration and permeability regulation (Albelda et al, 1991; 
DeLisser et al, 1994; Newman, 1999; Muller, 2003). PECAM-1, a mono-
spanning protein, exhibits six external immunoglobulin-like domains to 
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mediate homophilic interaction with circulating blood cells, which is thought to 
mediate leukocyte migration across the endothelium (Sun et al, 1996). In 
addition, PECAM-1 is capable of establishing heterophilic bindings, through 
its cytoplasmic tail, with matrix adhesion receptors such as integrins, to 
modulate cell adhesion and migration (Albelda et al, 1991; Jackson et al, 
1997). Through its cytoplasmic tail, PECAM-1 also associates with 
intracellular ȕ-catenin and protein tyrosine phophatase containing SRC 
homology-2 domain (SHP-2) which is likely to influence endothelial barrier 
integrity and intracellular signalling processes (Ilan et al, 2000; Bazzoni and 
Dejana, 2004; Mehta and Malik, 2006). 
 
Zonula occludens (ZOs) are members of the membrane associated guanylate 
kinase homologues (MAGUKs). ZOs (1²3) are known to stabilise tight 
junctions by means of bridging intracellular proteins with claudins, occludin 
and JAMs. However, recent evidence suggests that ZOs, particularly ZO-1 
could also bind to Į-catenin (Muller et al, 2005) and connexin-43 (Toyofuku et 
al, 1998), thus linking TJs through their cytoplasmic associated proteins to AJs 
and gap junctions, respectively (Bazzoni and Dejana, 2004). ZOs which form 
hetero-dimeric complexes either with actin cytoskeleton or with other members 
of the MAGUKs family through their multiple domains, including PDZ, SH-3 
and guanylate kinase (GUK), may play a potential role in modulation of 
intracellular adhesion and paracellular permeability (Mehta and Malik, 2006).  
1.3.3 Junctional structures regulate the vascular permeability 
Molecular heterogeneity, which is observed along the vascular tree, is an 
essential determinant of structural and functional differences in the 
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endothelium. TJs, which are predominant in vascular beds with a strict control 
of permeability such as the blood brain barrier and heart, are poorly developed 
in the post-capillary venules where most inflammatory responses take place. 
AJs and VE-cadherin in particular, play an important role in mediating and 
controlling site-specific permeability as evidenced by in vivo studies in which 
the systemic administration of blocking antibodies to VE-cadherin resulted in 
preferential alterations in vascular permeability in the lung and heart (Dejana et 
al, 2008; Dejana et al, 2009). Moreover, truncated VE-cadherin lacking its 
cytoplasmic tail was associated with partial disassembly of AJs and an 
incontrollable increase in permeability, further supporting the major role of the 
VE-cadherin-catenin complex in regulating endothelial permeability (Navarro 
et al, 1995; Dejana et al, 2008). AJs, which are known to interconnect with TJs 
at the intracellular level, possibly through ZO-1 and ZO-2 molecules, were 
found to control TJs by VE-cadherin-mediated upregulation of claudin-5, the 
building unit of endothelial TJs (Taddei et al, 2008). Therefore, VE-cadherin 
expression is a crucial factor which determines the junctional stability and 
regulates vascular permeability.  
 
Endothelial junctions are dynamic structures which undergo continuous 
remodelling and maintenance in rest and upon exposure to haemodynamic 
stimuli (Dejana et al, 2009). Paracellular exchange, which is controlled by the 
opening and closing of these junctions, is associated with dynamic contractions 
resulting in small gaps at the cellular cleft without complete cell separation 
(Figure 1.8, A and B) (Dudek and Garcia, 2001). The contractile status of 
endothelial cells, as most other cells, is the result of myosin light chain (MLC) 
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phosphorylation which is mediated by MLC kinase (MLCK) in a 
Ca+2/calmodulin-dependent manner (Garcia et al, 1995), RhoA from the small 
GTPase Rho family which controls actin organisation (Noda et al, 1995; 
Yoshioka et al, 2007), and by vascular endothelial protein tyrosine phosphatase 
(VE-PTP), an endothelial receptor-type phosphatase that interacts specifically 
with VE-cadherin (Nawroth et al, 2002). MLC phosphorylation generates a 
contractile force which induces actin reorganisation and dissociation of VE-
cadherin homophilic and heterophilic interactions, forcing these molecules to 
be internalised (Mehta and Malik, 2006). VE-cadherin re-localisation to the 
surface is possibly modulated by cytosolic p120-catenin, which is considered 
as a crucial feedback mechanism promoting VE-cadherin expression and 
assembly of intact AJs (Xiao et al, 2003; Reynolds and Carnahan, 2004; 
Vandenbroucke et al, 2008). Upon VE-cadherin re-establishment in AJs, 
members of the GTPases Rho family including Cdc-42 and Rac-1 are activated 
to further stabilise AJs by anchoring VE-cadherin with the actin cytoskeleton. 
Activated Cdc-42 and Rac-1 also inhibit the binding of IQRas GTPase 
activating protein (IQGAP-WRȕ-catenin, thereby enhancing the accessibility 
RIȕ-catenin to its partners including VE-cadherin, p120-FDWHQLQDQGĮ-catenin, 
and regulating AJs assembly (Mehta and Malik, 2006). An additional binding 
of VE-cadherin with vascular endothelial growth factor receptor (VEGFR-2) 
forms a multiprotein complex which limits its internalisation and improves the 
junctional stability (Lampugnani et al, 2006).  
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Figure 1.8 Mechanism of gap formation and inducible permeability in 
the endothelium. A) VE-cadherin associates with S ȕ-FDWHQLQ ȕFDW
and plakoglobin (plako) which in turn bind to DFWLQILODPHQWVWKURXJKĮ-
catenin (Į-cat). B) Phosphorylation (P) of VE-cadherin complex mediates 
VE-cadherin internalisation and increased vascular permeability. C) 
Inducible permeability is mediated by formation of intercellular gaps 
which is caused by cell retraction (Adapted from Dejana et al, 2008). 
 
TJs assembly is partially regulated by an atypical protein kinase C (PKC) in 
complex with other intracellular proteins such as Cdc-42 from the GTPase Rho 
family and PAR-3/PAR-6, the PDZ-containing proteins (Ruffer et al, 2004; 
Bazzoni and Dejana, 2004). JAM-3, which is known to increase endothelial 
permeability when expressed in endothelial cells, plays a potential role in 
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promoting continuous organisation and maintenance of TJs (Orlova et al, 
2006). Phosphorylation of TJs components by ZO-1-associated kinase (ZAK), 
protein kinase C (PKC) affecting ZO-1 and casein kinase II, which acts on 
occludin molecules, induces reorganisation of TJs and modulate junctional 
permeability. In addition, phosphorylation of AJs and actin cytoskeleton by 
protein kinase C (PKC) and GTPases (Rho and Rac), indirectly affect the 
stability of TJs, therefore contributing to regulation of vascular permeability 
(Bazzoni and Dejana, 2004). 
1.3.4 Modulation of vascular permeability 
The endothelium is capable of meditating inducible permeability in response to 
patho-physiological factors affecting endothelial cells (Figure 1.8, C). 
Inflammation, both in acute and chronic conditions, occurs predominantly in 
post-capillary venules where junctional complexity is low (Mehta and Malik, 
2006; Aird, 2007a). Most permeability-related studies use endothelial cells 
from large vessels such as the human umbilical vein (HUVEC) as they are 
easily obtainable and grown in vitro. The HUVEC model, as primary 
endothelial cells, is known to maintain the basic properties of all endothelial 
cells, including plasticity and molecular structure, and is generally used in vitro 
to mimic endothelial activity in vivo (Aird, 2007). Other cell lines, such as 
human dermal microvascular endothelial cells (HDMEC) and immortalised 
human microvascular endothelial cells (HMED-1), have been shown to express 
distinct phenotypic differences compared to HUVEC model, and are usually 
used to investigate site-related characteristics of the endothelium (Swerlick et 
al, 1992; Xu et al, 1994; Bonnefoy et al, 2001). A typical increase in vascular 
permeability, which is controlled by a dynamic balance of junctional 
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complexes and contractile forces (Dudek and Garcia, 2001), is usually 
mediated by phosphorylation of junctional proteins causing their dissociation 
from the actin cytoskeleton and possibly the formation of frank¶V intercellular 
gaps (Budworth et al, 1999; Andriopoulou et al, 1999; Bazzoni and Dejana, 
2004). Stimulation of endothelial cells by permeability increasing agents has 
been shown to target the adhesive VE-cadherin-catenin complex, emphasising 
the crucial role of VE-cadherin in regulating endothelial permeability. 
  
Vascular endothelial growth factor (VEGF) is an endothelial-specific mitogen 
which plays an important role in angiogenesis during development of the 
vasculature. VEGF induces an increase in vascular permeability, evidenced by 
in vivo studies in which exogenous administration of VEGF induced 
fenestration in vascular beds that normally do not have fenestrae including 
capillaries and venules of skin (Roberts and Palade, 1995). VEGF binds to 
VEGF receptors 1²3 on endothelial cells which initiates phosphorylation of 
VE-cadherin by kinases from the SRC family leading to the internalisation of 
VE-cadherin molecules and a subsequent increase in permeability (Wright et 
al, 2002; Weis et al, 2004; Gavard and Gutkind, 2006). VEGF also activates 
tyrosine phosphorylation of VE-cadherin and its associates, ȕ-catenin and 
p120-catenin, which in turn induces actin reorganisation and alters junctional 
structure and permeability (Esser et al, 1998; Dejana et al, 2008). 
 
Thrombin, a serine protease primarily involved in the coagulation cascade, is 
known to bind protease-activated receptor (PAR)-1 on endothelial cells causing 
an increase in vascular permeability and cellular trafficking during an 
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inflammation. Activation of PAR-1 initiates multiple phosphorylation cascades 
including myosin light chain (MLC) phosphorylation (Garcia et al, 1995; Verin 
et al, 2001), RhoA and protein kinase C (PKC) phosphorylation of VE-
cadherin complexes (Sandoval et al, 2001; Bogatcheva et al, 2002; 
Vandenbroucke et al, 2008). Disassembly of VE-cadherin junctional complex, 
including dissociation of SHP-2 phosphatase (Bazzoni and Dejana, 2004), is 
followed by internalisation of VE-cadherin which induces reorganisation of the 
actin cytoskeleton leading to cellular contraction and formation of intercellular 
gaps, which in turn is associated with increased vascular permeability (Mehta 
and Malik, 2006).  
 
Junctional complexes, VE-cadherin in particular, have shown susceptibility to 
proteolysis which is said to promote junctional disruption and modulate 
vascular permeability (Bazzoni and Dejana, 2004; Dejana et al, 2008). 
Thrombin and dengue virus infection have been shown to activate endothelial 
cells, promoting the production of acute inflammatory cytokines including IL-6 
(Day et al, 2006; Dewi et al, 2008) and IL-8 (Talavera et al, 2004), which in 
turn triggers tyrosine phosphorylation of junctional molecules (Nwariaku et al, 
2004) and modulate endothelial permeability. In addition, neutrophil derived 
proteolytic activities and gingipains, cysteine proteases derived from 
Porphyromonas gingivalis, have been shown to mediate increased vascular 
permeability and enhanced transmigration of monocytes through disruption of 
endothelial junctions and production of IL-8 (Lukacs et al, 1995; Moll et al, 
1998; Inomata et al, 2007). Protease-related alterations in the vascular 
permeability are also associated with reorganisation of actin filaments and 
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formation of intercellular gaps in the endothelial barrier as previously 
described (Blum et al, 1997; Moll et al, 1998; Hordijk et al, 1999; Young et al, 
2003). For instance, Schistosoma mansoni enzymatic extracts were shown to 
mediate paracellular permeability through a cAMP/protein kinase A pathway 
leading to increased phosphorylation of the MLCK (Trottein et al, 1999). For 
the reasons outlined above, this thesis addresses the interaction between 
Necator americanus larval enzymes and the endothelium and the effects of 
these parasites on vascular permeability.  
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Hypothesis and Aims 
 
The hypothesis of this thesis proposes that Necator americanus L3 larvae 
produce exsheathing and secretory enzymes to negotiate the skin and breach 
the paracellular integrity of the endothelium, the innermost lining of dermal 
vasculature, allowing larvae to gain access to the bloodstream. 
 
The primary aims of this work were: 
 
- To study the enzymatic profiles of Necator americanus larval 
exsheathing fluid (EF) and excretory/secretory (ES) products.  
- To investigate the effects of larval EF and ES products on extracellular 
(ECM) and skin macromolecules. 
- To study the interaction of larval EF and ES products with monolayers 
of human umbilical vein endothelial cells (HUVEC) as an ''in vitro'' 
model of the endothelium, specifically by investigating their effects on 
paracellular integrity of the endothelial barrier and the molecular 
mechanisms employed therein. 
 
  
 51 
 
 
 
 
 
 
 
 
 
 
2. Characterisation of Necator americanus larval products 
 
Chapter 2: Characterisation of Necator americanus larval products 
 
 52 
2.1 Introduction 
Although Necator americanus larvae are believed to infect the human host 
both mechanically and by secreting a mixture of enzymes (Kumar and 
Pritchard, 1992a; Loukas and Prociv, 2001), knowledge of the mechanisms by 
which these parasites enter the underlying vasculature is not well documented. 
Necator americanus larvae have been shown to express a wide range of 
enzymatic secretions, presumably with roles to play in the infection process 
(Matthews, 1975; Kumar and Pritchard, 1992; Williamson et al, 2004). 
Characterisation of these secretions is therefore crucial to understand their 
impact in the context of negotiating the human vascular endothelium. 
 
Classification of Necator americanus larval proteases was previously 
investigated using protease inhibitors against distinct classes of proteases 
(Kumar and Pritchard, 1992a; Brown et al, 1999). Necator americanus 
infective larval excretory/secretory (ES) products have been shown to contain 
serine, cysteinyl, aspartyl, and metalloproteases (Kumar and Pritchard, 1992a; 
Brown et al, 1999; Quinnell et al, 2004) whereas cysteinyl proteases were the 
only proteolytic enzymes reported by Kumar and Pritchard (1992a) in Necator 
americanus exsheathing fluid (EF). Metalloproteases such as aminopeptidases 
have been previously detected in the intestine of Necator americanus adult 
worms (McLaren et al, 1974) and later identified in the exsheathing fluid of the 
blood feeding nematode, Haemonchus contortus (Rogers and Brooks, 1978), 
setting a potential role for these enzymes to play in the exsheathment and 
penetration processes of the human hookworm Necator americanus.  
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Most of these proteases are gelatinolytic in nature (Kumar and Pritchard, 
1992a) and have an ability to degrade a number of skin macromolecules 
(Brown et al, 1999) and host haemoglobin (Williamson et al, 2003). Therefore, 
investigating the proteolysis of both gelatin and haemoglobin would be of 
major importance in describing protease profiles of larval enzymatic mixtures 
and determining their involvement in the process of infection. Casein, labelled 
with fluorescein isothiocyanate would also be beneficial as a quantitative 
indicator of proteolytic activities through the precise and sensitive 
measurement of casein degradation (Twining, 1984).  
 
The work presented here aimed at producing a detailed profile of Necator 
americanus larval proteases using protein and substrate gel electrophoresis and 
enzyme assays. Further characterisation of larval products was performed using 
different protease inhibitors. Treatment of larval products with anti worm IgG 
antibodies was also conducted to investigate their possible protective role 
against Necator americanus infection. 
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2.2 Methods 
2.2.1 Culture of infective Necator americanus larvae 
Infective Necator americanus larvae were cultured as described by Kumar and 
Pritchard (1992). Faecal material was collected from a Necator americanus 
infected individual, mixed with charcoal, 1% fungizone, and water to form a 
smooth paste which was applied as a thin layer on the upper half of 0.5 x 8 cm 
strips of Whatman chromatography paper. Each strip was then placed in a 15 
mL centrifuge tube (containing ~ 2 mL of distilled water) and incubated at 
room temperature for 8²10 days. The strips were carefully removed and the 
water containing the larvae transferred to a larger measuring cylinder. The 
larvae were allowed to settle for 1²2 hours and excess water was aspirated 
off. The concentrated larvae were washed extensively in RPMI 1640 medium 
containing penicillin (100 IU/mL), streptomycin (100 µg/mL) and 1% 
fungizone, counted (~ 3 live larvae/µL), and stored in the dark at room 
temperature until needed.  
2.2.2 Preparation of larval Necator americanus exsheathing fluid and 
excretory/secretory products 
Larval exsheathing fluid (EF) was prepared by bubbling carbon dioxide (100% 
CO2) through the larval suspension in media (RPMI 1640 medium containing 
penicillin (100 IU/mL), streptomycin (100 µg/mL) and 1% fungizone) for 2 
hours at room temperature. The media containing the EF was collected after 
centrifugation at 52 x g for 45 minutes, filter-sterilised and stored at -Û&7KH
H[VKHDWKHGODUYDHZHUHWKHQFXOWXUHGIRUDQDGGLWLRQDOKRXUVDWÛ&DQGWKH
excretory/secretory products (ES) were collected every 24 hours after 
Chapter 2: Characterisation of Necator americanus larval products 
 
 55 
centrifugation at 52 x g for 45 minutes. ES products were pooled, dialyzed 
against water for 4 KRXUV DW Û& ILOWHU-sterilised and stored at -Û& XQWLO
needed.  
 
The presence of lipopolysaccharide (LPS) in larval EF and ES products was 
estimated using an E-72;$7( NLW IROORZLQJ WKH PDQXIDFWXUHU¶V
recommendations and was not detected or else present at a level below the 
detection limits of this assay (0.015 EU/mL). 
2.2.3 Protein estimation 
The protein content of larval EF and ES products was estimated using the 
BioRad protein assay. A solution of bovine serum albumin (BSA) in media 
(RPMI 1640 medium containing penicillin (100 IU/mL), streptomycin (100 
µg/mL) and 1% fungizone) was used at a concentration of 25 mg/mL to 
prepare protein standards at a range of 0²25 µg/mL. In a 96 well Nunc plate, 
20 µL triplicates of BioRad protein dye reagent was added to 80 µL triplicates 
of both BSA standards and neat EF or ES samples. After mixing, the 
absorbance of all samples was measured using DYNEX MRX Microplate 
Reader at 595 nm. The absorbance of BSA standards was plotted against their 
known protein content and the protein concentrations of EF and ES samples 
were calculated using the equation of the standard curve. 
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2.2.4 Characterisation of Necator americanus larval products using 
Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis 
(SDS-PAGE) 
2.2.4.1 Preparation of SDS-PAGE gels 
In this project, proteins were separated on 10% acrylamide resolving gels under 
reducing conditions, unless otherwise described. Glass plates were carefully 
cleaned with distilled water, then ethanol and allowed to air-dry. To 12 mL of 
10% resolving gel solution, 60 µL of 10% ammonium persulphate (APS) and 6 
/RI1¶1¶1¶-tetramethylethylenediamine (TEMED) were added and the gel 
solution was quickly poured between the gel plates. Air bubbles were carefully 
removed by applying an overlay of tert-amyl alcohol (TAA) to the top surface 
of the gel and allowed to polymerise at room temperature for 1 hour. The gel 
was thoroughly washed with distilled water and excess moisture removed with 
filter paper before applying the stacking gel. For all SDS-PAGE gels, 1 mL of 
4% acrylamide solution was used as a stacking gel to which 10 µL of 10% APS 
and 4 µL of TEMED were added. A well forming comb was then inserted 
between the glass plates avoiding the formation of air bubbles and the stacking 
gel left to polymerise for 30 minutes.  
2.2.4.2 Sample preparation 
Samples were concentrated either by acetone or trichloroacetic acid (TCA) 
precipitation and loaded at 20 µg per lane. In brief, EF and ES samples were 
mixed with 1:4 (v/v) of ice cold acetone or 5:3 (v/v) of 5% TCA and 
precipitated overnight at 4Û&7&$RUDW-Û&DFHWRQH6DPSOHVZHUHWKHQ
centrifuged at 13000 x g for 10 minutes and the precipitate resuspended in 20 
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/RI[UHGXFLQJVDPSOHEXIIHU6DPSOHVZHUHUHGXFHGE\ERLOLQJDWÛ&
for 10 minutes and loaded onto the gel. Five to ten microliter of a protein 
molecular mass standard (EZ-Run Prestained Rec Protein Ladder) were also 
loaded on a single well per gel prior to running each gel at 20 mA constant 
current for 60²90 minutes, using BioRad PowerPac 200.  
2.2.4.3 Separation of proteins by two dimensional gel electrophoresis (2DE) 
EF and ES samples were concentrated as described above (using TCA) and 
approximately 100 µg of protein was resuspended in 125 µL of BioRad 
rehydration buffer. Samples were then loaded into the PROTEAN IEF focusing 
tray and ReadyStrip IPG strips (7 cm, pH 3²10) placed gel side down in the 
tray, avoiding the formation of air bubbles. Strips were overlaid with 2 mL of 
BioRad mineral oil and allowed to passively rehydrate overnight at room 
temperature. Isoelectric focusing (IEF) was programmed to commence 
automatically following rehydration with a maximum current of 50 µA/IPG 
VWULS DQG DQ HQG YROWDJH RI  9 DW Û& :KHQ WKH HOHFWURSKRUHVLV ZDV
completed, strips were drained for 5 seconds then transferred gel side up to a 
clean equilibration tray. Two milliliters of BioRad equilibration I with 2% 
dithiothreitol (DTT) and bromophenol blue was added to each IPG strip and 
the tray was gently shaken for 10 minutes. Buffer I was carefully discarded and 
replaced with 2 mL of BioRad equilibration buffer II with 2.5% iodoacetamide 
and bromophenol blue for 10 minutes. IPG strips were then dipped briefly in 
SDS-PAGE running buffer and placed gel side up on the back plate of a 10% 
SDS-PAGE gel. Strips were carefully pushed into the well, overlaid with 
0.25% agarose in 0.5 M Tris buffer (pH 6.8) and left for 5 minutes to allow the 
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agarose to solidify. Gels were then run at a constant current of 20 mA per gel 
for 60 minutes.  
2.2.4.4 Protein visualisation 
One and two dimensional SDS-PAGE gels were silver stained using a modified 
method by Yan et al (2000). Gels were washed three times in distilled water (5 
minutes per wash) prior to fixing in destain solution (25% methanol, 10% 
glacial acetic acid and distilled water) for 1 hour. To improve the contrast of 
the silver staining, gels were washed and left in distilled water overnight. Gels 
were then sensitized with 0.02% sodium thiosulphate for 1 minute and rinsed 
three times with distilled water (20 seconds each). 0.2% silver nitrate was 
added for 20²40 minutes and gels were washed twice (20 seconds each) and 
developed with a solution of 3% sodium carbonate, 0.05% formaldehyde and 
0.0004% sodium thiosulphate on an orbital shaker. The developer solution was 
discarded and the reaction stopped with 2% ethylene-diaminetetraacetic acid 
(EDTA) for 20 minutes. Finally, silver stained gels were washed and stored in 
distilled water if required.  
2.2.4.5 Protein identification 
Protein bands, separated on silver stained gels, were carefully excised and 
stored in PBS. Samples were analysed and proteins identified using matrix-
assisted laser desorption/ionization (MALDI) peptide mass fingerprinting as 
described by Gonnet et al (2003).    
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2.2.5 Detection of Necator americanus larval protease activity using 
substrate SDS-PAGE            
2.2.5.1 Preparation of substrate SDS-PAGE gels 
Following a method by Kumar and Pritchard (1992a), 10% substrate SDS-
PAGE gels were prepared by including 0.1% (w/v) of either gelatin or 
haemoglobin in the 10% resolving gel. Hyaluronidase activity was also 
assessed by incorporating 0.1% (w/v) of hyaluronic acid into a 12% SDS-
PAGE gel in a method modified from Hotez et al (1992). Substrate gels were 
run under non reducing conditions. EF and ES samples were concentrated 
using StrataClean Resin and centrifuged at 13000 x g for 10 minutes. Protein 
pellets were then resuspended in 20 µL of 2 x non reducing sample buffer 
ZLWKRXW'77LQFXEDWHGDWÛ&IRUPLQXWHVDQGORDGHGDW²10 µg per 
lane. Substrate gels were run at a constant current of 20 mA per gel for 60²90 
minutes then washed in 2.5% Triton X-100 for 20 minutes at room 
temperature. Gels were then washed twice in distilled water for 20 minutes 
each. 
2.2.5.2 Treatment of substrate SDS-PAGE gels 
After being washed, protease activity was observed by incubating substrate 
gels in phosphate buffered saline (PBS) with 5 mM of cysteine for 48 hours at 
Û&DQG UHIUHVKLQJ WKH EXIIHU HYHU\KRXUV 2WKHU VXEVWUDWH JHOVZHUH FXW
into individual strips, each strip was incubated with PBS/5 mM cysteine in the 
presence or absence of the protease inhibitors shown in Table 2.1, individually 
or in combination. Substrate gels containing hyaluronic acid were incubated in 
0VRGLXPDFHWDWHEXIIHUS+RYHUQLJKWDWÛ& 
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Table 2.1 Protease inhibitors used for substrate gel electrophoresis 
 
Protease inhibitors Concentrations used  
E64 (cysteine proteases) 1 µM, 100 µM 
Pepstatin A (aspartyl proteases)  1 µM, 100 µM 
1, 10- Phenanthroline (metalloproteases) 1 mM, 100 mM 
Phenyl methane sulphonyl fluoride 
(PMSF, serine proteases) 
1 mM, 100 mM 
 
2.2.5.3 Protein visualisation 
Larval protease activity was visualised by fixing substrate gels for 30 minutes 
in destain solution before being stained with 1% Coomassie Brilliant Blue 
R250 overnight while hyaluronidase activity was stained with 0.1% Stain-All, 
dissolved in 50% formamide. Activity was detected by destaining the gels for 
5²6 hours and was observed as clear bands against a blue background.   
2.2.6 Determination of Necator americanus larval protease activity using 
enzyme assays 
2.2.6.1 Preparation of Fluorescein Isothiocyanate (FITC) labelled casein 
Fluorescein isothiocyanate labelled casein was prepared by dissolving 1 g of 
casein and 40 mg of fluorescein isothiocyanate (FITC) in 100 mL of 50 mM 
sodium carbonate, 150 mM NaCl buffer, pH 9.6. The solution was stirred for 1 
hour at room temperature before being extensively dialysed against distilled 
ZDWHU IRUKRXUVDWÛ&7KHSURWHLQFRQFHQWUDWLRQRI),7&-labelled casein 
was then adjusted to 5 mg/mL, aliquoted and stored at -Û&XQWLOQHHGHG 
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2.2.6.2 Protease assays using FITC-labelled casein  
The effect of pH on protease activity present in larval EF and ES products was 
studied as previously described by Brown et al (1999). Briefly, larval EF/ES 
products (1 µg, 50 µL) were mixed with 10 µL of fluorescein isothiocyanate-
casein (FITC-casein, to a final concentration of 250 µg/mL) and 140 µL of 
buffer (pH 3²5.5, 0.1 M citric acid/sodium citrate buffer; pH 6²8, 0.1 M 
phosphate buffer; pH 8²10, 0.05 M 2-amino-2-methyl-1:3-propanediol-HCl 
buffer) containing 5 mM cysteine and incubated at Û& IRU  KRXUV 7KH
reaction was stopped by adding 120 µL of 5% trichloracetic acid (TCA) and 
the undigested protein was removed by centrifugation at 13000 x g for 10 
minutes. In a black 96 well microtitre plate, 20 µL of the supernatant were 
added to 80 µL of 0.5 M Tris- Cl (pH 8.5) and the fluorescence was measured 
in triplicates using DYNEX Microtiter Plate MFX Fluorometer (excitation = 
490 nm, emission detection = 525 nm).  
 
Using the same protocol, larval EF/ES products (1 µg, 50 µL) were incubated 
with 10 µL of FITC-labelled casein (250 µg/mL) at 37Û&IRUXSWRKRXUVDQG
the reactions were stopped one by one by adding 120 µL of 5% TCA at 
intervals of 30 minutes. 0.1 M phosphate buffer was used at pH 6, 6.5, 8 and 
8.5.  
 
To characterise the proteases present in larval secretions, EF/ES products (1 
µg, 50 µL) were pre-incubated with 20 µL of protease inhibitors E64 (1 µM), 
1, 10-phenanthroline (1 mM), pepstatin A (1 µM) and phenyl-methane sulfonyl 
fluoride (PMSF, 1 mM), individually or in a mixture for 30 minutes prior to the 
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addition of 10 µL of FITC-casein as described above. In this assay, only 
phosphate buffer (0.1 M, at pH 6.5 and 8) was used. A concentration-response 
assay was also carried using protease inhibitors at 1, 5, 10 and 100 times the 
concentration used above. Specific protease activity was obtained by 
subtracting values for a blank buffer control and presented as fluorescence 
units per hour per microgram of larval products (FU/h/µg). 
2.2.6.3 Detection of aminopeptidase activity in Necator americanus larval 
EF/ES products 
Aminopeptidase activity was studied by monitoring the release of 7-amino-4-
methylcoumarin (AMC) from a range of synthetic peptide substrates including 
H-Arg-AMC, H-Leu-AMC, H-Ala-AMC and H-Glu-AMC. Peptide substrates 
were prepared in PBS containing 1 mM CaCl2 and 1 mM MgCl2 and used at a 
concentration of 5 µM. In a black 96 well plate, 180 µL of each substrate 
solution was placed per well, to which 20 µL of larval EF/ES products (10 
JP/ ZHUH DGGHG 7KH VDPSOHV ZHUH LQFXEDWHG DW Û& RYHUQLJKW DQG WKH
release of AMC fluorescence was measured using DYNEX Microtiter Plate 
MFX Revelation Fluorometer (excitation = 360 nm, emission detection = 460 
nm).  
2.2.7 Inhibition of Necator americanus larval activity using IgG from 
post-infected individuals 
2.2.7.1 Preparation of IgG using protein G sepharose 
Plasmas were collected from control and individuals from Papua New Guinea 
(PNG), naturally infected with Necator americanus and specific IgG antibodies 
were prepared following a method by Pritchard et al (1990). Plasmas were 
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dialysed against PBS (pH 7.2) and passed down a protein G column. The 
column was extensively washed with PBS and the bound IgG antibodies were 
eluted with 0.1 M glycine buffer (pH 2.5) and collected in 1 M Tris buffer (pH 
9.5). The concentration of antibody solutions was measured using DYNEX 
MRX Microplate Reader at 405 nm and IgG samples were stored at -Û&XQWLO
required.      
2.2.7.2 Detection of activity of IgG against larval EF/ES products using 
Western blot 
Larval EF/ES and adult ES products were concentrated and prepared as 
described in section 2.2.4.2. Twenty micrograms of each product (20 µL per 
lane) were then loaded on a 10% SDS-PAGE gel and the gel was run at a 
constant current of 20 mA for 60²90 minutes. Proteins separated by SDS-
PAGE electrophoresis were transferred onto nitrocellulose membrane at a 
constant voltage of 26 V overnight, using a BioRad Mini Protean II Transfer 
Cell. Westerns blots were then blocked with 5% dried milk powder in Tris 
buffered saline (TBS) for 2 hours before being incubated RYHUQLJKWDWÛ&ZLWK
primary antibody (20 µg/mL of either control sera or post-hookworm infection 
IgG antibodies diluted in blocking buffer). Blots were extensively washed with 
TBS containing 0.05% Tween 20, and then incubated for 2 hours with a 
secondary anti human IgG conjugated to peroxidase and diluted 1:1000 (v/v) in 
blocking buffer. After being washed with TBS/0.05% Tween 20, antibody 
binding was visualised by incubating blots with horseradish peroxidase 
substrate chlornapthol (5 mg of chlornapthol dissolved in 1: 5 (v/v) 
ethanol/TBS and 3 µL of hydrogen peroxide added before use). Subsequent 
washing of Western blots in distilled water was used to stop the reaction.          
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2.2.7.3 Detection of activity of IgG against larval EF/ES products using 
Enzyme Linked ImmunoSorbent Assay (ELISA) 
$  ZHOO 1XQF 0D[L6RUE SODWH ZDV FRDWHG RYHUQLJKW DW Û& ZLWK  / RI
larval EF/ES, adult ES and adult homogenate per well (5 µg/mL diluted in 0.05 
M carbonate/bicarbonate buffer, pH 9.6). The plate was then gently washed in 
TBS/0.05% Tween 20 and blocked for 1 hour with 200 µL of 5% dried milk 
powder/ TBS per well. The plate was washed and incubated with 50 µL of 
either Papua New Guinea pooled plasma (PNG, as a control) or post-infection 
IgG, diluted in blocking buffer to a concentration of 20 µg/mL. The plate was 
washed again and an anti human-peroxidase IgG antibody was diluted 1:1000 
(v/v) in blocking buffer, added to individual wells (100 µL each) and incubated 
for 2 hours at room temperature. The antibody binding was then visualised by 
the addition of 100 µL of 3,3',5,5'-tetramethylbenzidine dihydrochloride per 
well (TMB, prepared by dissolving 1 tablet in 10 mL of 0.1 M sodium acetate 
(pH 6) and 2 µL of 30% hydrogen peroxide). After 30 minutes, the reaction 
was stopped by adding 50 µL per well of 2.5 M sulphuric acid and the 
absorbance measured using DYNEX MRX Microplate Reader at 450 nm.     
2.2.7.4 Inhibition of larval protease activity with post-infection anti worm 
IgG using FITC-labelled casein assay 
Larval EF/ES products (1 µg, 50 µL) were pre-LQFXEDWHG RYHUQLJKW DW Û&
with either control or post-infection anti worm IgG antibodies (at a final 
concentration of 0.5²50 µg/mL) as described in section 2.2.6.2. Phosphate 
buffer (0.1 M) was used at pH 6.5 and 8 only. FITC-labelled casein (10 µL, 
final concentration of 250 µg/mL) was then added and the mixture incubated 
IRUKRXUVDWÛ&7KHUHDFWLRQZDVWKHQVWRSSHGDVGHVFULEHGbefore and the 
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absorbance measured using DYNEX Microtiter Plate MFX Fluorometer 
(excitation = 490 nm, emission detection = 525 nm) and presented as 
fluorescence units per hour per microgram of larval products (FU/h/µg).  
2.2.8 Statistical analysis 
Data were analyzed with GraphPad Prism version 5.01. Values are presented as 
means ± SEM and statistical significance was determined by two-way ANOVA 
tests followed by Bonferroni post-tests. Statistical significance was defined as 
P < 0.05.   
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2.3 Results 
2.3.1 Characterisation of Necator americanus larval products using gel 
electrophoresis 
Necator americanus larval exsheathing fluid (EF) and excretory/secretory 
products (ES) were initially analysed using protein electrophoresis (Figure 
2.1). Separated proteins were never observed with Coomassie Blue while 
protein bands were detected with silver staining. Proteins were differentiated 
based on sample preparation (i.e. precipitation) showing difference in number 
of bands, bandwidth and band intensity. EF products showed a total of eight 
bands with molecular masses ranging from 20²135 kDa and twelve bands 
with molecular weight from 13²170 kDa using acetone and trichloroacetic 
acid (TCA) precipitation, respectively. Similarly, ES products showed a 
difference in protein profile, having eight to nine bands with molecular weight 
from 17²135 kDa or 11²60 kDa for acetone and TCA precipitation, 
respectively. Divergence among larval products was also observed unrelated to 
differences associated with sample preparation. In that prospect, EF proteins 
were mainly observed at molecular weights of 55²170 kDa whereas ES 
protein bands were concentrated at molecular weights from 11²60 kDa. 
Although these profiles established a difference in proteins present in larval EF 
and ES products, further investigation and characterisation of larval products 
was required.     
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         EF             ES              EF             ES 
 
  a- Precipitation with acetone           b- Precipitation with 5% TCA 
 
Figure 2.1 Larval products separated on SDS-PAGE gels and prepared 
by (a) acetone precipitation; (b) 5% TCA precipitations. Gels were silver 
stained as described in the Methods. Molecular weights represent the 
protein ladder (black) and extra protein bands (red). 
  
Larval products were further characterised using two-dimensional 
electrophoresis (Figure 2.2). Proteins, which were loaded at approximately 100 
micrograms per gel, showed partial separation for ES products at acidic pH 
(pointed by arrow heads). In contrast, no protein spots were observed with EF 
products. Similar results were obtained when repeated. In addition, protein 
fingerprinting was less informative since no proteins were detected. These 
findings suggested that higher total protein contents might be required for 
better protein profiling and accurate characterisation of larval products.  
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           pH  3  ĺ  10 
 
a- ES products 
pH  3  ĺ  10 
 
b- EF products 
Figure 2.2 Larval products separated on two dimensional SDS-PAGE 
gels, (a) ES products; (b) EF larval products. The optimised TCA 
precitipation was used to concentrate larval samples. Following 
separation, gels were silver stained and labelled with arrow heads pointing 
at protein spots. 
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2.3.2 Characterisation of protease activity in Necator americanus larval 
products using substrate gels 
Protease activity present in Necator americanus larval products was examined 
using substrate gel electrophoresis. Gelatin and haemoglobin were used as 
substrates as described in the Methods. Protease activity is detected as clear 
bands against a dark background, as evidence for substrates being degraded by 
larval products (Figure 2.3). Since larval products were equally loaded on gel 
wells, differences in number, bandwidth and intensity of the clear band was 
proportional to the protease activity per sample. Gelatin was degraded by EF 
and ES products, resulting in a single clear band at 25 kDa while two clear 
bands (20 and 27 kDa) were observed on haemoglobin gels. Degradation of 
substrates indicated the presence of active proteases in larval products at 
molecular weights of 20, 25 and 27 kDa. Based on the intensity of the clear 
bands, ES products demonstrated a greater ability to degrade both gelatin and 
haemoglobin (only at 27 kDa) than EF products. Results suggested that 
compared to EF products, ES proteases were either stronger or present in larger 
quantities. Both EF and ES products demonstrated no ability to degrade 
hyaluronic acid as shown in Figure 2.3 (c). 
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                               Hyaluronidase ES      EF 
    
c- Hyaluronic acid 
 
Figure 2.3 Substrate gels showing degradation of (a) gelatin; (b) 
haemoglobin; (c) hyaluronic acid by Necator americanus larval products. 
Equal quantities of larval products were loaded per lane and protease 
activity was evident, appearing as clear bands against a dark background. 
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Protease activity was further characterised using specific protease inhibitors 
(Figure 2.4). Degradation of gelatin was inhibited by 1, 10-phenanthroline 
(partially when used at 10 mM and completely when used at 100 mM), 
indicating that metalloproteases were primarily present in EF products. 
Protease activity was also inhibited by PMSF, only when used at a high dose 
(100 mM), indicating the presence of a serine protease in larval EF products at 
low quantities. The use of other protease inhibitors was slightly effective when 
used at high doses (only E64 at 100 µM) as little to no inhibition of protease 
activity was observed. Similar results were reported using ES products as 
shown in Figure 2.4 (b). These results suggested that substrate gel 
electrophoresis was inconclusive and therefore other techniques should be used 
to further characterise protease activity present in larval products.      
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         EF     PMSF            E64         Pepstatin A    Phenanthroline 
 
         
 
 
         ES        PMSF            E64        Pepstatin A     Phenanthroline 
 
 
Figure 2.4 Effect of protease inhibitors on degradation of gelatin by 
larval: (a) EF products and (b) ES products. Inhibition of protease activity 
was detected when clear bands disappeared (arrowheads) or appeared 
smaller in size (*).   
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2.3.3 Characterisation of protease activity in Necator americanus larval 
products using enzyme assays  
2.3.3.1 Effect of pH on larval protease activity  
The proteolysis of FITC-labelled casein as a function of pH is shown in Figure 
2.5. Optimal pH for protease activity ranged between 6 and 8.5 with two peaks 
appearing at pH 6.5 and 8. At optimal pH, protease activity was found to be 
proportional to time of incubation and the highest specific activity was 
obtained after running the reaction for 2 hours (Figure 2.6). Overall, protease 
activity was significantly higher in ES products (Figure 2.7). These results are 
in line with both protein separation (Figure 2.1, b) and substrate gel 
electrophoresis (Figure 2.3, a and b) emphasising that proteases present in 
larval ES secretions are either more active or present at higher quantities 
compared to exsheathing products (EF). 
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Figure 2.5 Effect of pH on protease activities present in Necator 
americanus larval (a) EF products; (b) ES products. FITC-casein was used 
as a substrate and protease activity was presented as the mean ± SEM of 
fluorescence units/microgram of products/hour. SEM bars are not visible 
in (b) because of the reproducibility of the assay.   
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b- ES products
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Figure 2.6 Time-related changes of protease activity in (a) EF 
products; (b) ES products. Specific activity was determined at optimal pH 
over a period of 2 hours.  
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Figure 2.7 Protease activities in larval products at optimal pH. 
Products were incubated with FITC-casein substrate. Specific activity was 
measured after 2 hours and presented as the mean ± SEM of fluorescence 
units/microgram of products/hour. ** = P < 0.001, compared to protease 
activities of the same product at different pH.  
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2.3.3.2 Characterisation of protease activity using FITC-labelled casein 
Protease inhibitors were used to further characterise the protease activities in 
Necator americanus larval EF and ES products. Inhibitors were quality 
controlled by assaying them against their class specific proteases (Table 2.2). 
Inhibitors were reported to cause a reduction of at least 90% in protease 
activities, except for 1, 10-phenanthroline (~ 59%). Percentage of inhibition 
indicated that protease inhibitors might be useful for further identification and 
classification of larval proteases. 
 
Table 2.2 Inhibition of specific protease activities. Inhibitors were 
used at their optimal pH and inhibition was determined as the percentage 
of reduction in protease activity to the total specific activity.    
  
Protease  Protease inhibitor % Inhibition  
Trypsin (serine 
proteases, 5 µg) 
PMSF used at 1 mM, pH 8  88% 
Papain (cysteine 
proteases, 5 µg) 
E64 used at 1 µM, pH 6 95.5% 
Leucine aminopeptidase 
(metalloprotease, 5 µg) 
1, 10-Phenanthroline used 
at 1 mM, pH 7.2 
59% 
Pepsin (aspartyl 
proteases, 5 µg) 
Pepstatin A used at 1 µM, 
pH 5 
91.5% 
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The contribution of different protease classes to larval EF and ES proteolytic 
activities was examined at their optimal pH (6.5 and 8). Overall, protease 
activity in both EF and ES products was decreased by individual inhibitors 
especially PMSF (at pH 6.5 and 8). Reduction was most significant when all 
inhibitors (PMSF, E64, pepstatin A, and 1, 10-phenanthroline) were combined 
together, as shown in Figure 2.8. Table 2.3 summaries the inhibition of 
protease activities (Figure 2.8) as the percentage of reduction in proteolysis of 
FITC-casein to the specific activity observed with larval products. Protease 
activity in ES products was noticeably inhibited by PMSF at pH 6.5 and 8 
while EF proteases were significantly inhibited at pH 8. These results indicate 
the presence of serine proteases in both EF and ES products, which are 
primarily active not only at pH 8 (optimal pH for PMSF), but also at pH 6.5. 
Inhibition of cysteine proteases by E64 was highest at pH 6.5 suggesting that 
cysteine proteases are markedly active in larval products at this pH. Unlike EF 
products, cysteine proteases were considerably inhibited by E64 in ES products 
at pH 8, signifying that cysteine proteolytic activity in ES products was not 
affected by pH. These findings indicated that cysteine proteases were distinctly 
present in larval ES products and to a lesser extent in EF products.               
At pH 6.5 and 8, a modest inhibition of protease activity by pepstatin A 
(optimal pH for pepstatin A is 5) was indicative of the partial involvement of 
aspartyl proteases in both EF and ES products. Inhibition by 1, 10-
phenanthroline was higher with ES products and highest at pH 6.5 indicating 
that although metalloproteases were present in both larval products, proteases 
were exceptionally more active in ES products at pH 6.5. In addition, the use of 
all protease inhibitors in combination which resulted in the greatest inhibition  
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Figure 2.8 Characterisation of protease activities present in Necator 
americanus larval products at their optimal pH; a) EF and b) ES products. 
The specific activity was obtained by subtracting values for a blank buffer 
control and presented as the mean ± SEM of fluorescence units/ 
microgram of products/ hour. ** = P < 0.001, * = P < 0.01 by comparing 
each sample to their control (+ EF (a) or ES (b) at the same pH). 
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of proteolytic activity, confirming the presence of the four main protease 
classes; serine, cysteine, aspartyl and metalloproteases in larval EF and ES 
products. 
 
Table 2.3 Summary of inhibition of protease activities present in 
Necator americanus larval products. Inhibition was determined as the 
percentage of reduction in protease activity to the total specific activity in 
larval products at their optimal pH.   
 
Protease Inhibitors EF products ES products 
pH 6.5 pH 8 pH 6.5 pH 8 
E64 (1 µM) 
Pepstatin A (1 µM) 
PMSF (1 mM) 
1, 10-phenanthroline (1 mM) 
All inhibitors 
- 13.6 
- 9.62 
- 21.11 
- 10.31 
- 31.58 
- 1.97 
- 15.88 
- 33.72 
- 8.96 
- 51.66 
- 18.58 
- 13.31 
- 28.07 
- 26.5 
- 41.87 
- 16.69 
- 16.56 
- 27.83 
- 11.82 
- 40.49 
 
 
A dose-response inhibition assay was carried out using protease inhibitors at 
1²100 times their recommended doses (Figure 2.9). Evidently, no complete 
inhibition of protease activity was observed with individual inhibitors. 
Responses to the 100 x doses were statistically similar to those of 1, 10 and 50 
x recommended doses as higher dosage produced slightly further inhibition of 
protease activities.  
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                       c- EF products, pH 8
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Figure 2.9 Dose-response inhibition of protease activities in Necator 
americanus larval products, (a) EF products at pH 6.5; (b) ES products at 
pH 6.5; (c) EF products at pH 8; (d) ES products at pH 8. Protease 
inhibitors were used at 1²100 times the recommended dose and protease 
activities were determined using FITC-casein as a substrate. Results are 
presented as the mean ± SEM of fluorescence units/microgram of 
products/hour. 
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Table 2.4 Summary of the dose-response inhibition of protease 
activities of Necator americanus larval products. Inhibition was presented 
as the percentage of reduction in protease activity (FITC-casein) to the 
total control activity in larval products at the highest and lowest dosage of 
inhibitors.   
 
Protease Inhibitors EF products ES products 
pH 6.5 pH 8 pH 6.5 pH 8 
1 X 100X 1X 100 X 1 X 100 X 1 X 100 X 
E64 
Pepstatin A 
PMSF 
1, 10-phenanthroline 
13.6 
9.6 
21.1 
10.3 
22.4 
23.1 
28.4 
20.8 
1.9 
15.8 
33.7 
8.9 
20.9 
19.7 
40.2 
28.8 
18.5 
13.3 
28.0 
26.5 
26.2 
32.7 
38.3 
20.6 
16.6 
16.5 
27.8 
11.8 
28.4 
18.4 
36.2 
29.1 
 
Table 2.4 summarises the dose-response relationship of specific protease 
activities and the use of protease inhibitors at 1 x and 100 x their recommended 
dosage. Although further inhibition of protease activities was detected at 100 x 
doses (maximum of approximately 40%), complete inhibition of proteolytic 
activity in larval products was never observed. Data suggested that other 
factors possibly including pH optima for each protease inhibitor and emergence 
of resistance might account for the low inhibition levels.   
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Thus far, Necator americanus larval EF and ES products: 
 
- Exhibited a characteristic difference in their protein and proteolytic 
profiles in a quantitative and a qualitative manner. 
- Demonstrated pH dependent proteolytic activities against FITC-casein 
substrate with the optimal pH ranging between 6 and 8.5. 
- Demonstrated the presence of serine, cysteine, aspartyl and 
metalloproteases, and complete inhibition of their activities was not 
observed even in the presence of all protease inhibitors in a cocktail. 
- Using gel electrophoresis and enzyme assays, ES proteolytic activity 
was shown to involve either more/ or more active proteases than EF 
activity. 
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2.3.3.3 Further characterisation of enzymatic activity in Necator americanus 
larval products using synthetic substrates 
The enzymatic activity against a number of aminopeptidase substrates was 
determined after 24 hours of incubation with larval products (Figure 2.10). 
Results demonstrated a significant increase of leucine and arginine 
aminopeptidase activities in EF products (P < 0.001), assayed with H-Leu-
AMC and H-Arg-AMC. Alanine aminopeptidase activity was also 
considerably increased in EF products while glutamate aminopeptidases were 
not significantly active. Unlike EF products, aminopeptidase activities were 
markedly reduced after 24 hours incubation with ES products with the 
exception of leucine aminopeptidase activity which was significantly 
increased.  
 
        a- EF products
H-Glu H-Ala H-Leu H-Arg
0
100
200
300
T0
T24
   ***
***
**
AMC substrates
Pe
pt
id
a
se
 
a
ct
iv
ity
 
(F
U/
P g
)r
 
SE
M
 
 
Chapter 2: Characterisation of Necator americanus larval products 
 
 85 
       b- ES products
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Figure 2.10 Aminopeptidase activity in Necator americanus larval, (a) 
EF products; (b) ES products; (c) EF vs ES products. Activity is presented 
as the mean ± SEM of fluorescence units/ microgram of larval product. 
Significance was defined as * = P < 0.05, ** = P < 0.01 and *** = P < 0.001.   
 
 
Aminopeptidase substrates were hydrolysed to a higher degree (P < 0.001) 
with EF than ES products indicating the predominant presence of these 
aminopeptidases in EF products.  
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2.3.4 Inhibition of Necator americanus larval activity using IgG from 
individuals post-infection 
2.3.4.1 Characterisation of post-infection anti worm IgG antibodies 
Western blots were used to detect larval antigens using post-infection anti 
worm IgG antibodies, developed against adult ES antigens. A band of 37 kDa 
was observed with adult ES and larval ES products while EF antigens were not 
detected (Figure 2.11). Sera from uninfected individuals was used as a control 
and was found unable to detect antigens in larval EF and ES as well as adult ES 
(Figure not included here). In an ELISA assay (Figure 2.12), only adult ES and 
homogenate antigens were statistically recognised by post-infection IgG 
antibodies. Larval ES antigens were detected to a smaller degree while EF 
antigens were not recognised, supporting data from the Western blots. Papua  
                                   kDa 
 
               
                       EF          ES       Adult ES 
Figure 2.11 Detection of Necator americanus larval antigens using post-
infection antiworm IgG antibodies, developed against adult ES antigens. 
Sera was collected from naturally infected individuals and prepared as 
described in the Methods.    
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Figure 2.12 Interaction of post-infection anti worm IgG antibodies with 
Necator americanus products. Significance is determined against blank 
and between samples and recognised as ** = P < 0.01 and *** = P < 0.001. 
 
New Guinea (PNG) pooled plasmas were used as a positive control to confirm 
the presence of antigens in larval, adult and homogenate products. Detection of 
antigens was significantly higher with PNG pooled IgG antibodies especially in 
larval ES, adult ES and homogenate products. 
2.3.4.2 Effect of post-infection anti worm IgG antibodies on Necator 
americanus larval activity 
The effect of treatment of Necator americanus larval products with antibodies 
is described in Table 2.5. Control sera produced a decrease in proteolysis of 
FITC-casein, not exceeding 5% at all doses. Post-infection IgG antibodies 
caused a considerable increase in inhibition of both EF and ES activity, 
mirrored by a significant decrease in proteolysis of FITC-casein at doses of 
antibodies from 0.1²10 µg/sample. 
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Although inhibition levels were markedly higher at pH 8, they did not exceed 
50% of the total activity in larval products, raising the possibility that anti 
worm IgG antibodies were pH sensitive and possibly acting as a competitive 
substrate to larval enzymes. 
 
Table 2.5 Effect on Necator americanus larval activity following 
treatment with post-infection IgG antibodies, presented as the percentage 
of reduction in proteolysis of FITC-casein to the total control activity in 
larval products. Antibodies were used at different concentrations and at 
optimal pH. AW: anti worm IgG, CT: control sera. 
 
IgG 
Concentration 
(µg/sample) 
EF products ES products 
pH 6.5 pH 8 pH 6.5 pH 8 
AW CT AW CT AW CT AW CT 
0.1 
0.5 
1 
5 
10 
-19.5 
-23.9 
-27.3 
-28.8 
-30.4 
-3.6 
-4.5 
-2.9 
-3.4 
-3.6 
-38.8 
-41.5 
-45.1 
-41.9 
-49.0 
-0.6 
-0.8 
-2.3 
-1.9 
-4.1 
-8.3 
-15.3 
-18.5 
-19.5 
-25.9 
-0.8 
-0.9 
-1.1 
-0.4 
-1.5 
-19.6 
-28.4 
-28.0 
-32.5 
-35.3 
-0.3 
-0.5 
-0.7 
-1.4 
-0.6 
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2.4 Discussion 
The electrophoretic separation of Necator americanus larval products 
demonstrated the presence of most proteins within a molecular weight range of 
11²60 kDa in the excretory/secretory products (ES) while the exsheathing 
fluid (EF) contained essentially proteins of 55²170 kDa. Based on the 
proteolytic activity observed at ~ 21 kDa (Figures 2.1, b and 2.3, b), the band 
could possibly be assigned to the aspartic APR-1 as previously reported by 
Williamson et al (2002) while the 40 kDa protein (Figure 2.1, b) is likely the 
cysteine ASP-2 proteases following previous work by Goud et al (2005). In 
addition, a zinc-dependent metalloprotease is probably resolving at 50 kDa as 
shown in previous work by Hawdon et al (1995). Moreover, the occurrence of 
a 55²56 kDa protein is likely to reflect the presence of calreticulin in both EF 
and ES products (to a lesser degree), which was previously reported by 
Pritchard et al (1999) and Winter et al (2005). Further investigation of larval 
products using two-dimensional gel electrophoresis demonstrated a partial 
separation of ES products with few protein spots resolving at 11²27 kDa 
(acidic pH) and a single protein spot at 30 kDa (basic pH). Peptide 
fingerprinting was also less informative as a result of the low detection levels 
of larval products, suggesting that larger quantities of total larval proteins 
should be used for better protein profiling.  
 
The involvement of proteases in larval EF and ES products was studied using 
gelatin and haemoglobin on substrate gels. The degradation of gelatin was 
caused by gelatinolytic proteases with an apparent molecular weight of 25 kDa 
while haemoglobin was hydrolysed by proteases of 20 and 27 kDa.  Variation 
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in the number, size and intensity of clear bands suggested the involvement of a 
number of proteases in the degradation of substrates, which was more evident 
with ES products. These findings supported the involvement of a multi-
protease cascade in the degradation of haemoglobin reported by Williamson et 
al (2002 and 2003) as well as the gelatinolytic activity of larval products, 
previously described by Kumar and Pritchard (1992a). Unlike the infective 
Ancylostoma larval extracts, hyaluronidase activity was not present in both EF 
and ES products indicating that migration of Necator americanus larvae 
through the skin is not mediated by the activity of this class of enzymes as 
described previously by Hotez et al (1992). Gelatinolytic activity in EF 
products was considerably inhibited by 1, 10-phenanthroline while partial 
inhibition was only observed with PMSF and E64 at doses outside the 
recommended range, indicating that this gelatinolytic enzyme is a mixture of 
metallo-, serine and cysteine proteases. Since similar results were observed 
with ES products (also using haemoglobin), classification of larval proteases 
using substrate gels was limited therefore requiring a better protein profiling 
method. 
 
Since generating EF and ES products in large scale was both complicated and 
time consuming, enzyme assays using FITC-labelled casein as a substrate were 
used as a better technique for the characterisation of Necator americanus larval 
products. Results demonstrated a pH related protease activity which was 
optimal between pH 6 and 8.5 with sharp peaks at pH 6.5 and 8 for both the 
exsheathing fluid (EF) and the excretory/secretory products (ES). The effect of 
pH on protease activity was most evident after 2 hours of incubation with 
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FITC-casein and proteolysis was significantly high with EF products at pH 6.5 
and higher with ES products at pH 8. Knowing the normal skin pH ranges 
between 4.5 and 6.5 (Yosipovitch et al, 1993), these results suggest that 
protease activity in the exsheathing fluid (EF) is likely to be involved in the 
penetration process at the skin surface whereas the excretory/secretory 
products (ES) are believed to help the larvae move deeper in the skin, finally 
arriving at the blood microcirculation.  
 
Using protease inhibition assay, proteolytic activity in larval products was 
primarily inhibited by PMSF at pH 6.5 and 8. The predominant presence of 
serine proteases in both EF and ES products at optimal pH suggested a 
potential role of serine proteases during the exsheathment of Necator 
americanus larvae and the penetration of skin. The presence of cysteine 
proteases in larval products was reflected by the inhibition of proteolytic 
activity using E64 which was highest in ES products at pH 6.5. Findings 
indicated that cysteine proteases may be involved in the exsheathment of larvae 
as previously described by Kumar and Pritchard (1992a) and during the 
penetration process.  
 
Activity of aspartyl and metalloproteases were also pH dependent and 
considerably different in EF and ES products. Although moderately present in 
larval products as mirrored by the partial inhibition of activity by 1, 10-
phenanthroline, metalloproteases were noticeably present in ES products and 
exceptionally more active at pH 6.5 indicating they may be important for 
Necator americanus larvae to negotiate the different layers of the skin. The 
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presence of aspartyl proteases in larval products was modest at pH 6.5 and 8, 
unlike previous findings by Brown et al (1999) which described these 
proteases to be predominant in larval ES products. Previous studies illustrated 
the major role of this class of proteases as digestive enzymes to the blood-
feeding behaviour of most nematodes including Necator americanus species 
(Brown et al, 1995; Williamson et al, 2002). However at early stages of larval 
invasion, aspartyl proteases are likely to be involved in the penetration process, 
ultimately allowing species to enter the host.   
 
In addition, the use of all protease inhibitors in combination indicated that no 
protease is singly essential and that the penetration process may be mediated by 
the contribution of all proteolytic activities in the larval products. The 
involvement of more than one protease is likely due to the complexity of and 
the need to negotiate the different layers of skin (i.e. epidermis and dermis) to 
reach the vasculature. The use of protease inhibitors in combination was 
expected to cause complete inhibition of proteolytic activities in larval 
products. This is probably due to the fact that individual inhibitors work best at 
their optimal pH (Table 2.2), while this assay was carried out at pH 6.5 and 8 
only. Since complete inhibition of protease activities was never observed 
(Brown et al, 1999), a dose-response inhibition assay was performed to 
determine if total inhibition of protease activity could be obtained. The use of 
higher doses of each inhibitor caused further increase in inhibition levels but 
proteolytic activities were never eliminated. Data emphasised that other factors 
possibly including the involvement of additional larval enzymes in FITC-
Chapter 2: Characterisation of Necator americanus larval products 
 
 93 
casein proteolysis and emergence of resistance against protease inhibitors 
might account for the considerably partial inhibition of proteolytic activities. 
Necator americanus larval products were also examined using a number of 
aminopeptidase substrates. Exsheathing fluids demonstrated a significant 
presence of leucine, arginine and to a lesser extent alanine aminopeptidase 
while enzymatic activity in ES products was moderate and contained leucine 
aminopeptidase only. The presence of leucine aminopeptidases in adult 
Necator americanus species was previously confirmed by McLaren et al 
(1974) and later in the exsheathing fluid of other nematodes by Rogers and 
Brooks (1977 and 1978). The large presence of aminopeptidases in EF 
products suggested an important role of these enzymes during and after 
exsheathment as proposed by Kumar and Pritchard (1992a) while the presence 
of leucine aminopeptidases in ES products indicated their potential 
involvement in the hydrolysis of both skin and serum molecules (Williamson et 
al, 2003).  
 
Proteolytic enzymes have been suggested as a potential mechanism for Necator 
americanus LQIHFWLRQ DOORZLQJ ODUYDH WR JDLQ DFFHVV WR WKH KRVW¶V
PLFURFLUFXODWLRQ DQG SURWHFW WKHPVHOYHV DJDLQVW WKH KRVW¶V LPPXQH V\VWHP
(Pritchard et al, 1990). Targeting these proteases using IgG antibodies, 
developed against adult ES products aimed at providing total inhibition of 
larval activities and early protection against Necator americanus infection. The 
interaction of post-infection anti worm IgG antibodies and larval products was 
initially determined using Western blots, in which only adult and larval ES 
products were detected. The use of ELISA assay demonstrated a major ability 
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of these antibodies to capture adult ES antigens while detection of larval ES 
antigens was minimal. Although the presence of antigens in larval EF products 
was confirmed using PNG pooled plasmas, EF antigens were not detected 
using post-infection IgG antibodies. Being specific to adult and to a lesser 
extent, larval excretory/secretory products suggested a partial similarity in 
antigens present in both adult and larval ES product. Previous knowledge 
showed larval ES products to contain certain antigens including calreticulin 
(Pritchard et al, 1999; Kasper et al, 2001), aspartic Na-APR-1 (Williamson et 
al, 2002; Pearson et al, 2009) and cysteine Na-ASP-2 (Hawdon et al, 1999) 
proteases, previously reported in adult ES product.         
 
Although specificity of post-infection anti worm IgG antibodies was limited, 
treatment of Necator americanus larval products with these antibodies 
produced a considerable decrease in the proteolysis of FITC-casein, indicated 
by a parallel increase in inhibition of both EF and ES activity. Although 
inhibition levels were highest using 10 µg of antibodies per sample, reduction 
in proteolysis of casein never exceeded 50%. Inhibition is possibly due to anti 
worm IgG acting as a competitive substrate to larval enzymes rather than 
targeting specific, functional connections in their structures. Thus, the use of 
antibodies with better specificity to target active sites of larval EF and ES 
antigens would be more beneficial in inhibiting the infection at early stages and 
providing total protection against these species.   
 
In conclusion, the characteristic presence of serine, cysteine, aspartyl and 
metalloproteases in larval EF and ES products and the potential role of protease 
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inhibitors and post-infection IgG antibodies in inhibiting larval proteolytic 
activities will be considered in studying the involvement of Necator 
americanus larval enzymes in penetrating the skin and the underlying 
vasculature.  
  96 
 
 
 
 
 
 
 
 
 
 
 
 
3. Interaction between Necator americanus larval products and 
the human skin 
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3.1 Introduction 
As obligate skin penetrators, Necator americanus species are believed to 
combine mechanical forces and enzymatic activities to migrate through the 
VNLQDQGJDLQDFFHVVWRWKHKRVW¶VPLFURFLUFXODWLRQ0DWWKHZV3UHYLRXV
work by Hawdon et al (1993) indicates that Necator americanus L3 larvae 
remain in the skin for up to 48 hours post infection, during which time larvae 
are believed to alter their enzymatic repertoire to penetrate the skin and migrate 
to the blood circulation. Thus, understanding the molecular structure of the 
skin would be beneficial to investigate the mechanisms behind skin penetration 
by Necator americanus larvae.  
 
Skin is the largest organ of the body, and serves as a protective barrier against 
environmental factors and foreign pathogens. Two major functional layers are 
characteristic of the human skin, each with a specific role to play. The 
epidermis is the outermost stratified, keratinizing epithelium anchored to a 
basement membrane which is in turn connected to the underlying layer, the 
dermis. The latter is a dense connective tissue layer containing the vascular 
network, the glands i.e. sweat and sebaceous and the hair follicles and 
originates from the dermal fibroblast. The main structural macromolecules of 
the dermis are collagens, elastin, fibronectin and laminin, primarily 
contributing to the structural complexity and multifunctional nature of the skin. 
Collagens I and III, being the major components of the dermis, co-exist as 
individually banded fibrils and play important roles in maintaining the stability 
of the skin. Collagens V, VI and VII have also been shown to occur in the skin 
in the form of fibrils with a role to play in anchoring principal fibres to the 
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surrounding matrix components and cells. Unlike other types of collagen, 
collagen IV is a non fibrillar molecule with a primary role in securing the 
basement membrane to the dermis and keratinocytes. Other matrix molecules 
including fibronectin and laminin are multifunctional proteins with a major role 
in cellular adhesion (Ruoslahti, 1988; Terranova et al, 1980) and cross linking 
of the extracellular matrix (Timpl and Martin, 1997) and basement membranes 
(Kucharz, 1992), respectively.  
 
The aim of this section of the work is to explore the possible involvement of 
larval enzymes in skin penetration, by studying their proteolytic effects on both 
individual and skin-derived extracellular matrix macromolecules. This was 
performed using electrophoretic separation (SDS-PAGE) in combination with 
Western blotting.   
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3.2 Methods 
3.2.1 Preparation of human skin extracts 
Human skin samples were obtained from the forearm of healthy volunteers 
with no skin complications. Skin samples were collected as 4 mm-diameter 
punch biopsies (i.e. 0.125 cm2, ~ 5 mg wet weight), extracted in 250 µL of 0.1 
M phosphate buffer pH 6 and stored at -Û&LQDOLTXRWVRI/XQWLOQHHGHG
Before use, skin aliquots were thawed and precipitated by adding 4 volumes of 
ice cold acetone and freezing for 1²2 hours at -Û&3UHFLSLWDWHGSURWHLQZDV
obtained by centrifuging at 13000 x g for 10 minutes and resuspended in 20 µL 
of 2 x reducing sample buffer per sample. Extracted proteins were reduced by 
ERLOLQJIRUPLQXWHVDWÛ&DQGVHSDUDWHGE\6'6-PAGE electrophoresis.        
3.2.2 Effect of larval EF/ES products on the degradation of human 
skin/extracellular matrix (ECM) molecules 
3.2.2.1 Preparation of SDS-PAGE gels 
SDS-PAGE gels were prepared as described in section 2.2.4.1. Protein 
separation of skin extracts and all extracellular matrix molecules (ECM) was 
carried on 10% SDS-PAGE gels except for laminin which was loaded on 6% 
SDS-PAGE gels.     
3.2.2.2 Treatment of skin/ECM with Necator americanus larval products 
Extracellular matrix molecules (ECM) were incubated with Necator 
americanus larval products following a modified method from Brown et al 
(1999). Ten micrograms of human collagen I, III, IV, V, fibronectin and 
ODPLQLQZHUHLQFXEDWHGRYHUQLJKWDWÛ&LQWKHSUHVHQFHRUDEVHQFHFRQWUROV
Chapter 3: Necator americanus larvae and Skin  
 
 100 
of 2 µg of larval EF/ES products. Proteins were then precipitated with ice cold 
acetone as described in section 2.2.4.2 and the precipitate was resuspended in 
20 µL of 2 x reducing sample buffer. Finally, proteins were reduced by boiling 
IRUPLQXWHVDWÛ&DQGVHSDUDWHGXVLQJ6'6-PAGE electrophoresis. Skin 
extracts (20 µL, ~ 0.4 mg wet weight) were also treated as before in the 
presence or absence (controls) of 2 µg of larval EF/ES products individually 
and processed as for ECM molecules.          
3.2.2.3 Treatment of skin/ECM molecules with larval products in the 
presence of protease inhibitors 
Prior to incubation with larval EF/ES products, both skin extracts and ECM 
molecules were pre-LQFXEDWHG IRUKRXUVDWÛ&ZLWKDPL[WXUHRISURWHDVH
inhibitors containing E64 (1 µM), pepstatin A (1 µM), 1, 10-phenanthroline (1 
mM) and PMSF (1 mM). Upon addition of 2 µg of larval EF/ES products, 
samples were treated and processed as described in section 3.2.2.2 and 
separated using SDS-PAGE electrophoresis.   
3.2.2.4 Treatment of skin/ECM molecules with larval products in the 
presence of anti worm IgG 
6NLQH[WUDFWVDQG(&0PROHFXOHVZHUHLQFXEDWHGRYHUQLJKWDWÛ&ZLWK µg 
of post-infection anti worm IgG antibodies per sample. Larval EF/ES products 
were then added at 2 J SHU VDPSOH DQG LQFXEDWHG RYHUQLJKW DW Û& 6NLQ
extracts and ECM molecules were then processed as described in section 
3.2.2.2 and subjected to separation using SDS-PAGE electrophoresis.  
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3.2.3 Visualisation of Necator americanus larval activity 
3.2.3.1 Western Blot 
Proteins separated on SDS-PAGE gels were transferred onto nitrocellulose 
membrane at a constant voltage of 26 V overnight, using a BioRad Mini 
Protean II Transfer Cell. Westerns blots were then blocked with 5% dried milk 
SRZGHU LQ 7%6 IRU  KRXUV EHIRUH EHLQJ LQFXEDWHG RYHUQLJKW DW Û& ZLWK D
primary antibody as shown in Table 3.1. All antibodies were used at a 
concentration of 0.8 µg/mL and diluted in blocking buffer. Blots were 
extensively washed with TBS containing 0.05% Tween 20, then incubated for 
2 hours with a secondary antibody conjugated to either peroxidase or alkaline 
phosphatase and diluted in blocking buffer as shown in Table 3.1. Following 
two TBS/0.05% Tween 20 washes, each lasting for 20 minutes, antibody 
binding was visualised by incubating blots with horseradish peroxidase 
substrate chlornapthol (5 mg of chlornapthol dissolved in 5 mL of 1: 5 (v/v) 
ethanol/TBS and 3 µL of hydrogen peroxide added before use) or alkaline 
phophatase substrate (20 mL of 0.75 M Tris (pH 9.6) containing 82.5 µg/mL of 
5-bromo-4-chloro-3indolyl phosphate and 154 µg/mL of nitroblue tetrazolium 
(NTZ)). The reaction was then stopped by washing blots in distilled water. 
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Table 3.1 Antibodies used to visualise proteins transferred to Western 
blots. 
 
Protein Primary antibody  Secondary antibody  
Collagen I  Goat anti human collagen I Anti goat- alkaline 
phosphatase (1:500) 
Collagen III  Goat anti human collagen III Anti goat- alkaline 
phosphatase (1:500) 
Collagen IV  Goat anti human collagen IV Anti goat- alkaline 
phosphatase (1:500) 
Collagen V  Goat anti human collagen V Anti goat- alkaline 
phosphatase (1:500) 
Fibronectin  Rabbit anti human fibronectin  Anti rabbit- alkaline 
phosphatase (1:2500) 
Laminin  Rabbit anti human laminin Anti rabbit- alkaline 
phosphatase (1:2500) 
           
3.2.3.2 Coomassie Blue staining  
Gels were fixed for 30 minutes in destain solution before being stained with 
Coomassie Brilliant Blue R250 overnight, on a rocking platform. Proteins 
separated on SDS-PAGE gels were visualised by destaining the gels for 5²6 
hours and were observed as blue bands against a clear background.   
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3.2.4 Assay of transglutaminase activity 
Transglutaminase activity was detected following a method by Slaughter et al 
(1992). Dimethyl casein was dissolved in 0.1 M Tris-HCl (pH 8.5) at a 
FRQFHQWUDWLRQ RI  PJP/ )ROORZLQJ KHDWLQJ DW Û& IRU  PLQXWHV
insoluble dimethyl casein was removed by centrifugation at 13000 x g for 20 
minutes and the supernatant solution was used to coat the wells of a 96 well 
1XQF 0D[L6RUE SODWH RYHUQLJKW DW Û&  / SHU ZHOO ([FHVV GLPHWK\O
casein was removed by careful aspiration then the wells were blocked with 3% 
bovine serum albumin (BSA) in 0.1 M Tris-HCl (pH 8.5) for 30 minutes at 
room temperature. The wells were washed twice with 0.1 M Tris-HCl (pH 8.5). 
Transglutaminase activity was assayed in triplicate by adding 200 µL per well 
of a mixture containing 5 mM CaCl2, 10 mM dithiothreitol (DTT), 0.5 mM 5'-
Biotinoyl-amino hexanoylamino-pentylamine, EF/ES products between 5% 
and 50% (v/v) and 0.1 M Tris-HCl (pH 8.5). The plate was incubated for 45 
PLQXWHV DW Û& DQG WKH UHDFWLRQ VWRSSHG E\ ZDVKLQJ WKH ZHOOV ZLWK  0
EDTA then 0.1 M Tris-HCl, pH 8.5. Extravidin-peroxidase was diluted 1:1000 
(v/v) in 3% BSA/0.1 M Tris-HCl (pH 8.5), added at 200 µL per well and 
incubated for 1 hour at room temperature. The wells were then washed once 
with 0.01% Triton X-100 and twice with 0.1 M sodium acetate, pH 6. Activity 
was then visualised by the addition of 100 µL of 3,3',5,5'-tetramethylbenidine 
dihydrochloride per well (TMB, prepared by dissolving 1 tablet in 10 mL of 
0.1 M sodium acetate (pH 6) and 2 µL of 30% hydrogen peroxide). After 10 
minutes, the reaction was stopped by adding 50 µL per well of 2.5 M sulphuric 
acid and the absorbance measured using DYNEX MRX Microplate Reader at 
450 nm.    
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3.2.5 Statistical analysis 
Data were analyzed with GraphPad Prism version 5.01. Values are presented as 
means ± SEM and statistical significance (P < 0.05) was determined by two-
way ANOVA tests followed by Bonferroni post-tests.   
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3.3 Results 
3.3.1 Degradation of extracellular matrix (ECM) molecules by Necator 
americanus larval products 
The digestion of extracellular matrix macromolecules (ECM) was investigated 
as a function of Necator americanus proteolytic activity. No hydrolysis of 
collagen type I was observed although bands of small molecular weight (~ 84 
and 55 kDa) disappeared on treatment with both EF (Lane 3) and ES (Lane 2) 
products (Figure 3.1, a and a'). The breakdown of collagen type III was not 
observed with Coomassie Blue staining (Figure 3.1, b) while Western blots 
showed an evident degradation with ES products as mirrored by the appearance 
of protein bands at 55 and 29 kDa (Figure 3.1, b'). Besides the 37 kDa band, 
protein products of smaller molecular weights were relatively weak following 
treatment with ES products and disappeared with EF products (Figure 3.1, b'). 
Unlike collagen type III, minimal degradation of collagen type IV was 
observed on Western blots, featuring the disappearance of proteins at 29 and 24 
kDa with ES and EF products, respectively (Figure 3.1, c'). Major changes in 
the breakdown of collagen IV by EF products were observed with Coomassie 
Blue staining as demonstrated by the fading of the 135 kDa protein and the 
appearance of strong protein bands at 123 and 37 kDa. Bands at 78 and 52 kDa 
were missing with both EF and ES products whereas the 100 kDa protein band 
was only absent with ES products. Treatment with ES products also caused 
smaller proteins to disappear as shown in Figure 3.1 (c). No degradation of 
collagen type V was observed, as shown in Figure 3.1 (d). The formation of 
proteins at 208 kDa was noticeable with EF products, additional to fading of 
proteins at 145 and 14 kDa and the disappearance of bands at 17, 20 and 21 
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kDa (Figure 3.1, d). Proteins with molecular weights of 20²50 kDa also 
disappeared in the presence of EF and ES products while bands at 84 and 52 
kDa were only observed with ES products (Figure 3.1, d'). Both larval EF and 
ES products also exhibited the presence of distinct protein bands at 100 and 62 
kDa.  
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Figure 3.1 The breakdown of extracellular matrix (ECM) by Necator 
americanus larval products described in: (a²f) gels stained with 
Coomassie Blue and (a'²f') Western blots. Gels were labelled for protein 
molecular weight (black), extra protein bands (red) and arrowheads point 
at breakdown products.      
Lane 1, ECM molecules as controls; 
Lane 2, ECM molecules + ES products; 
Lane 3, ECM molecules + EF products.  
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Hydrolysis of fibronectin was evident with both EF and ES products as 
demonstrated by the total disappearance of proteins at 220, 166, 107 and 93 
kDa (Figure 3.1, e). Proteins of smaller molecular weights were formed at 40, 
35 and 24 kDa, stronger with EF products. Individual bands were observed at 
58 kDa (EF only) and at 21 and 15 kDa (ES products). On Western blots, the 
degradation of fibronectin resulted in a single band at 35 kDa with ES products 
while the presence of proteins at 58, 35 and 29 kDa was noted with EF 
products (Figure 3.1, e'). 
  
Degradation of laminin was minimal as illustrated in Figure 3.1 (f). Protein 
bands at 135, 55, 21 and 18 kDa were relatively weak with ES products while 
only proteins at 55 and 21 kDa were observed with EF products. Figure 3.1 (f ') 
shows an evident breakdown of laminin with ES products, described by the 
fading of the 135 kDa protein and the strong presence of proteins at 80 and 50 
kDa. However, breakdown products by EF products were absent at 80 kDa and 
weaker at 50 kDa (Figure 3.1, f ').   
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Figure 3.2 Western blots showing degradation of ECM by Necator 
americanus larval products. (a) Collagen I; (b) Collagen III; (c) Collagen 
IV; (d) Collagen V; (e) Fibronectin; (f) Laminin. Molecular weights are 
shown either in black (protein ladder) or red (extra bands) and 
arrowheads point at recovered protein bands.   
Lane 1, ECM molecules as controls;  
Lane 2, ECM molecules + ES products; 
Lane 3, ECM molecules + EF products; 
Lane 2', ECM molecules + ES + post-infection IgG;  
Lane 3', ECM molecules + EF + post-infection IgG;  
Lane 2'', ECM molecules + ES + All inhibitors;  
Lane 3'', ECM molecules + EF + All inhibitors.  
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Inhibition of Necator americanus proteolytic activity was investigated using 
either post-infection anti worm IgG antibodies or a mixture of serine, cysteine, 
aspartyl and metalloprotease inhibitors. No changes in the hydrolysis of both 
collagens I and V were observed when pre-treated with either post-infection 
IgG or a mixture of all inhibitors (Figure 3.2, a and d, Lanes 2'²3''). 
Degradation of collagen IV and laminin was not altered in the presence of post-
infection IgG antibodies while minimal inhibition of proteolytic breakdown 
was observed using all inhibitors in combination. Changes in collagen IV 
hydrolysis included the reappearance of proteins of 24 kDa with both EF and 
ES products and the disappearance of the 29 kDa bands with EF products only 
(Figure 3.2, c, Lanes 2'' and 3''). Inhibition of laminin breakdown eliminated 
the 50 kDa band with EF products while proteins at this molecular weight 
faded leading to the appearance of a strong band at 80 kDa with ES products 
(Figure 3.2, f, Lanes 2'' and 3''). Anti worm IgG antibodies produced no change 
in the degradation of collagen III except for the reappearance of weak bands at 
55 and 37 kDa (Figure 3.2, b, Lanes 2' and 3'). However, degradation of 
collagen III was greatly inhibited in the presence of all protease inhibitors as 
demonstrated by the reappearance of proteins of small molecular weights 
including 84, 62, 50, 40 and 37 kDa. Protein band at 29 kDa was not observed 
with ES products while bands at 55 kDa were relatively weaker and associated 
with an increase in the intensity of proteins at 145 kDa (Figure 3.2, b, Lanes 2'' 
and 3''). Similarly, fibronectin proteolysis was partially inhibited by protease 
inhibitors as evidenced by the emergence of protein bands at 166 and 83 kDa 
and the absence of proteins at low molecular weight (i.e. 35 kDa) with EF 
products (Figure 3.2, e, Lanes 2'' and 3''). Post-infection IgG antibodies 
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produced less inhibition of fibronectin breakdown as illustrated by the presence 
of proteins of low molecular weights including 58, 40 and 24 kDa for both ES 
and EF, respectively (Figure 3.2, e, Lanes 2' and 3'). 
 
In line with previous findings, in which treatment of collagen V with larval 
products induced the formation of a new, larger proteins (208 kDa), the 
presence of transglutaminases in Necator americanus larval products was 
investigated. Transglutaminase activity was significantly present in EF 
products and significantly higher in ES products as shown in Figure 3.3.    
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Figure 3.3 Transglutaminase activity in Necator americanus larval 
products. Activity is compared to controls containing no larval products. 
Activity is presented as the mean ± SEM and *** = P < 0.001; ** = P < 
0.01.  
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3.3.2 Degradation of human skin by Necator americanus larval products 
Electrophoretic separation of skin extracts demonstrated the presence of a 
strong protein band at 68 kDa and relatively weak bands at 100, 55, 40, 24 and 
14 kDa (Figure 3.4, Control). Incubation of human skin with Necator 
americanus larval EF and ES products for 2 hours at 37Û&ZDVIRXQGWRFDXVH
no major changes in the protein profile of human skin. In addition to the 
marked reduction in the intensity of the 68 kDa protein band, EF products 
resulted in the disappearance of the 100, 55, 40 and 14 kDa protein bands 
(Figure 3.4, Lane 2) while ES products caused the bands at 40, 37 and 14 kDa 
to disappear.  
 
 
 
Figure 3.4 SDS-PAGE gels showing the effect of Necator americanus 
larval products on human skin. Optimal extraction of skin samples was 
obtained using 0.1M phosphate buffer as described in the Methods. 
Molecular weight of protein ladder (black), extra protein bands (red) and 
arrowheads point at changes in protein profile. 
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Human skin was shown to contain different extracellular matrix 
macromolecules including collagens I and III, fibronectin and laminin (Figure 
3.5, a²f, Lane 2). The presence of collagen I was mirrored by characteristic 
protein bands at 145, 135 and 58 kDa (Figure 3.5, a) while the presence of 
collagen III was confirmed following the detection of proteins, most 
importantly at 145, 135 and 93 kDa (Figure 3.5, b). While fibronectin was 
detected as a single band at 58 kDa, laminin involved a strong protein band at 
135 kDa, with a less intense band at 80 kDa (Figure 3.5, e and f, respectively). 
Collagens IV and V were not significantly present in human skin extracts as 
shown in Figure 3.5 (c and d). Human skin was compared to ECM proteins run 
as controls in Lanes 1 (a²f).  
             
Necator americanus larval products were found to cause minimal or no 
breakdown of collagen I, fibronectin and laminin in the skin, as shown in 
Figure 3.6 (a, c and d; Lanes 3 and 4). Changes included the disappearance of 
protein bands at 100 and 58 kDa (collagen I) and fading of the 40 kDa 
(fibronectin) with ES products. However, collagen III was considerably 
hydrolysed as featured by the loss of most protein bands except for proteins at 
135 kDa (with both EF and ES products), at 145 kDa (only with EF products) 
and traces of proteins at 50 kDa (Figure 3.6, b; Lane 3 and 4). These changes 
were not inhibited in the presence of either a mixture of protease inhibitors or 
post-infection IgG antibodies (Figure 3.6, a²d; Lane 3'²4'').  
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Figure 3.5 Western blots showing the presence of ECM molecules in 
the human skin. Molecular weights are shown either in black (protein 
ladder) or red (extra protein bands).   
Lane 1, ECM molecules as controls; 
Lane 2, human skin. 
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Figure 3.6 Effect of Necator americanus larval products on human skin 
macromolecules. Molecular weights are shown either in black (protein 
ladder) or red (extra protein bands). 
Lane 1, ECM molecules as control; 
Lane 2, human skin as control; 
Lane 3, human skin + ES products; 
Lane 4, human skin + EF products;  
Lane 3', human skin + ES + post-infection IgG;  
Lane 4', human skin + EF + post-infection IgG;  
Lane 3'', human skin + ES + All inhibitors; 
Lane 4'', human skin + EF + All inhibitors.  
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3.3.3 Comparison of the effects of Necator americanus larval products on 
ECM and human skin 
The difference in the degradation of laminin, fibronectin, collagen I and III by 
larval products is summarised in Figure 3.7. Necator americanus larval EF and 
ES products demonstrated a great ability to digest most extracellular matrix 
proteins when used in isolation (Lanes 1²3), while ECM molecules present in 
human skin were not so easily digested (Lanes 1'²3'). Degradation of both 
collagen I and III was greater with ES products, featured by the disappearance 
of protein bands at 100 and 58 kDa (collagen I) and 145 and 100 kDa (collagen 
III) from human skin as opposed to proteins of small molecular masses when 
collagens were used in isolation (Figure 3.7, a and b; Lanes 1²3). Collagen 
III, both in human skin and alone, was also degraded by EF products as shown 
in Figure 3.7 (b). Unlike collagen I and III, fibronectin and laminin from the 
human skin were not degraded by larval products while these molecules, when 
used separatly, were greatly degraded by ES products as previously described 
in Figure 3.1.      
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Figure 3.7 Western blots comparing degradation of extracellular 
matrix (Lanes 1²3) and human skin macromolecules (Lanes 1'²3') by 
Necator americanus larval products. Molecular weights are shown either 
in black (protein ladder) or red (extra protein bands). 
Lane 1, ECM molecules as control; 
Lane 2, ECM molecules + ES products; 
Lane 3, ECM molecules + EF products; 
Lane 1', human skin as control; 
Lane 2', human skin + ES products; 
Lane 3', human skin + EF products.  
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3.4 Discussion 
In order to invade the human host, Necator americanus larvae have to 
penetrate the skin and migrate through the dermal connective tissue to reach 
the microcirculation. In this work, Necator americanus larval products 
demonstrated a great ability to digest most extracellular matrix (ECM) 
macromolecules including collagens III and IV, fibronectin and laminin, as 
tested by SDS-PAGE and Western blots (Figures 3.1). Unlike previous work 
by Brown et al (1999), no degradation was observed with collagens I and V, 
indicating that larval enzymes are selective towards specific ECM molecules. 
Collagens I and III are predominantly present in the connective tissue and the 
walls of blood vessels in the skin. The molecular structure of collagen I is 
complex and accounts for its resistance to non-specific proteolytic degradation, 
making collagen III a suitable alternative target for larval proteases. In 
addition, degradation of fibronectin and laminin suggested a possible loss of 
their ability to interact with other ECM molecules and maintain the structural 
stability of the skin, as previously proposed by Hotez et al (1990) and most 
recently by Williamson et al (2006). Since collagen IV and laminin are the 
main components of basement membranes (Timpl and Brown, 1996; Timpl, 
1996), the breakdown of these molecules indicated that larval proteolytic 
activities can also create an access point for the larvae to penetrate all basement 
membranes as well as the walls of the blood vessels in the skin. Thus, our 
findings suggested that Necator americanus larval products target these 
molecules to disturb the structure of the skin and create an opening for larvae 
to migrate to the blood circulation.  
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The digestion of ECM proteins was significantly different with larval products, 
described by a selective degradation of collagen III and laminin with ES 
products and a greater affinity for collagen IV by EF products. The degradation 
of fibronectin was also different showing a single, strong protein with ES 
products opposed to multiple protein bands of lesser intensity with EF 
products. The characteristic variation in the degradation of individual ECM 
proteins might be explained by the characteristic divergence in larval enzymes, 
previously described in chapter 2. Besides exsheathment, results indicated that 
EF products, which showed a considerable ability to degrade matrix 
macromolecules, might also be involved in early stages of larval penetration 
allowing Necator americanus species to advance in the skin, as previously 
reported by Kumar and Pritchard (1992a). ES products, however, are most 
likely responsible for further larval migration deep down the skin and gaining 
access into the microcirculation. 
 
Unlike other matrix proteins, treatment of collagen V with larval products 
resulted in the disappearance of protein bands of small molecular weight and 
the emergence of new proteins with high molecular weight (Figure 3.1, d). This 
was indicative of the possible involvement of larval enzymes in the cross-
linking of small proteins and the creation of strong protein bands which are 
resistant to proteolytic cleavage (Collighan and Griffin, 2009). Further 
investigation confirmed the presence of transglutaminase activity in both EF 
and ES products, as suggested by Kasper et al (2001). The presence of 
transglutaminase has been reported in a number of parasites including 
Onchocerca volvulus (Lustigman et al, 1995), Plasmodium falciparum (Adini 
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et al, 2001) and others, the inhibition of which was found to prevent the 
moulting of L3 larvae to L4 stage larvae (Lustigman et al, 1995; Rao et al, 
1999; Chandrashekar and Mehta, 2000). Transglutaminase activity, which was 
significantly higher in ES products, therefore suggested an important role in the 
long-term maintenance and survival of Necator americanus species as well as 
the progression of the parasitic infection. 
  
Total inhibition of the enzymatic breakdown of ECM proteins with EF and ES 
products was never observed. Treatment with post-infection anti worm IgG 
antibodies demonstrated no inhibitory effect on the hydrolysis of most ECM 
molecules exclusive of fibronectin. Results suggested that the competitive 
binding of these antibodies to larval enzymes, as previously described in 
chapter 2, might account for the low inhibition of the enzymatic activity. 
However, the hydrolysis of collagens III, IV, fibronectin and laminin was 
greatly inhibited in the presence of all protease inhibitors in combination, as 
illustrated by the reappearance of original proteins bands (Figure 3.2, a²f). 
Inhibition of ECM degradation suggested that larval proteases are primarily 
involved in the hydrolysis of matrix proteins, therefore playing a major role in 
the degradation of connective tissue and migration of Necator americanus 
larvae in the skin (Brown et al, 1999). Thus, targeting larval proteases using 
specific protease inhibitors would prevent larval penetration and be beneficial 
in the course of treatment of Necator americanus infection, as suggested by 
Kumar and Pritchard (1992a) and Brown et al (1999). Protease inhibitors 
produced no change in the degradation of collagen V, indicating that larval 
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proteases are relatively selective and confirming that other enzymes were 
involved in the hydrolysis of collagen V. 
  
Although investigating the effect of larval products on individual matrix 
macromolecules has been informative, it might give different views of what 
really happen in the human skin due to the complex nature of the latter. No 
major degradation of skin extracts was observed with EF and ES products, 
compared to matrix molecules (Figure 3.4). This is likely due to the fact that 
using ECM proteins in isolation ignored the major protective role of the skin as 
featured by the complex molecular structure and the presence of tissue-derived 
protease inhibitors, which are possibly responsible for the low degradation 
profile of skin macromolecules by larval products. Protease inhibitors, which 
have been shown to exist in the skin including cysteine (Zeeuwen et al, 2009) 
and serine inhibitors (Rao et al, 1995; Rao et al, 1998) are believed to provide 
important regulatory and protective functions against uncontrolled proteolytic 
degradation from host and external pathogens. To date, the presence of aspartyl 
and metalloproteases inhibitors in the skin was not confirmed, which might 
account for the significant involvement of these protease classes in the skin 
penetration, as described by Brown et al (1999).  
   
The presence of collagens I, III, fibronectin and laminin in the skin extracts 
was confirmed using Western blots (Figure 3.5). Collagen IV was not observed 
while traces of collagen V were hardly detectable. Larval products 
demonstrated an ability to degrade skin-collagen III which was significantly 
greater with ES products while minimal digestion of collagen I and fibronectin 
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was observed. Results suggested that larval products target molecules with low 
complexity (e.g. collagen III) to create a fast and easy breach for the larvae to 
enter the host. Targeting other skin macromolecules including collagen I, 
fibronectin and laminin might require stronger proteolytic activity and larger 
numbers of species due to their complex structure, mainly responsible for the 
protective nature of the skin. In addition, degradation of skin macromolecules 
was primarily related to the characteristic presence of proteolytic enzymes in 
Necator americanus larval products, as described above. Total inhibition of 
proteolytic activities on skin macromolecules was not observed suggesting a 
potential involvement of other enzymes in the digestion process, which should 
be addressed in the future. EF products, causing noticeable breakdown in the 
skin-ECM molecules, confirmed their potential involvement in the initial 
stages of larval migration in the skin while ES products were proved essential 
for further progression towards the underlying vasculature. 
 
In summary, 
- Individual macromolecules including collagen III and IV, fibronectin 
and laminin showed a great susceptibility to larval products, suggesting 
that Necator americanus larvae might target these proteins to disturb 
the stability of the skin. 
- Skin-originated collagen III was more susceptible to larval proteolytic 
activity compared to collagen I and fibronectin, suggesting that skin 
macromolecules might be resistant to proteolysis by larval products. 
- Transglutaminase activity was present in both EF and ES products, 
possibly with a role to play in the maintenance of Necator americanus.  
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4. Interaction of Necator americanus larval products and the 
vascular endothelium 
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4.1 Introduction 
The vascular endothelium forms the intact, innermost layer of the vessel wall, 
which acts as a physical barrier to maintain vascular homeostasis and regulate 
vascular permeability. As part of the infection process, Necator americanus 
larvae are required to enter the vasculature, presumably by disrupting the 
vascular endothelium, as has been shown for other parasites such as Dirofilaria 
(Boreham, 1984) and Schistosoma (Fallon et al, 1996). Migration of 
Schistosoma mansoni through/ during the lung-stage was shown to be activated 
by excretory/secretory products during which parasites attach to endothelial 
cells (Trottein et al, 1999). Schistosoma-related studies revealed that parasitic 
enzymes induced a decrease in vascular permeability using bovine brain 
capillary endothelial cells (BBCEC) in vitro (Trottein et al, 1999), while 
intradermal administration of Schistosoma extracts was associated with 
increased vascular permeability and local oedema in vivo (Teixeira et al, 1993; 
Fallon et al, 1996). Other studies highlighted the potential involvement of 
proteases secreted by Schistosoma mansoni (Han et al, 2002; Hansell et al, 
2008) and Porphyromonas gingivalis (Imamura et al, 1995), in parasite-
induced increase in vascular permeability. Several studies have shown vascular 
permeability to change in response to physiological and pathological factors 
including permeability increasing agents such as vascular endothelial growth 
factor (VEGF) and inflammatory mediators including histamine and thrombin 
(Lampugnani et al, 1995; Esser et al, 1998; Vogel et al, 2001), as well as 
cytokines such as IL-6 and IL-8 (Ali et al, 1999; Petreaca et al, 2007). Most of 
these mediators have been reported to trigger series of phosphorylation 
cascades leading to increased permeability, which is described in section 1.3.4.  
Chapter 4: Necator americanus larval products and Endothelium 
 
 130 
Human umbilical vein endothelial cells (HUVEC) have been used successfully 
to model interactions between the malaria parasite Plasmodium falciparum and 
the ova of the bilharzia fluke Schistosoma mansoni and vascular endothelium 
(Cooke and Nash, 1995; Lejoly-Boisseau et al, 1999). In these studies, live 
Schistosoma mansoni eggs were shown to adhere to endothelial cells, 
particularly in post-capillary venules, using an in vitro flow assay using 
HUVEC cultures, while Plasmodium falciparum parasitized red blood cells 
were shown to adhere to HUVEC through intercellular adhesion molecule 
(ICAM-1). The HUVEC model, which is known to maintain the general 
properties of all endothelial cells including plasticity and molecular structure, 
has been used here to address the interaction of Necator americanus larval 
enzymes with the endothelium for the first time. This interaction was studied 
by exposing HUVEC monolayers to well defined hookworm larval exsheathing 
fluid (EF) and secretions (ES), with cell monolayer integrity being examined 
using transendothelial electrical resistance (TEER) and tracer permeability.  
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4.2 Methods 
4.2.1 Isolation of human umbilical vein endothelial cells (HUVEC) 
Human umbilical vein endothelial cells (HUVEC) were isolated from freshly 
collected umbilical cords, obtained at elective caesarean section from normal 
pregnancies, using the method of Jaffe et al (1973). Umbilical cords were 
collected in sterile 0.9% (w/v) NaCl saline containing 200 IU/mL penicillin 
DQGȝJP/VWUHSWRP\FLQDQGVWRUHGDWÛ&IRUXSWRKRXUVEHIRUHXVH
The vein at each end of the umbilical cord was cannulated with a three-ways 
stopcock and secured by tying Vincryl suture (2/0, 75 cm) around the cord at 
these ends. The vein was then perfused with pre-warmed sterile 0.9% (w/v) 
saline to remove any residual blood contents and ensure the cord is not 
damaged at any point. HUVEC were harvested by means of collagenase type II 
digestion whereby the umbilical vein was filled with Medium M199 
supplemented with 200 IU/mL penicillin,  ȝJP/ VWUHSWRP\FLQ  ȝJP/
fungizone and 0.5 mg/mL collagenase type II. Following incubation of the cord 
IRU  PLQXWHV DW Û& DQG XQGHU  &22 in a water bath containing pre-
ZDUPHG VWHULOH  ZY VDOLQH SOXV  ,8P/ SHQLFLOOLQ DQG  ȝJP/
streptomycin, the collagenase solution was passed back and forth through the 
vein using 10 mL syringes attached to stopcocks at each end of the cord to 
ensure that endothelial cells were detached from the vessel wall. The resulting 
endothelial cell suspension was collected in M20 (M199 supplemented with 
 ,8P/SHQLFLOOLQȝJP/VWUHSWRP\FLQ ȝJP/IXQJL]RQHDQG
(v/v) heat inactivated fetal bovine serum (FBS)), centrifuged at 1000 rpm for 5 
minutes at room temperature and resuspended in growth medium (M20 
supplemented with 5ȝJP/HQGRWKHOLDOFHOOJURZWKVXSSOHPHQW(&*6DQG
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ȝJP/KHSDULQDQGDOORZHGWRDWWDFKWRDZYJHODWLQFRDWHGFP2 
tissue culture flask.  
4.2.2 Maintenance, subculture and seeding of HUVEC on Transwells 
Cells were cultured on 1% gelatinised T25 cm2 flasks in growth medium M20; 
Medium 199 supplemented with 20% (v/v) heat inactivated fetal bovine serum 
(FBS), 100 IU/mL penicillin, 100 µg/mL streptomycin, 2 µg/mL fungizone, 
150 µg/mL endothelial cell growth supplement (ECGS), and 50 µg/mL 
heparin, at Û&DQG&22 in air. At 90²100% confluence, HUVEC were 
detached by incubating endothelial cells with 0.05% trypsin/ 0.02% EDTA for 
 PLQXWHV DW Û& DQG WKH UHDFWLRQ ZDV VWRSSHG E\ DGGLQJ JURZWK PHGLXP
HUVEC were then collected by centrifugation (1000 rpm for 5 minutes) and 
the pellet was resuspended in growth medium plus ECGS at 150 µg/mL, and 
heparin at 50 µg/mL. HUVEC were seeded on 1%  (w/v) gelatin coated 
transwells (12 mm, 0.4 µm) at a density of 105 cells per well and growth 
medium was refreshed every 24 hours (200 µL and 700 µL in the apical and 
basal chamber, respectively).  
4.2.3 Experimental design 
4.2.3.1 Treatment of HUVEC monolayers with EF/ES products 
For studies on endothelial barrier function, HUVEC cells were used up to the 
third passage. At confluence, HUVEC monolayers were incubated with EF/ES 
SURGXFWVIRUKRXUVDWÛ&DQG&22 in air. Growth medium was carefully 
aspirated from the apical chamber and replaced with EF/ES products while 
medium in the basal chamber was refreshed. To avoid fetal bovine serum 
(FBS) inhibiting the enzymatic activity of larval products, EF/ES products 
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were diluted in M0 (M199 supplemented with 100 IU/mL penicillin, 100 
µg/mL streptomycin and 2 µg/mL fungizone with no added FBS) and assayed 
at different concentrations (0.05²1.5 µg/mL). Į- thrombin, a serine protease 
was used as a positive control at 0.15 U/mL. HUVEC monolayers with no 
added EF/ES products were used as controls and compared to HUVEC 
monolayers treated with larval products in this assay.    
4.2.3.2 Apical/basal treatment of HUVEC monolayers with EF/ES products 
The apical/basal treatment of HUVEC monolayers was based on replacing 
growth medium in the apical, basal or both chambers with larval products. 
EF/ES products were diluted in medium M0 (to a concentration of 1.5 µg/mL) 
and incubated with confluent HUVEC monolayers for 2 hours at Û&DQG
CO2 in air. Treatment-free HUVEC monolayers, with no added EF/ES 
products, were used as controls and compared to treated HUVEC monolayers.     
4.2.3.3 Treatment of HUVEC monolayers with protease inhibitors 
EF/ES products were pre-incubated with protease inhibitors individually or in a 
PL[WXUH IRUPLQXWHV DWÛ&3URWHDVH LQKLELWRUVZHUHGLOXWHGZLWK530,-
 PHGLXP WR D W\SLFDO ZRUNLQJ FRQFHQWUDWLRQ IROORZLQJ PDQXIDFWXUHUV¶
recommendations, as shown in Table 4.1. EF/ES products, pre-treated with 
protease inhibitors, were added to the apical and basal sides of confluent 
HUVEC monolayers at a concentration of 1.5 µg/mL and incubated for 2 hours 
DW Û& DQG  &22 in air. Control HUVEC monolayers were treated with 
EF/ES products, free of inhibitors, and used for comparison to monolayers 
treated in the presence of protease inhibitors. The effect of treatment of 
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HUVEC monolayers with protease inhibitors, individually or in combination, 
with no larval products was investigated and is described in Appendix 3.  
 
Table 4.1 List of protease inhibitors used. 
 
Protease inhibitors Concentrations used  
E64 (cysteine proteases) 1 µM 
Pepstatin A (aspartyl proteases) 1 µM 
1, 10- Phenanthroline (metalloproteases) 1 mM 
Phenyl methane sulphonyl fluoride (PMSF, 
serine proteases) 
1 mM 
 
4.2.3.4 Treatment of HUVEC monolayers with post-infection anti worm IgG 
antibody 
()(6SURGXFWVJP/ZHUHLQFXEDWHGRYHUQLJKWDWÛ&ZLWK µg/mL 
of either control or post-infection anti hookworm IgG, previously described in 
section 2.2.7.1. EF/ES products, pre-treated with IgG, were added to the apical 
and basal sides of confluent HUVEC monolayers and incubated for 2 hours at 
Û& DQG  &22 in air. HUVEC monolayers, treated with EF/ES products 
only, were used as controls, compared to monolayers treated with larval 
products in the presence of IgG.   
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4.2.4 Assays of endothelial permeability 
4.2.4.1 Transendothelial electrical resistance (TEER) 
After HUVEC were seeded on gelatin coated transwells, the transendothelial 
electrical resistances (TEER) of the monolayers were monitored over a period 
of 6 days, using an EVOM resistance meter (World Precision Instruments) as 
shown in Figure 1 until they reached a steady level (~ 72²74 FP2). 
Measurements were made 20 minutes after refreshing the medium. During 
treatment with EF/ES products (described in section 4.2.3), the resistance 
across HUVEC monolayers was measured in triplicate at 20 minutes intervals. 
Specific TEER values were then calculated by subtracting the resistance of a 
cell-free transwell insert from the resistance measured across individual 
monolayers. At the end of the 2 hours period, medium from the apical and 
basal chambers were collected and stored at -Û&IRUIXUWher analysis and the 
wells were transferred to a new plate to study the leakage of tracer across 
HUVEC monolayers. 
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Figure 4.1 Schematic representation of the experimental apparatus 
used to measure transendothelial electrical resistance (TEER). Electrodes 
measure the electrical current, carried by ions across HUVEC 
monolayers, as the change in voltage between the apical and basal 
compartments of the transwells. 
   
4.2.4.2 Leakage of TRITC- Albumin 
The leakage of tetramethylrhodamine isothiocyanate TRITC-albumin (~ 68 
kDa) across pre-treated HUVEC monolayers was assessed, described in 
sections 4.2.3.1²4.2.3.4. TRITC-albumin tracer was dissolved in RPMI-1640 
phenol red-free medium with 20% FBS to a concentration of 50 mM and added 
to the apical chamber (200 µL each). Cells were incubated and alternated 
EHWZHHQ Û& DQG URRP WHPSHUDWXUH RQ DQ RUELWDO VKDNHU WR HQVXUH
homogenous distribution of tracer) over a total period of 2 hours. Triplicate, 20 
µL aliquots were collected from the basal chamber at 20²30 minutes intervals 
and made up to 100 µL with RPMI-1640 medium with 20% FBS. Retrieved 
aliquots from the basal chamber were immediately replaced. The amount of 
 EVOM 
Meter 
 
0.4 µm 12 mm transwell plate 
Apical 
Chamber 
Basal 
Chamber 
Electrodes 
HUVEC monolayer 
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tracer-fluorescence crossing individual monolayers was then measured using 
DYNEX Microtiter Plate MFX Fluorometer (excitation = 530 nm, emission = 
590 nm) and values were converted to concentrations of the tracer, TRITC- 
albumin. The leakage of TRITC-albumin across cell-free transwell inserts was 
measured by collecting 20 µL aliquots from the basal chamber at 20²30 
minutes intervals. Retrieved aliquots were immediately replaced and made up 
to 100 µL with RPMI 1640 medium with 20% FBS. 
 
Figure 4.2 Schematic of the experimental apparatus used to measure 
the leakage of tracer across HUVEC monolayers.  
4.2.4.3 Standard curve for TRITC-albumin tracer 
TRITC-albumin tracer was dissolved in RPMI 1640 phenol red-free medium 
with 20% FBS to a known concentration (0²100 mM) and added to the apical 
chamber of the insert (200 µL each). The amount of tracer-fluorescence was 
measured using DYNEX Microtiter Plate MFX Fluorometer (excitation = 530 
nm, emission = 590 nm) and plotted against the concentration of TRITC- 
albumin to generate a standard curve.   
Tracer/RPMI 
HUVEC layer 
0.4 µm 12 wells transwell plate 
 
RPMI 1640  
+ 20% FBS 
2.   Replace with 
60 µl of RPMI-
1640 + 20% FBS 
1.  Take 3 x 20 µl 
samples per time 
point 
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4.2.5 Immunocytochemistry  
HUVEC monolayers were gently washed and fixed for 10 minutes in 1% (w/v) 
paraformaldehyde (PFA) in PBS (pH 7.2), permeabilised for 10 minutes with 
0.15% (v/v) Triton X-100, and blocked for 30 minutes in phosphate buffered 
saline (PBS) containing 5% (v/v) normal human serum, all at room 
WHPSHUDWXUH&HOOVZHUHLQFXEDWHGRYHUQLJKWDWÛ&ZLWKDSULPDU\DQWLERG\DV
shown in Table 4.2. After washing with 0.1% BSA/PBS, cells were incubated 
for 2 hours at room temperature, in the dark, with a secondary antibody (Table 
4.2). Both primary and secondary antibodies were diluted to the appropriate 
concentration with bovine serum albumin (0.1% BSA/PBS), unless otherwise 
stated. Staining for F-actin was performed by incubating cells with FITC 
conjugated phalloidin (50 µg/mL in PBS) for 2 hours at room temperature, in 
the dark. HUVEC cells were washed twice with 0.1% BSA/PBS followed by 
one wash with PBS and finally mounted in Vectorshield with propidium iodide 
to visualise the nuclei. Cells were then observed using a Leica TCS SP2 
confocal laser scanning microscope (n = 3).   
 
Table 4.2 List of antibodies used in immunocytochemistry.  
 
Junctional 
molecules 
Primary antibody Secondary antibody 
VE-Cadherin Monoclonal anti-CD 144 
(used at 10 µg/mL) 
FITC conjugated anti-mouse 
IgG, diluted to 1:50 (v/v) 
Occludin Polyclonal anti-occludin 
(used at 25 µg/mL) 
TRITC conjugated anti-rabbit 
IgG, diluted to 1:10 (v/v) 
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4.2.6 Microscopy 
4.2.6.1 Phase microscopy 
HUVEC monolayers were grown to confluence on 1% (w/v) gelatin coated 
tissue culture flasks and the morphology of cells was visualised using a Nikon 
phase-contrast microscope. The confluence of HUVEC cultures was checked 
before any experiment and imaging was performed using a Nikon Coolpix 995 
digital camera at different magnifications.   
4.2.6.2 Confocal microscopy 
Leica TCS SP2 confocal laser scanning microscope was used to image 
HUVEC monolayers following immunocytochemistry. Cell monolayers were 
scanned using the glycerol immersion lens with an objective magnification of 
63 x. The viewer window was used to arrange, manipulate and produce images 
with the maximum intensity. Finally both multi-channel and single images 
were named accordingly and saved as snapshots.   
4.2.7 Statistical analysis 
Where appropriate, data were analyzed with GraphPad Prism version 5.01. 
Values are presented as means (n = 3) ± SEM and statistical significance was 
determined by two-way ANOVA tests followed by Bonferroni post-tests. 
Statistical significance was defined as P < 0.05.  
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4.3 Results 
4.3.1 Characterisation of human umbilical vein endothelial cell 
monolayers (HUVEC) 
4.3.1.1 Integrity of normal HUVEC monolayers 
Transendothelial electrical resistance (TEER) and solute permeability assays 
were used to evaluate the physical integrity of endothelial monolayers, not 
stimulated by Necator americanus larval product. TEER showed a rapid 
increase during the first 48 hours, followed by a plateau of 72²7 FP2 
when HUVEC monolayers reached confluence (Figure 4.3).   
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Figure 4.3 Transendothelial electrical resistance across HUVEC 
monolayers. TEER was measured, in triplicates, using EVOM resistance 
meter and values are presented as the mean ± SEM.  
 
Conversion of fluorescence units to concentration of TRITC-albumin (i.e. the 
number of TRITC moles per mole of albumin) aimed at eliminating any 
sources of variation in our data. The standard curve, shown in Figure 4.4, 
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described the relationship between fluorescence and concentration of tracer 
between 0 and 100 mM. The linearity of the standard curve, as evidenced by an 
R2 value of 0.9992, allowed the use of a straight line equation to determine 
unknown concentrations of TRITC-albumin, in subsequent experiments.  
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Figure 4.4 Standard curve for TRITC-albumin. Values are presented 
as the mean ± SEM. The relationship between TRITC-albumin 
concentrations and fluorescence was linear.    
 
To investigate the effect of medium in the permeability assay, TRITC-albumin 
was dissolved in media with or without phenol red at a concentration of 50 
mM, and the amount of fluorescence was measured, as described in section 
4.2.4.2. Figure 4.5 summarises that the yield of TRITC-albumin was 
significantly higher (63 mM) when dissolved in Medium 20 (M199 with 
phenol red, containing 20% FBS), compared to RPMI-1640 (with 20% FBS), 
phenol red-free (49.9 mM). Media containing phenol red was shown to 
interfere with fluorescence, resulting in inaccurate readings, therefore the use 
of RPMI-1640, phenol-red free, was approved for the following experiments.     
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Figure 4.5 Effect of media on TRITC-albumin concentration. The 
concentration of tracer, dissolved in different media, was measured and 
values are presented as the mean of concentration ± SEM, *** = P < 0.001, 
compared to RPMI-1640 + 20% FBS. 
 
The quantity of TRITC-albumin crossing the transwell inserts increased over 
the 2 hour-period and was significantly higher in the absence of cell 
monolayers (Figure 4.6). The presence of confluent HUVEC monolayers, as 
assessed by TEER, significantly reduced the leakage of TRITC-albumin by ~ 
81% after 2 hours, as opposed to cell-free inserts. The percentage of TRITC-
albumin recovered from the basal compartment was calculated (Equation 4.1).  
 
100)mM50(minalbuTRITCofinputOriginal
monolayersgnicrossminalbuTRITCofoniConcentrat u

 
 
Equation 4.1 Formula of percentage leakage of TRITC-albumin to the 
original input 
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Table 4.3 Percentage of TRITC-albumin leakage across transwell 
inserts, calculated using equation 4.1.   
 
A recovery of 22.3% of the original tracer input was observed with cell-free 
inserts, as compared to a 4.3% with confluent HUVEC monolayers (Table 4.3). 
Equilibrium was never achieved over the 2 hour-study indicating the 
importance of endothelial cells in regulating solute permeability across 
HUVEC monolayers.     
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 Figure 4.6 Leakage of TRITC-albumin across HUVEC monolayers. 
TRITC-albumin concentrations are presented as the mean ± SEM. *** = P 
< 0.001 and ** = P < 0.01 compared to cell monolayers.   
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basal chamber after 120 minutes 
Cell-free 
HUVEC monolayer 
22.3 
4.3 
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Plotting TEER against tracer leakage, both measured across HUVEC 
monolayers, demonstrated a strong inverse relationship and linear relationship 
as demonstrated by an R2 of 0.7439 between these two parameters of 
endothelial permeability (Figure 4.7). Hence, high resistance across HUVEC 
monolayers is mirrored by low solute/tracer leakage, indicating high 
confluence of these monolayers.  
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Figure 4.7 A plot of TEER across HUVEC monolayers against their 
permeability to TRITC-albumin.   
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4.3.1.2 Morphology of HUVEC monolayers 
Morphological features of HUVEC cultures were investigated using phase-
contrast microscopy. Early in their growth, HUVEC cells showed an elongated 
morphology (Figure 4.8, a). At confluence, reached by 48²72 hours, cells 
exhibited typical cobblestone morphology as shown in Figure 4.8 (b). 
 
 
 
 
Figure 4.8 Phase contrast micrograph of HUVEC cells grown to a) 
90% confluence and b) 100% confluence. Bars = 100 µm. 
100 µm 
100 µm 
a 
b 
24 h 
48 h 
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4.3.1.3 Junctional molecules present in HUVEC monolayers 
The organisation of cell to cell junctions in confluent HUVEC monolayers was 
studied using confocal microscopy. Confluent endothelial monolayers 
exhibited a significant presence and continuity of the adherens junction protein, 
VE-Cadherin, while the tight junction molecule, occludin, was present but 
weak, showing a patchy distribution (Figure 4.9, a and b). F-actin filaments 
were mostly localised at the periphery, cell-cell border (Figure 4.9, d), with 
some stress fibers (Figure 4.9, c). Changes in junctional integrity in response to 
Necator americanus larval EF/ES products are described in chapter 5.   
  
  
Figure 4.9 Immunostaining of HUVEC monolayers against junctional 
molecules. a) VE-Cadherin, b) occludin, c) and d) F-actin. Nuclei were 
stained with propidium iodide (red) in (a), (b) and (d). Bars = 20 µm.  
a  b 
 c  d 
 Ż 
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4.3.2 Interaction of Necator americanus larval products with human 
umbilical vein endothelial cell monolayers (HUVEC) 
4.3.2.1 Effects of concentration of larval products on monolayer permeability 
Changes in endothelial permeability as assessed by a decrease in resistance 
(TEER) and an increase in tracer leakage across endothelial monolayers were 
related to concentration of EF/ES products in the culture medium. The decrease 
in monolayer resistance was dose-dependent and continued over a period of 2 
hours, as shown in Figures 4.10 (a and b). Both EF and ES products caused a 
statistically significant reduction of TEER from control values (- 46.8% and - 
50.9%, P < 0.001 respectively) when used at a final concentration of 1.5 µg/mL 
(P < 0.001, Figure 4.10, c). 7KHVHULQHSURWHDVHĮ-thrombin was also found to 
induce a reduction in TEER across HUVEC monolayers (P < 0.001).  
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Figure 4.10 Changes in transendothelial electrical resistance (TEER) 
across HUVEC monolayers following treatment with larval, a) EF 
products and b) ES products. c) Percentage changes from control TEER at 
different concentrations of EF/ES products at the end of the 2 hour-study. 
TEER values are presented as a percentage of reduction in original TEER 
± SEM. * = P < 0.01, ** = P < 0.001 compared to original resistance of 
untreated controls. 
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Changes in HUVEC resistance correlated with a dose-dependent (0.05²1.5 
µg/mL) and time-related increase in levels of TRITC-albumin crossing treated 
monolayers over the 2 hour-study, compared to untreated monolayers (Figure 
4.11, a and b). Although similar in pattern, ES products significantly 
demonstrated greater tracer leakage at any one dose compared to EF products 
and Į-thrombin (Figure 4.11, (c); Table 4.4). The percentage of increase in 
TRITC-albumin leakage across treated monolayers, as opposed to control 
HUVEC monolayers was calculated using Equation 4.2.  
 
100
monolayerscontrolgsincrostracerof.Conc
monolayerstreatedgsincrostracerof.Concmonolayerscontrolgsincrostracerof.Conc u
  
Equation 4.2 Formula of percentage of TRITC-albumin leakage to 
control HUVEC monolayers     
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b- ES products
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Figure 4.11 Leakage of TRITC-albumin across HUVEC monolayers 
following treatment with a) EF products, b) ES products and c) EF vs. ES 
products at the end of the 2 hours-study. TRITC-albumin concentrations 
were calculated by subtracting tracer leakage across a blank monolayer 
and reported as the mean ± SEM. Significance was defined as * = P < 0.01 
and ** = P < 0.001, compared to untreated controls.  
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Table 4.4 describes permeability at the end of the 2 hour-period as the 
percentage increase in TRITC-albumin leakage across treated monolayers 
compared to untreated HUVEC monolayers, calculated using equation 4.2. A 
gradual increase in tracer leakage was observed as a function of the 
concentration of larval products in medium (0.05²1.5 µg/mL). For all the 
following experiments, larval EF and ES products were used at a concentration 
of 1.5 µg/mL, which caused a significant increase of 85.1% and 135.6%, 
respectively, compared to an increase of 72.2% caused by the positive control, 
Į-thrombin. 
 
Table 4.4 Percentage of increase in TRITC-albumin leakage across 
treated HUVEC monolayers, compared to control HUVEC monolayers 
after 2 hours.  
 
Concentration of larval 
products (µg/mL) 
% of increase in TRITC-albumin leakage 
EF ES 
0.05 + 24.5 + 42 
0.25 + 47.8 + 57.8 
0.5 + 59.3 + 82.8 
1.0 + 70.9 + 98.5 
1.5 + 85.1 + 135.6 
Thrombin (0.15 U/mL) + 72.2 
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4.3.2.2 Effects of apical/basal administration of larval products on monolayer 
permeability 
The increase in endothelial permeability was significantly higher than basally-
treated monolayers (P < 0.001) when larval products were administered to the 
apical chamber and highest when applied to both chambers of transwells. The 
latter resulted in a reduction in TEER compared to control values (- 46.8% 
(EF) and - 50.9% (ES)) as opposed to the reduction of - 37.3% (EF) and - 
40.5% (ES), observed with apical treatment of HUVEC monolayers as shown 
in Figure 4.12 (a). This was associated with an increase in tracer leakage 
(74.8% vs. 85.1% for EF, 130.3% vs. 135.6% for ES) following larval 
treatment of the apical and both chambers, as described in Table 4.5. Tracer 
leakage, shown in Figure 4.12 (b), displayed a biphasic pattern with a slow 
increase in TRITC-albumin crossing HUVEC monolayers, which were treated 
on the apical and both chambers, over the first 40 minutes of the permeability 
assay. Significant tracer leakage was then observed as early as 60 minutes post-
treatment (apical and both chambers only, P < 0.01) and was found to increase 
over the 2 hour-study (Figure 4.12, b).  
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Figure 4.12 Effects of apical/basal administration of larval products on 
monolayer permeability. a) Percentage of reduction in TEER from 
untreated HUVEC monolayers, during treatment with larval products. 
TEER values are presented as a percentage of reduction in TEER ± SEM, 
** = P < 0.01 and *** = P < 0.001 compared to original TEER of untreated 
controls. b) Leakage of TRITC-albumin over time with larval products at 
the apical, basal or both chambers. TRITC-albumin concentrations are 
reported as the mean ± SEM. ** = P < 0.01, *** = P < 0.001 compared to 
untreated controls. 
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In contrast, the presence of both larval products individually in the basal 
chamber caused a significant decrease in monolayer resistance (- 24.7% for EF, 
- 30.6% for ES, P < 0.01)  as shown in Figure 4.12 (a), and a slow increase in 
tracer leakage which continued over the 2 hour-assay (Figure 4.12, b). A minor 
increase in TRITC-albumin levels (1.4% for EF, 8.6% for ES) was observed 
after the 2 hour-permeability assay, compared to untreated monolayers (Table 
4.5). 
 
Table 4.5 Percentage of increase in TRITC-albumin leakage across 
treated monolayers, calculated following equation 4.2. Significance was 
defined as P < 0.05 compared to untreated HUVEC monolayers with *** = 
P < 0.001.   
 
Administration of 
larval products 
% of increase in TRITC-albumin leakage 
EF ES 
Apical (***) + 74.8 + 130.3 
Basal + 1.4 + 8.6 
Both Chambers (***) + 85.1 + 135.6 
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4.3.2.3 Effects of protease inhibition of larval products on monolayer 
permeability  
The use of protease inhibitors singly and in combination prior to treatment of 
HUVEC monolayers with larval EF/ES products resulted in a better 
preservation of endothelial barrier properties as revealed by improved TEER 
and reduced tracer leakage across treated monolayers. Inhibitors, used together, 
were the most effective treatment resulting in a minimal reduction in TEER 
(16.6% for EF, 18.4% for ES) compared to the resistance of individually-
treated (especially with PMSF; 27.9% for EF, 33.3% for ES) and inhibitor-free 
(46.8% for EF, 50.9% for ES) monolayers (Figure 4.13, a). The measured 
TEER values agreed with the subsequent, statistically significant reduction in 
tracer leakage values measured post-treatment and summarised in Table 4.6. 
The use of inhibitor cocktails resulted in an increase in tracer leakage of 28.4% 
vs. 85.1% (EF) and 32.5% vs. 135.6% (ES), compared to inhibitor-free 
monolayers. Individual inhibitors also showed a significant reduction in tracer 
leakage, such as PMSF associated with leakage of 60.8% vs. 85.1% (EF) and 
84.9% vs. 135.6% (ES) compared to untreated, inhibitor-free monolayers, as 
demonstrated in Figure 4.13 (b).  
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Figure 4.13 Effects of protease inhibition of larval products on 
monolayer permeability. a) Percentage change in transendothelial 
electrical resistance (TEER) from control resistance during treatment with 
larval products. TEER values are presented as a percentage of reduction 
in resistance ± SEM, ** = P < 0.01 and *** = P < 0.001, compared to 
reduction in TEER of EF/ES treated controls. b) TRITC-albumin leakage 
across HUVEC monolayers post-treatment with protease inhibitors. 
Tracer concentrations are reported as the mean ± SEM. * = P < 0.05 and 
** = P < 0.01, compared to EF/ES treated controls.  
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Table 4.6 describes the percentage increase in tracer leakage across HUVEC 
monolayers, treated with larval products in the presence of protease inhibitors. 
Inhibitors, used individually, were associated with a moderate increase in tracer 
leakage while treatment with all inhibitors, in combination, demonstrated the 
lowest leakage of TRITC-albumin (shown in red), compared to monolayers 
treated with larval EF/ES products only (shown in bold). Of note was that 
preservation of endothelial permeability was greater with inhibition of ES 
products than EF products (P < 0.05).  
 
Table 4.6 Percentage of increase in TRITC-albumin leakage across 
treated monolayers, after the 2 hour-permeability assay. 
  
Concentration of larval 
products (µg/mL) 
% of increase in TRITC-albumin leakage 
EF ES 
E64 + 75.9 + 89.1 
Pepstatin A + 73.1 + 96 
1, 10 phenanthroline + 77.2 + 93.3 
PMSF + 60.8 + 84.9 
All inhibitors + 28.4 + 32.5 
Controls (+ EF or ES) + 85.1 + 135.6 
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4.3.2.4 Effects of post-infection IgG antibodies on monolayer permeability 
The use of IgG antibodies, taken from individuals naturally infected with 
Necator americanus, induced no change in the disruption of endothelial 
monolayers caused by Necator americanus larval products. In Figure 4.14 (a 
and b) describing larval-induced reduction in monolayer resistance, both post-
infection IgG and control sera (from healthy, non infected individuals) were 
unable to prevent the significant decrease in TEER, previously described with 
larval EF and ES products. TEER, measured after the 2 hour-treatment, was 
significantly reduced to ~ 45% and 51%, with EF and ES respectively (Figure 
4.14, c).  
 
   a- EF products
0 30 60 90 120
40
50
60
70
80
Control (+EF)
+ Control sera
+ Post-infection IgG
Untreated (HUVEC)
Time (minutes)
TE
ER
 (:
.
cm
2 )
r  S
EM
 
Chapter 4: Necator americanus larval products and Endothelium 
 
 159 
b- ES products
0 20 40 60 80 100 120
30
40
50
60
70
80
Control (+ES)
+ Control sera
+ Post-infection IgG
Untreated (HUVEC)
Time (minutes)
TE
ER
 (:
.
cm
2 )
r  S
EM
 
c- EF vs ES products
ES EF
-60
-40
-20
0
Control (+ES or EF)
+ Control sera
+ Post-infection IgG
%
 
o
f r
e
du
ct
io
n
 
fr
o
m
 
o
ri
gi
n
a
l T
EE
R
r  S
EM
 
Figure 4.14 Changes in TEER across HUVEC monolayers, following 
treatment of larval products with post-infection IgG antibodies; a) EF 
products and b) ES products. c) Percentage of reduction from control 
TEER for EF and ES products at the end of the 2 hour-treatment. TEER 
values are presented as a percentage of reduction in original TEER ± SEM 
and statistically compared to EF/ES treated controls. 
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In accordance with changes in monolayer resistance, treatment with post-
infection IgG and control sera was associated with a significant, continuous 
increase in TRITC-albumin leakage, compared to antibody-free monolayers 
(Figure 4.15, a and b). At the end of the 2 hour- permeability assay, tracer 
leakage was significantly higher than that across untreated HUVEC 
monolayers, except for those ES-treated monolayers in the presence of post-
infection IgG (Figure 4.15, c). Although a modest inhibition of larval-induced 
increase in tracer leakage was observed, these results indicated that post-
infection IgG were unable to preserve monolayer integrity by inhibiting larval 
activities. 
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b- ES products
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Figure 4.15 Leakage of TRITC-albumin across HUVEC monolayers 
post-treatment with post-infection anti worm IgG antibodies, in response 
to; a) EF products, b) ES products and c) EF vs. ES products at the end of 
the 2 hour-study. TRITC-albumin concentrations are presented as the 
mean ± SEM. * = P < 0.05 and ** = P < 0.01, compared to untreated 
HUVEC controls. 
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4.4 Discussion 
Human umbilical vein endothelial cells (HUVECs) were used as an in vitro 
model of the human endothelium to study the interaction between Necator 
americanus larval enzymes and the vascular endothelium. The physical 
integrity of HUVEC monolayers was examined using transendothelial 
electrical resistance (TEER) and solute permeability assays. A rapid increase in 
TEER values was characteristic of the 48 hours post-seeding on transwell 
inserts and indicative of the continuous growth of HUVEC monolayers. Once 
confluent, the resistance across HUVEC monolayers reached a ceiling of 72 
WR FP2 which was maintained over the following 72 hours (Figure 4.3). 
The resistance measured in these HUVEC monolayers was higher than that 
demonstrated in a study by Blum et al (1997), in which TEER values of 
FRQIOXHQW +89(& PRQROD\HUV UHDFKHG D PD[LPXP RI  FP2. The 
difference between these studies may be due to growing HUVEC monolayers 
at different passages, as described by Man et al (2008). All the cultures used in 
this study were used at passages 1²3, ensuring restrictive, confluent HUVEC 
monolayers with all molecular occupancy of endothelial junctions (Figure 4.9). 
However, HUVEC monolayers exhibited lower resistance than other cell lines 
including human brain endothelial cells (150²155 FP2), as reported by 
Blum et al (1997). This is primarily due to the almost-total absence of tight 
junctions-associated proteins in HUVEC monolayers, previously described in 
the literature (Stins et al, 1997), and re-examined in this thesis. Figure 4.9 (b) 
showed that occludin, the tight junction molecule which is abundantly present 
in endothelial cells from vascular beds with restrictive permeability, was 
moderately observed in HUVEC endothelial monolayers, mostly accounting 
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for the considerably low resistance of these monolayers and re-emphasising the 
molecular heterogeneity observed in the endothelium, as described in section 
1.3.3.    
 
Resistance across HUVEC monolayers had a strong inverse linear relationship 
with tracer leakage, suggesting that the integrity of endothelial monolayers at 
confluence was associated with the highest resistance and the lowest solute 
permeability (Dewi et al, 2004; Dewi et al, 2008). The great ability of 
confluent HUVEC monolayers to reduce tracer leakage compared to cell-free 
inserts (by 81%), allowed these monolayers to be used as a predictor of 
putative substances that can enhance endothelial permeability.  
 
The morphology of HUVECs changed from elongated, early in their growth, to 
a typical cobblestone shape with more cell to cell contacts once monolayers 
reached confluence. These observations emphasised that the increase in the 
integrity of endothelial monolayers accounted for the increase in their 
resistance and subsequently, their barrier functions. VE-cadherin, the adhesion 
molecule which is detected only in vascular endothelial cells (Liaw et al, 1990; 
Lampugnani et al, 1992; Leach et al, 1993), is believed to increase the 
stabilisation of junctional structure by being anchored to the actin cytoskeleton 
(Dejana et al, 2000; Firth, 2002). In this study, confluent HUVEC monolayers 
exhibited a continuous presence of VE-cadherin at cellular junctions while F-
actin was localised peripherally, at cell to cell borders (Figure 4.9).  
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In this chapter, studies were focused on investigating changes in the vascular 
permeability related to larval enzymatic activity. Results demonstrated a dose 
related increase (0.05²1.5 µg/mL) in HUVEC monolayer permeability to 
albumin following treatment with larval products, as shown by reduced 
transendothelial electrical resistance (TEER) and increased leakage of TRITC-
albumin (Figures 4.10 and 4.11, respectively). Disruption of endothelial barrier 
functions (i.e. permeability) was most significant upon treatment with larval ES 
products emphasising the potential involvement of excretory/secretory (ES) 
products in the penetration process and the interaction between Necator 
americanus larvae and the endothelium. Bacteria, such as Prophyromonas 
gingivalis, were also shown to gain access to the host by inducing an increase 
in vascular permeability in response to parasitic proteinases (Imamura et al, 
1995). In addition, treatment of HUVEC monolayers with larval products at 
high doses was also associated with significant alterations in their barrier 
properties, observed as early as 40 minutes post-treatment, indicating that a 
strong presence of larval products may associate with an earlier disruption of 
WKH HQGRWKHOLXP DQG IDVWHU HQWU\ RI ODUYDH LQWR WKH KRVW¶V PLFURFLUFXODWLRQ
However, the use of larval products at low doses (i.e. 0.05 µg/mL) induced a 
significant reduction in monolayer resistance but had no major effect on tracer 
leakage across treated monolayers, implying that TEER is a more sensitive 
marker to changes in endothelial permeability.  
 
A two-phase increase in monolayer permeability was induced by larval 
products applied to the apical chamber or following apical and basal 
simultaneous treatments of HUVEC monolayers and is described as a slow 
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increase in tracer leakage during the first 40 minutes and a subsequent rapid 
increase over the last 60 minutes of the assay. However, basal treatments of 
HUVEC monolayers were associated with a slow, non significant increase in 
permeability (i.e. tracer leakage). These changes suggest that direct bathing 
with larval products allowed them to negotiate and disturb endothelial 
monolayers faster compared to monolayers treated from the basal side. The 
increase in permeability upon basal treatments may be delayed due to the need 
to navigate multiple layers (i.e. plastic membrane and gelatin coating in the 
experimental setup), before reaching the cells. In vivo, larval-induced 
permeability upon apical application may account for larval migration from the 
blood into the surrounding tissue during the lung-stage, possibly with similarity 
to transendothelial migration of leukocytes during inflammatory reactions 
(Moll et al, 1998) while increased permeability following basal application 
may facilitate larval entry into the microcirculation. Larvae are therefore 
required to breach the basement membrane before reaching the endothelium 
which is possibly facilitated by the ability of Necator americanus larval 
enzymes to digest skin macromolecules including collagen IV and laminin, the 
main components of all basement membranes, as described in chapter 3.  
 
The use of enzyme inhibitors demonstrated the importance of the combined 
effect of serine, cysteinyl, aspartyl and metalloproteases in modulating 
endothelial permeability (Figure 4.13). Although the use of all inhibitors in 
combination exhibited the highest protection of endothelial integrity, a total 
preservation of endothelial barrier functions was never seen which suggests 
that other larval enzymes may also be involved, therefore requiring further 
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characterisation of larval EF and ES products. This also suggests that enzyme 
inhibitors are not wholly effective, even as cocktails, against mixed enzyme 
populations. In addition, treatment with larval products might also trigger the 
activation of matrix metalloproteinases (MMPs) from endothelial cells which 
in turn, can be partially responsible for inducing an increase in vascular 
permeability (Lafleur et al, 2001; Alexander, 2002; Johannsson et al, 2007). 
Inactivation of tissue-associated protease inhibitors might also be triggered in 
the presence of Necator americanus larval enzymes leading to an increase in 
vascular permeability, as previously observed with Schistosoma mansoni 
species (Hansell et al, 2008). Furthermore, post-infection IgG were unable to 
prevent larval-induced endothelial permeability, indicating that these 
antibodies act as a competitive substrate to larval enzymes, not affecting the 
functionality of these enzymes as suggested in chapters 2 and 3, and that 
antibodies against specific larval enzymes may be required to provide better 
protection against hookworm infection at early stages. Due to the significance 
of larval migration during early stages of the hookworm infection, mechanisms 
underlying larval-induced permeability will be addressed in chapter 5.  
  167 
 
 
 
 
 
 
 
 
 
 
 
5. Cellular mechanisms underlying endothelial responses to 
Necator americanus larval products 
Chapter 5: Cellular mechanisms 
 168 
5.1 Introduction 
Vascular permeability has been shown to change in response to 
pathophysiological stimuli including permeability increasing agents such as 
vascular endothelial growth factor (VEGF), proteases and inflammatory 
mediators including histamine and thrombin (Imamura et al, 1995; Esser et al, 
1998; Vogel et al, 2001; Hansell et al, 2008). The pro-inflammatory effects of 
thrombin, a serine protease of major importance in the coagulation cascade, 
and gingipains, cysteine proteases derived from Porphyromonas gingivalis, 
have been shown to be mediated by activation of endothelial cells to promote 
the production of acute inflammatory cytokines including IL-6 (Day et al, 
2006) and IL-8 (Inomata et al, 2007), respectively. Neutrophil derived 
proteolytic activities have also been shown to mediate increased vascular 
permeability and enhanced transmigration of monocytes through the activation 
of endothelial cells and IL-8 release (Lukacs et al, 1995; Moll et al, 1998).  
 
On a morphological and a functional basis, one of the major structures 
regulating vascular permeability is the inter-endothelial cleft. Junctional 
adhesion molecules located in this cleft are essential for establishing strong 
homotypic and heterotypic connections and anchoring junctional molecules to 
the cellular actin cytoskeleton, promoting stabilisation of junctions (Dejana et 
al, 2000; Firth, 2002). Protease-related alterations in vascular permeability 
concurred with reorganisation of actin filaments and formation of intercellular 
gaps in the endothelial barrier, as described previously by Moll et al (1998) and 
Young et al (2003). In addition, disruption of essential adhesion molecules at 
endothelial cell to cell contacts has been reported, evidenced by the 
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remodelling of VE-cadherin in response to actin modulating stimuli (Hordijk et 
al, 1999). The involvement of junctional components in modulating the 
vascular permeability has been described in section 1.3.4. 
 
In chapter 4, Necator americanus larval enzymes induced an increase in 
vascular permeability, which might be related to cytotoxic effects of larval 
enzymes causing endothelial cells to detach and leading to a degree of 
disruption in the endothelial integrity. However, junctional structures present 
another potential gateway for Necator americanus larvae to breach the 
endothelium and enter the blood circulation. In this chapter, the effects of 
Necator americanus larval EF and ES products on the viability of cells and on 
cell to cell junctions were investigated. The latter involved staining for actin 
filaments and VE-cadherin, the main junctional components with a major role 
to play in modulating permeability, as described in section 1.3.4. In addition, 
larval-induced activation of endothelial cells was determined by measuring 
cellular secretions of cytokines (IL-6 and IL-8) and VEGF, which have been 
implicated in protease-induced vascular permeability.  
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5.2 Methods 
5.2.1 Quantification of cellular responses using Enzyme Linked 
ImmunoSorbent Assay (ELISA) 
Following treatment with EF/ES products, cell supernatants were collected, 
centrifuged for 10 minutes at 13000 x g to remove cell debris, and stored at -
Û&SHQGLQJDQDO\VLV+XPDQ9(*),/-6 DuoSet® ELISA Development kit 
and IL-8 ELISA kit were used to quantify VEGF, IL-6 and IL-8 in the 
VXSHUQDWDQWVDFFRUGLQJWRWKHPDQXIDFWXUHUV¶UHFRPPHQGDWLRQV7able 5.1). In 
brief, a capture antibody was diluted to an appropriate working concentration 
and used to coat a 96 well Nunc MaxiSorb plate (100 µL per well). The plate 
ZDVVHDOHGDQGLQFXEDWHGRYHUQLJKWDWURRPWHPSHUDWXUHRUDWÛ&,/-8 only) 
after which time wells were extensively washed with PBS containing 0.05% 
Tween 20 and blocked for 1 hour at room temperature with 1% bovine serum 
albumin in PBS (300 µL of 1% BSA/PBS per well). Following three washes 
with PBS/0.05% Tween 20, standards and cell supernatants were diluted in 1% 
BSA/PBS, added as 100 µL per well and incubated for 2 hours at room 
temperature. The wells were carefully aspirated and washed with PBS/0.05% 
Tween 20 and 100 µL of an appropriate detection antibody was added per well 
and incubated for 2 hours at room temperature. After careful washing, 100 µL 
of Streptavidin-Horseradish Peroxidase (HRP, diluted 1:200 (v/v) in 1% 
BSA/PBS) was added per well and incubated for 30 minutes at room 
temperature. Extensive washing of the wells was followed by the incubation of 
100 µL of TMB substrate solution per well (prepared as described in section 
2.2.7.3) for 20 minutes at room temperature and the reaction was stopped by 
adding 50 µL of 2.5 M sulphuric acid per well.  
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Table 5.1 Summary of materials used in the ELISA procedure.   
  
Step  VEGF  IL-6 IL-8 
Capture  
antibody  
Diluted with PBS 
and used at 1 
µg/mL 
Diluted with PBS 
and used at 2 
µg/mL 
Diluted in 0.1 M 
phosphate buffer, 
pH 9.0 and used at 
1 µg/mL 
Standards Diluted with 1% 
BSA/PBS, 
concentration range 
1²60 pg/mL, 
overnight at room 
temperature 
Diluted with 1% 
BSA/PBS, 
concentration range 
1²75 pg/mL, 
overnight at room 
temperature  
Diluted with 1% 
BSA/PBS/0.05% 
Tween 20, 
concentration range 
0.1²100 pg/mL, 
RYHUQLJKWDWÛ& 
Samples Diluted 1:2 (v/v) 
with 1% BSA/PBS 
Diluted 1:2 (v/v) 
with 1% BSA/PBS 
Diluted 1:2 (v/v) 
with 1% BSA/PBS/ 
0.05% Tween 20 
Detection 
antibody 
Diluted with 1% 
BSA/PBS and used 
at 100 ng/mL 
Diluted with 1% 
BSA/PBS and used 
at 200 ng/mL 
Diluted with 1% 
BSA/PBS/0.05% 
Tween 20 and used 
at 1 µg/mL 
Detection 
limits 
1²2000 pg/mL 1²600 pg/mL 0.1²1000 pg/mL 
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The optical density of each plate was immediately determined using a DYNEX 
MRX Microplate Reader at 450 nm. Samples were assessed in duplicate and 
results are expressed as means ± standard error of the mean (SEM). 
5.2.2 Estimation of cell viability 
Cells were grown to confluence on 1% gelatin coated-96 well plates and 
treated with EF/ES products at 1.5 µg/mL, as described in section 4.2.3.2. 
Treated HUVEC monolayers were then exposed to 100 µL/well of resazurin 
solution used at a concentration of 10 µg/mL (in pre-ZDUPHG+DQN¶V%DODQFHG
6DOW6ROXWLRQDQGLQFXEDWHGDWÛ&DQG&22 in air for 1 hour (Kim et al, 
2009). Viability was determined as the ability of live cells to oxidise resazurin 
to the fluorescent resorufin. Fluorescence was measured using FLUOstar 
Galaxy Microplate Plate Reader (excitation = 530 nm, emission detection = 
590 nm) and values were expressed as the percentage of the fluorescence 
compared to untreated HUVEC controls.  
5.2.3 Immunocytochemistry  
5.2.3.1 Staining 
Post-treatment, HUVEC monolayers were gently washed and fixed for 10 
minutes in 1% (w/v) paraformaldehyde (PFA), permeabilised for 10 minutes 
with 0.15% (v/v) Triton X-100, and blocked for 30 minutes in phosphate 
buffered saline (PBS) containing 5% (v/v) normal human serum, at room 
temperature (described in section 4.2.5). Cells, stained for VE-cadherin, were 
LQFXEDWHG RYHUQLJKW DW Û& ZLWK PRQRFORQDO DQWL-CD 144 (at 10 µg/mL) 
followed by extensive washing with 0.1% BSA/PBS. The secondary antibody, 
FITC conjugated anti-mouse IgG (diluted to 1:50 (v/v)) was then added and 
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cells were incubated for 2 hours at room temperature, in the dark. Staining for 
F-actin was performed by incubating cells with FITC conjugated phalloidin (50 
µg/mL in PBS) for 2 hours at room temperature, in the dark. Both primary and 
secondary antibodies were diluted to the appropriate concentration with bovine 
serum albumin (0.1% BSA/PBS). Finally, cells were washed twice with 0.1% 
BSA/PBS followed by one wash with PBS and mounted in Vectorshield with 
propidium iodide to visualise the nuclei. Cells were then observed and imaged 
using a Leica TCS SP2 confocal laser scanning microscope, as described in 
section 4.2.6.2.  
5.2.3.2 Quantification of VE-Cadherin immunocytochemistry 
Quantification of VE-Cadherin staining was carried out using a systematic 
random selection method (Gunderson et al, 1999), in Adobe Photoshop 7. Four 
representative images per sample were analysed for certain features of 
junctional adhesion using grid counting including continuous, discontinuous 
(or stitch) and total loss of junctional VE-Cadherin from cell to cell contacts. 
Images were outlined and a grid superimposed. The size of the single grid box 
was 5 x 5 cm2. A number was chosen, blind, from 1²8 and used as a starting 
point. Counting was carried out on grid boxes falling at the chosen number, by 
counting left to right, top to bottom and so on. Once four grid boxes in each 
image were counted, counting was stopped. These numbers were averaged then 
converted to a percentage of the staining feature to the total number of VE-
cadherin junctions counted per sample.        
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5.2.4 Statistical analysis 
Data were tested for significant differences using two-way ANOVA tests, 
followed by Bonferroni post-tests, and statistical significance was defined as P 
< 0.05. Analysis was carried out using GraphPad Prism version 5.01 and values 
are presented as means ± SEM.   
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5.3 Results 
5.3.1 Viability of endothelial cells 
Necator americanus larval products exhibited no cytotoxic effects on 
endothelial cells, as demonstrated by no significant changes in the metabolism 
of resazurin by HUVEC cells post-treatment with larval EF and ES products, 
compared to untreated control cells (Figure 5.1). Visual examination of 
HUVEC monolayers also proved that both untreated and larval-treated 
monolayers showed no cell detachment or disaggregation of HUVEC 
monolayers.   
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Figure 5.1 Effects of Necator americanus larval activity on cell viability 
using resazurin metabolism assay. Viability, determined as the ability of 
viable cells to oxidise resazurin to the fluorescent resorufin, was measured 
in HUVEC monolayers post-treatment with EF/ES products. Results are 
presented as the percentage of resorufin fluorescence from HUVEC 
monolayers post-treated compared to untreated controls ± SEM. The 
optical reading of fluorescent resorufin in untreated HUVEC controls was 
644.13 ± 57.36. Treatment with both EF and ES products demonstrated no 
statistically significant changes in cell viability (P > 0.05).  
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5.3.2 Quantification of endothelial cell responses to Necator americanus 
larval activities 
5.3.2.1 Effects of concentration of larval products on endothelial cell 
responses 
The values of the optical density obtained from the ELISA standards were 
plotted against their concentrations and used to construct standard curves for 
VEGF and cytokines. Conversion of the optical density to concentration of 
secretions (pg/mL) aimed at eliminating any sources of variation in our data 
and generated semi-logarithmic graphs for VEGF, IL-6, and IL-8 as shown in 
Figure 5.2 (a²c). An equation of a straight trendline was also generated and 
used to determine unknown concentrations of VEGF, IL-6, and IL-8 in 
subsequent experiments.  
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Figure 5.2 Standard curves of the optical density plotted against the 
concentration of a) VEGF, b) IL-6, and c) IL-8. Values are expressed as 
the mean of the optical density ± SEM. A semi-logarithmic equation for 
each graph was generated. 
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To assess the effects of larval products on the release of VEGF and cytokines 
from endothelial cells, levels of VEGF, IL-6, and IL-8 were determined in 
culture supernatants from cells pre-treated with EF/ES products, using ELISA. 
While larval products (both EF and ES) caused almost no change in VEGF 
release from HUVEC cultures (Figure 5.3, a), a significant increase in 
endothelial secretion of IL-6 (~ 2 fold) and IL-8 (~ 9 fold) was observed post-
treatment with larval ES products at a final concentration of 1.5 µg/mL (Figure 
5.3, b and c).  
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Figure 5.3 Quantification of a) VEGF, b) IL-6, and c) IL-8 secretions 
from HUVEC cells following treatment of monolayers with Necator 
americanus larval EF and ES products. Secretions were measured in 
duplicates and values are expressed as the mean of their concentrations 
(pg/mL) in the culture supernatants ± SEM. Statistical significance was 
determined as ** = P < 0.01 and *** = P < 0.001 compared to cytokine 
secretions from untreated HUVEC controls (no EF or ES).   
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Changes in VE-cadherin staining were associated with alterations in monolayer 
permeability and endothelial cytokine secretions. Different concentrations of 
larval EF (Figure 5.4, a²e) and ES products (Figure 5.4, a'²e') induced a 
dose-dependent fragmentation of the continuous, junctional VE-cadherin, 
ultimately leading to total loss of VE-cadherin staining and the formation of 
wide intercellular gaps at higher concentrations (Figure 5.4). Quantification of 
VE-cadherin patterns emphasised the dose-dependent effects of larval EF and 
ES products on the integrity of HUVEC monolayers, as described by the 
significant decrease in the percentage of cellular junctions expressing 
continuous VE-cadherin (Figure 5.5, a) and the associated increase in the total 
loss of junctional VE-cadherin (Figure 5.5, c). The latter was significantly 
detected in the presence of ES products at a concentration as low as 0.5 µg/mL, 
opposed to EF products (1 µg/mL, Figure 5.5, c). However, the percentage of 
cellular junctions exhibiting discontinuous VE-cadherin was significantly 
higher than control monolayers and illustrated no dose-related response to 
larval products. Additionally, larval EF and ES products caused dose-related 
changes in F-actin localisation, loss of cortical actin, and increase in stress 
fibres and perinuclear actin, as seen in Figure 5.6. Thrombin, a serine protease, 
was used as a positive control which resulted in similar changes in the 
junctional VE-cadherin and F-actin localisation (Figures 5.4 and 5.6).  
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Figure 5.4 Micrographs showing localisation of VE-cadherin at cellular 
junctions in monolayers treated with either EF (a²e) or ES products (a'²
e'). HUVEC monolayers were pre-treated with larval EF/ES products at 
0.05 µg/mL (a, a'), at 0.25 µg/mL (b, b'), at 0.5 µg/mL (c, c'), at 1 µg/mL (d, 
d'), and at 1.5 µg/mL (e, e'). Nuclei were stained with propidium iodide 
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(red) and Bars = 20 µm. Arrowheads point at gaps in the monolayer, and * 
shows regions of discontinuous VE-cadherin.    
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Figure 5.5 Effects of Necator americanus larval activities on the pattern 
of VE-cadherin expression in HUVEC monolayers, described as 
continuous (a), discontinuous (b), and total loss of junctions (c). VE-
cadherin expression is presented as the percentage of each pattern to the 
total number of junctions, counted per sample, ± SEM. Significance was 
defined as *** = P < 0.001, ** = P < 0.01, and * = P < 0.05 compared to 
untreated controls (no EF or ES).   
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Figure 5.6 Effects of Necator americanus larval activities on localisation of F-actin 
filaments at cellular junctions in monolayers treated with either EF (a²e) or ES products 
(a'²e'). HUVEC monolayers were pre-treated with larval EF/ES products at 0.05 µg/mL 
(a, a'), at 0.25 µg/mL (b, b'), at 0.5 µg/mL (c, c'), at 1 µg/mL (d, d'), and at 1.5 µg/mL (e, 
e'). Nuclei were stained with propidium iodide (red). Bars = 20 µm, arrowheads point at 
gaps in the monolayer and ** shows appearance of perinuclear actin. 
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5.3.2.2 Effects of apical/basal administration of larval products on endothelial 
cell responses 
Treatment of HUVEC monolayers with larval ES products from the apical, 
basal and both chambers induced a significant increase in the levels of secreted 
IL-6 (P < 0.01) and IL-8 (P < 0.001), as shown in Figure 5.7. Although all 
significant, alterations in IL-6 and IL-8 secretions were highest following 
treatment in both chambers (~ 2 fold and ~ 13 fold, respectively) compared to 
cytokine levels observed with the apical-treatment only (~ 1.6 fold and ~ 8 
fold, respectively). These results signify a direct correlation between IL-6 and 
IL-8 release and changes in endothelial permeability, mainly caused by larval 
ES products. Treatment with EF products exhibited similar levels of secreted 
IL-6 and IL-8 compared to untreated HUVEC controls (P > 0.05). 
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Figure 5.7 Effects of the apical/basal administration of larval products 
on HUVEC secretions of a) IL-6 and b) IL-8. Values are expressed as the 
mean of cytokine concentrations (pg/mL) ± SEM and significance is 
presented as ** = P < 0.01 and *** = P < 0.001, compared to cytokine 
production by untreated HUVEC monolayers (no EF or ES).   
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Consistent with changes in monolayer permeability and cytokine secretions, 
junctional VE-cadherin and F-actin filaments were also observed to be 
disrupted subsequent to treatment of HUVEC monolayers with larval products 
in the apical or both chambers (Figures 5.8 and 5.10, respectively). This is 
consistent with the significant reduction in the percentage of cellular junctions 
expressing continuous VE-cadherin and the major increase in the total loss of 
VE-cadherin upon treatment with larval products in the apical and both 
chambers (Figure 5.9, a and c). Basal treatment with both EF and ES products 
appeared to have a lesser effect on junctional structure (Figure 5.8; b, b') and 
caused no significant loss of VE-cadherin staining (Figure 5.9, b). The 
percentage of discontinuous VE-cadherin staining in treated monolayers was 
significantly higher than untreated monolayers at any one time, except for 
monolayers treated with EF products in the basal chamber (Figure 5.9, b). 
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Figure 5.8 Changes in localisation of VE-cadherin at cellular junctions 
in response to apical/basal administration of Necator americanus larval EF 
(a²c) or ES products (a'²c'). Confluent HUVEC monolayers were 
treated with larval products as described in section 4.2.3.2, in the apical (a, 
a'), basal (b, b'), and both chambers (c, c'). Nuclei were stained with 
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propidium iodide (red). Bar = 20 µm, arrowheads point at gaps in the 
monolayer, and * indicates discontinuous VE-cadherin.    
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Figure 5.9 Effects of the apical/basal administration of Necator 
americanus larval products on the pattern of VE-cadherin expression in 
HUVEC monolayers, described as continuous (a), discontinuous (b), and 
total loss of junctions (c). VE-cadherin expression is presented as the 
percentage of each pattern to the total number of junctions, counted per 
sample, ± SEM and statistical significance is defined as *** = P < 0.001, ** 
= P < 0.01, and * = P < 0.05 compared to untreated controls (no EF or ES).
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Figure 5.10 Effects of the apical/basal administration of Necator 
americanus larval EF (a²c) or ES products (a'²c') on the localisation of 
F-actin filaments. Confluent HUVEC monolayers were treated with larval 
products in the apical (a, a'), basal (b, b'), and both chambers (c, c'). Bar = 
20 µm, arrowheads point at gaps in the monolayer. 
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5.3.2.3 Effects of protease inhibition of larval products on endothelial cell 
responses  
Measuring VEGF and cytokines release from HUVEC monolayers, pre-treated 
with four protease inhibitors individually or in a mixture, showed that both EF 
and ES products induced significant alterations in IL-6 and IL-8 production 
(Figure 5.11, a and b). The use of inhibitors separately to block protease 
activities in EF and ES products caused a decrease in IL-6 and IL-8 release by 
endothelial cells (ranging from 0²25%), with PMSF resulting in the highest 
reduction in cytokine production (26% and 42% for IL-6 and IL-8 responses to 
ES products, respectively). However, the use of all inhibitors together 
demonstrated a greater reduction in the levels of secreted IL-6 (40.7%, P < 
0.001) and IL-8 (52.0%, P < 0.0001) in response to larval ES products only. 
Hence, alterations in the endothelial permeability are largely dependent on the 
differential contributions of all studied protease classes. Again, cells treated 
with EF products resulted in no significant increase in secreted IL-6 and IL-8 
(P > 0.05).  
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Figure 5.11 Effects of protease inhibition of larval activities on 
endothelial secretions of a) IL-6 and b) IL-8. HUVEC monolayers were 
treated with larval EF/ES products pre-incubated with protease inhibitors 
as described in section 4.2.3.3. Values are presented as the mean of the 
concentration of secreted cytokines (pg/mL) ± SEM and statistically 
compared to cytokine secretions from HUVEC monolayers treated with 
EF/ES products in the absence of protease inhibitors (* = P < 0.05, ** = P 
< 0.001, and *** = P < 0.0001). 
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Protease inhibition of larval products reduced loss of monolayer integrity when 
inhibitors were used in combination, with minimal disruption of both VE-
cadherin (Figure 5.12, a and b) and F-actin (Figure 5.14, a and b) at cell²cell 
junctions being observed. Pre-treatment of larval products with a mixture of all 
inhibitors illustrated a significant preservation in monolayer integrity, 
described by an increase in the number of junctions expressing continuous VE-
cadherin (up to 50²90% vs. ~ 25% with EF/ES treated monolayers) and the 
associated reduction in the total loss of VE-cadherin junctions (to less than 
10% compared to ~ 40²50% with EF/ES treated monolayers) as shown in 
Figure 5.13 (a and c). Additionally, a significant increase in the percentage of 
cellular junctions with a continuous VE-cadherin pattern was observed upon   
treatment of HUVEC monolayers with larval products in the presence of the 
protease inhibitors E64 (ES only) or PMSF (both EF and ES). Changes in the 
number of cellular junctions with a discontinuous VE-cadherin pattern were 
not significant with the exception of monolayers treated with ES products in 
the presence of a cocktail of all inhibitors (Figure 5.13, b), indicating that the 
proteases studied are jointly responsible for the VE-cadherin and F-actin 
disruption and eventually alterations in endothelial integrity and permeability. 
Monolayers with the lowest preservation of continuous VE-cadherin in the 
presence of 1, 10 phenanthroline and pepstatin A, exhibited higher levels of 
cellular junctions with a discontinuous VE-cadherin expression (Figure 5.13, a 
and b). 
 
 
 
 
 
 
Chapter 5: Cellular mechanisms 
 197 
 
  
  
  
 
 
 
 
 
 
 
 
a- EF products 
1, 10 phenanthroline PMSF 
Pepstatin A E64 
All inhibitors Control (+EF) 
* 
* 
* 
* 
Ź 
Ź 
Ź Ź 
Ź 
* 
* 
* 
Ź 
Ź 
Ź 
* 
* 
* 
* 
* 
Chapter 5: Cellular mechanisms 
 198 
 
  
  
  
Figure 5.12 Immunostaining of HUVEC monolayers for junctional VE-
cadherin following administration of a) EF and b) ES products, pre-
treated with protease inhibitors, individually; 1 mM 1, 10 phenanthroline, 
1 mM PMSF, 1 µM pepstatin A, and 1 µM E64; or in combination. Nuclei 
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were stained with propidium iodide (red). Bar = 20 µm, arrowheads point 
at gaps in the monolayer, and * shows regions of discontinuous VE-
cadherin.   
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Figure 5.13 Effects of protease inhibition of larval products on the 
pattern of VE-cadherin expression in HUVEC monolayers, described as 
continuous (a), discontinuous (b), and total loss of junctions (c). VE-
cadherin expression is presented as the percentage of each pattern to the 
total number of junctions, counted per sample, ± SEM and statistical 
significance is defined as *** = P < 0.001, ** = P < 0.01, and * = P < 0.05 
compared to treated controls (with EF or ES only).  
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Figure 5.14 Immunostaining of HUVEC monolayers for F-actin filaments 
following administration of a) EF and b) ES products, pre-treated with protease 
inhibitors, individually; 1 mM 1, 10 phenanthroline, 1 mM PMSF, 1 µM 
pepstatin A, and 1 µM E64; or in combination. Bar = 20 µm, arrowheads point at 
gaps in the monolayer and ** shows rearrangement into perinuclear actin.   
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5.3.2.4 Effects of post-infection IgG antibodies on endothelial cell responses 
Treatment of HUVEC monolayers with larval products in the presence of post-
infection IgG had no significant effect on cytokine production compared to 
monolayers which were treated with larval products only (Figure 5.15, a and 
b). The use of post-infection IgG antibodies caused a similar increase in 
secreted IL-6 and IL-8 compared to EF/ES treated monolayers while the 
presence of control sera resulted in significantly higher levels of both cytokines 
in the culture supernatants in response to ES products indicating that post-
infection IgG has very weak anti-larval activity.  
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Figure 5.15 Effects of larval products, pre-treated with post-infection 
IgG antibodies, on endothelial secretions of a) IL-6 and b) IL-8. HUVEC 
monolayers were treated as described in section 4.2.3.4 and their 
secretions are expressed as the mean of cytokine concentrations (pg/mL) ± 
SEM. Significance is presented as * = P < 0.05 and ** = P < 0.01, 
compared to treated HUVEC controls (+ EF or ES only).   
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In line with changes in endothelial permeability and cytokine secretions, post-
infection IgG antibodies demonstrated no ability to inhibit disruption of 
junctional VE-cadherin and F-actin, associated with larval proteolytic activities 
(Figure 5.16 and 5.18). Quantification of junctional VE-cadherin reflected 
previous observations and demonstrated no significant preservative effect of 
these antibodies on the number of junctions expressing continuous VE-
cadherin staining (Figure 5.17, a). The use of post-infection IgG antibodies was 
also found to cause no major alterations in the number of discontinuous VE-
cadherin junctions compared to EF/ES treated monolayers (no IgG), although a 
significant reduction in the total loss of VE-cadherin junctions was observed in 
the presence of ES products (Figure 5.17, c).  
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Figure 5.16 Changes in the localisation of VE-cadherin in HUVEC 
monolayers in response to larval EF (a²c) and ES products (a'²c'). 
Monolayers were treated with larval products only (a, a'), or larval 
products pre-incubated with either control sera (b, b') or post-infection 
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IgG antibodies (c, c'). Nuclei were stained with propidium iodide (red). 
Bar = 20 µm, arrowheads point at gaps in the monolayer, and * indicates 
discontinuous VE-cadherin.  
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Figure 5.17 Changes in the pattern of VE-cadherin expression in 
HUVEC monolayers, post-treatment with post-infection IgG antibodies; 
continuous (a), discontinuous (b), and total loss of junctions (c). VE-
cadherin expression is presented as the percentage of each pattern to the 
total number of junctions, counted per sample, ± SEM and statistical 
significance is defined as * = P < 0.05 compared to treated controls (with 
EF or ES only).  
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Figure 5.18 Changes in the localisation of F-actin filaments in HUVEC 
monolayers in response to larval EF (a²c) and ES products (a'²c'). Monolayers 
were treated with larval products only (a, a'), or larval products pre-incubated 
with either control sera (b, b') or post-infection IgG antibodies (c, c'). Bar = 20 
µm and arrowheads point at gaps in the monolayer. 
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5.4 Discussion 
Necator americanus larval exsheathing products and secretions exhibited no 
direct cytotoxicity against endothelial cells, suggesting that the penetration 
process is not associated with cellular death and emphasising that larval 
enzymes are most likely to cause structural disturbance of the endothelial 
barrier to allow larvae to enter the host.  
 
In all experiments, the increase in endothelial permeability was associated with 
a moderate, but significant, increase in IL-6 and a large, significant increase in 
IL-8 secretion (Figure 5.3, b and c), with no increase in VEGF release (Figure 
5.3, a). Larval ES products caused a dose related increase in IL-6 and IL-8 
release from HUVEC cells suggesting a major role of both cytokines in 
modulating endothelial permeability and barrier properties in response to 
Necator americanus larval secretions. These results agree with previous work, 
in which endothelial permeability was shown to be mediated in part by IL-6 
(Ali et al, 1999; Dewi et al, 2004) and most significantly by IL-8, in a VEGF 
independent manner (Petreaca et al, 2007). EF products, which have also been 
shown to induce endothelial permeability, resulted in no significant increase in 
IL-6 and IL-8 secretions suggesting that EF-induced permeability is not 
mediated by cytokines. In addition, activation of endothelial cells in response 
to ES products only, which is determined by cytokine production, might be 
related to the differential contribution of proteases and possibly other enzymes 
in ES but not in EF proteolytic activities, as described in chapter 2.   
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The increase in cytokine secretions also mirrored intercellular gap formation in 
endothelial monolayers at VE-cadherin rich junctions. Larval products caused a 
dose dependent disruption of endothelial junctional structures described as a 
significant increase in the loss of VE-cadherin (Figures 5.4 and 5.5) and a non 
dose related increase in the number of VE-cadherin junctions showing a 
discontinuous pattern, suggesting that larval enzymes are likely to facilitate 
migration by inducing fragmentation of junctional VE-cadherin molecules, 
ultimately leading to total loss of these junctions and the formation of 
intercellular gaps. Additionally, disruption of F-actin filaments which is 
thought to be triggered by secreted cytokines including IL-6 and IL-8 (Blum et 
al, 1997), eventually led to rearrangement into actin stress fibers, cell retraction 
and emergence of noticeable gaps. These results highlight the potential role of 
larval enzymes in the penetration process as they navigate the endothelium and 
gain access by targeting the stability of cellular junctions.   
 
A significant increase in secretions of IL-6 and IL-8 was also observed 
following administration of larval products to the apical and both apical and 
basal sides of HUVEC monolayers (Figure 5.7), together with a significant 
elevation in the loss of VE-cadherin junctions and the formation of wide gaps 
in the treated monolayers (Figures 5.8²5.10). Basal treatments, however, 
caused a relatively considerable increase in cytokine release in response to 
larval ES products only, again highlighting the important role of larval ES 
activity in mediating the interaction between Necator americanus larvae and 
the endothelium and their ability to create gateways for the larvae during the 
penetration stage. The significant increase in the number of discontinuous VE-
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cadherin junctions observed with basal treatments emphasised that the delayed 
disruption of endothelial monolayers upon basal treatment is potentially related 
to the need to navigate a multi-layered structure to reach the cells while the 
more rapid structural disturbance observed upon apical administration is most 
likely caused by direct interaction of endothelial cells with larval products, 
possibly accounting for larval migration from the blood into the surrounding 
tissues.  
 
The use of protease inhibitors aimed at investigating their ability to protect the 
endothelial integrity of HUVEC monolayers in the presence of larval products. 
Protease inhibitors, when used in a cocktail, demonstrated a significantly great 
ability to reduce the levels of secreted IL-6 and IL-8 following treatment with 
ES products confirming the differential contribution of all proteases in the 
activation of cellular production of cytokines during the penetration process. 
These changes were mirrored by a significant preservation of monolayer 
properties as indicated by less disruption of junctional stability (Figure 5.12 
and 5.14). Although the presence of enzyme inhibitors prevented further loss of 
monolayer integrity as described by a significant reduction in the total loss of 
VE-cadherin junctions and the formation of gaps, a complete inhibition of 
cytokine production and fragmentation of junctional molecules was not 
observed, suggesting that other enzymes may also be involved in modulating 
endothelial permeability and that enzyme inhibitors are not wholly effective, 
even as cocktails, against this mixed enzyme population. Activation of matrix 
metalloproteinases (MMPs) from endothelial cells by larval products is also 
possible and can be partially responsible for triggering an increase in 
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endothelial permeability (Lafleur et al, 2001; Alexander, 2002; Johannsson et 
al, 2007). The use of post-infection IgG antibodies resulted in no significant 
changes in the release of IL-6 and IL-8 and junctional disruption, suggesting 
that enzyme-specific antibodies might be required for a pronounced inhibitory 
role and to provide protection against Necator americanus infection. Moreover, 
failure of post-infection IgG to prevent disruption of the endothelial barrier 
suggests that infected individuals are not producing an appropriate response to 
eliminate these parasites, hence possibly accounting for the high rates of re-
infection.  
 
Stimulation of endothelial cells by inflammatory agents such as thrombin has 
been shown to induce endothelial barrier dysfunction by activating a number of 
phosphorylation cascades, eventually triggering conformational changes in the 
barrier structure and creating an opening of the paracellular pathway (Yuan, 
2002). This is primarily driven via actomyosin contraction initiated by myosin 
light chain (MLC) phosphorylation, which is tightly linked to actin 
microfilament reorganisation previously described by Garcia et al (1995) and 
Verin et al (2001). Phosphorylation of most adhesion molecules linking VE-
cadherin to actin by protein kinase C (PKC) was also shown to mediate 
disruption of VE-cadherin junctions and therefore is most likely involved in the 
mechanisms of increased endothelial permeability (Bogatcheva et al, 2002; 
Sandoval et al, 2001). Our results confirmed that larval enzymes triggered a 
series of intracellular signalling reactions by targeting endothelial junctional 
molecules including VE-cadherin and F-actin. Cytokine-induced tyrosine 
phosphorylation of junctional molecules (Nwariaku et al, 2004) and 
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modulation of the actin-myosin contractile system (Blum et al, 1997; Hordijk 
et al, 1999) have been suggested as potential mechanisms for regulating 
adherens junctions, thereby altering endothelial barrier functions and 
paracellular permeability (Leach et al, 1995; Budworth et al, 1999). IL-6 
release from endothelial cells in inflammatory state demonstrated a critical 
involvement of reactive oxygen species (ROS) and phosphorylation of 
adhesion molecules by protein kinase C (Ali et al, 1999; Desai et al, 2002), 
therefore inducing functional alteration in vascular permeability which was 
associated with morphological dissociation of VE-cadherin-catenin complex 
from their cytoskeletal anchor (Desai et al, 2002; Yuan, 2002). However, IL-8 
seems to induce permeability as a result of cytoskeletal actin filaments 
rearrangement by activating phosphorylation of actomyosin contraction and 
stimulating transactivation of the IL-8 receptors CXCR1 and CXCR2 
(Schraufstatter et al, 2001; Gavard et al, 2009) and VEGFR2 which in turn, is 
required for endothelial gap formation (Petreaca et al, 2007). Future 
investigations of cytokine-induced permeability may lead to elucidation of the 
mechanisms highlighted in this project.  
In conclusion, we have demonstrated that Necator americanus larval products 
were capable of interacting with the endothelial monolayer causing increased 
endothelial permeability in parallel with elevated IL-6 and IL-8 release. At the 
cellular mechanistic level, larval products also caused junctional disruption and 
gap formation, which in reality would permit Necator americanus larvae to 
pass through the endothelium and enter the microcirculation. The contribution 
of a repertoire of larval enzymes to this process suggests that multiple enzymes 
may have to be targeted to prevent the infection process.  
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The primary aim of this work was to understand the importance of larval 
secretions in penetrating the skin and the underlying vasculature during 
Necator americanus infection. The hypothesis in this thesis suggested that 
Necator americanus L3 larvae produce exsheathing and secretory proteases 
which disrupt junctional integrity via paracellular routes causing a breach in 
the endothelial barrier and allowing entry of larvae to the bloodstream. Thus, 
understanding the enzymatic profiles of Necator americanus larval secretions 
and studying their immunological and biological impacts on an in vitro model 
of the endothelium were the main aims of this thesis.  
 
The second chapter focused on generating detailed protein profiles of Necator 
americanus larval exsheathing fluids (EF) and excretory/secretory (ES) 
products. The involvement of proteases in larval EF and ES products was 
studied using substrate gel electrophoresis and further characterised using 
enzyme assays. Results demonstrated a pH related protease activity against 
FITC-casein which was optimal between pH 6 and 8.5 for both the exsheathing 
fluid (EF) and the excretory/secretory products (ES). The proteolytic effects at 
pH 6.5 suggested a major role of larval enzymes in both EF and ES products at 
the early stages of migrating through the skin surface, pH of which ranges 
between 4.5 and 6.5 (Yosipovitch et al, 1993), while the significant enzymatic 
activity in ES products at pH 6.5 to 8 highlighted their potential role in the 
penetration process, allowing larvae to move deeper in the skin and reach the 
microcirculation. The predominant presence of serine and cysteine proteases in 
EF products suggested an important role of these proteases during the 
exsheathment of Necator americanus larvae as previously described by Kumar 
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and Pritchard (1992a), while their considerable presence in ES products 
signified their potential role during larval migration in the skin, as described 
above. The involvement of serine, cysteine and metalloproteases in the 
gelatinolytic activity of both EF and ES products confirmed the major 
importance of these proteases in negotiating the different layers of the skin 
(Kumar and Pritchard, 1992a). However, the modest presence of aspartyl 
proteases in larval EF and ES products indicated that these proteases might be 
partially involved in skin penetration and possibly mediate different 
developmental processes of Necator americanus larvae at this stage. The high 
presence of aminopeptidases in EF products also suggested an important role 
of these enzymes during and after exsheathment as proposed by Kumar and 
Pritchard (1992a) while the presence of leucine aminopeptidases in ES 
products indicated their potential involvement in the hydrolysis of both skin 
and serum molecules (Williamson et al, 2003). Hence, the characteristic 
contribution of all proteolytic activities in the larval products suggested that the 
penetration process may be mediated by the activity of more than one protease, 
likely due to the complex nature of WKHVNLQDQGWKHQHHGWRVXUYLYHWKHKRVW¶V
immune system as proposed by Pritchard et al (1990). Proteolysis of 
haemoglobin, possibly in a multi-protease cascade (Williamson et al, 2002), 
also suggested that proteases in EF and ES products are of major importance in 
the feeding behaviour of larvae as reported by Williamson et al (2003a).  
 
The absence of hyaluronidase activity in larval EF and ES products, as 
described in chapter 2, indicated that unlike the infective Ancylostoma species 
(Hotez et al, 1992), Necator americanus larval migration through the skin 
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might not be mediated by the activity of hyaluronidase, an enzyme responsible 
for the degradation of hyaluronic acid which serves as cell to cell adhesion 
bridges in the different layers of the skin (Miyake et al, 1990). Therefore, 
chapter 3 focused on studying the proteolytic effects of larval EF and ES 
products on skin macromolecules. Necator americanus larval products 
demonstrated a selective degradation of collagen III and laminin with ES 
products, a greater affinity for collagen IV by EF products and a different 
pattern of hydrolysis of fibronectin by larval EF and ES products suggesting 
that the characteristic difference in larval enzymes is responsible for variation 
in the degradation of individual extracellular matrix (ECM) proteins. These 
results also indicated that EF products, which are of major importance during 
the exsheathment of larvae, might play an additional role in early stages of 
larval penetration allowing Necator americanus species to advance in the skin, 
as previously reported by Kumar and Pritchard (1992a) while ES products are 
most likely responsible for further larval migration through the deeper layers of 
the skin. Degradation of collagen IV and laminin, the main components of all 
basement membranes (Timpl and Brown, 1996; Timpl, 1996), and fibronectin 
and collagen III by larval proteases suggested that Necator americanus larvae 
disturb the structure of the skin possibly by directing larval proteolytic 
activities to target the skin molecules and create an opening for larvae to 
migrate to the blood circulation. 
 
The proteolysis of skin macromolecules upon treatment with larval EF and ES 
products was minimal as featured by the modest digestion of collagen I and 
fibronectin while degradation of collagen III was significant and greater with 
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ES products, as described in chapter 3. This is likely due to the complex 
structure of the skin, which unlike individual ECM proteins, was shown to 
contain tissue-derived protease inhibitors such as cysteine and serine protease 
inhibitors (Rao et al, 1995; Rao et al, 1998; Zeeuwen et al, 2009), with a role 
to play in the regulatory and protective functions of the skin against 
uncontrolled proteolysis from host or environmental pathogens. Hydrolysis of 
collagen III suggested that larval products might target proteins with low 
molecular complexity to create a fast and easy breach for the larvae to enter the 
host while targeting other skin macromolecules including collagen I, 
fibronectin and laminin might require stronger proteolytic activity and larger 
numbers of species due to their complex structures. Degradation of ECM and 
skin macromolecules, which was primarily related to the characteristic 
presence of proteolytic enzymes in Necator americanus larval products, 
supported the potential role of EF products in the initial stages of larval 
migration and highlighted the major role of ES products in negotiating the 
connective tissue and progressing towards the underlying vasculature. 
 
Unlike other matrix proteins, treatment of collagen V with larval products 
indicated a possible involvement of larval enzymes in the cross-linking of 
small proteins and the creation of strong protein bands which were resistant to 
proteolytic cleavage (Collighan and Griffin, 2009). Transglutaminase, 
responsible for the cross-linking of peptides, has been reported in a number of 
parasites including Onchocerca volvulus (Lustigman et al, 1995), Plasmodium 
falciparum (Adini et al, 2001) and in Necator americanus larval EF and ES 
products, as described in chapter 3. The inhibition of transglutaminase was 
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found to prevent the moulting of L3 larvae to L4 stage larvae (Lustigman et al, 
1995; Rao et al, 1999; Chandrashekar and Mehta, 2000), therefore suggesting 
an important role of these enzymes in the long-term maintenance and survival 
of Necator americanus species as well as the progression of the parasitic 
infection. 
 
In order to study the effect of Necator americanus species on the vasculature, 
human umbilical vein endothelial cells (HUVEC) were used as an in vitro 
model of the vascular endothelium, as described in chapter 4. The HUVEC 
model is known to establish no phenotypic features and to maintain the general 
properties of endothelial cells from different vascular beds. Since Necator 
americanus larvae encounter the vascular endothelium at different stages of 
their journey in the host (i.e. including the skin and lungs), the HUVEC model 
was used to describe the basic interaction of larvae with the endothelium. In 
this work, the electrical resistance of HUVEC monolayers reached a maximum 
RI  WR  FP2 at confluence which was significantly higher than that 
reported by Blum et al (1997) and concur with recent work by Man et al 
(2008), a significant difference possibly related to using HUVEC cultures at 
different passages. High transendothelial electrical resistance (TEER) across 
HUVEC monolayers was associated with typical cobblestone morphology of 
cells. At a molecular level, confluent HUVEC monolayers demonstrated a 
continuous strong expression of vascular endothelial cadherin (VE-cadherin) at 
cellular junctions and a clear presence of actin filaments (F-actin) but a weaker 
occludin was observed. The latter was not therefore studied. Results here 
emphasised the role of VE-cadherin and actin filaments in maintaining the 
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integrity of the endothelial junctions as previously described in the literature 
(Dejana et al, 2000; Firth, 2002). Hence, based on the hypothesis, Necator 
americanus larvae are believed to facilitate their entry to the microcirculation 
by disturbing the molecular integrity of HUVEC monolayers, eventually 
mediating alterations in endothelial permeability.  
  
Changes in the endothelial barrier functions, featured as the permeability of 
endothelial monolayers, were examined in relation to larval enzymatic activity. 
Studies were carried by measuring transendothelial electrical resistance 
(TEER) and tracer leakage across HUVEC monolayers during and post-
treatment with larval products, respectively. Larval enzymes caused a 
concentration related increase in endothelial permeability, leading to earlier 
disruption of the endothelium at high doses, possibly as a result of targeting the 
integrity of monolayers to facilitate entry of Necator americanus larvae into 
the blood circulation. However, the use of larval products at low doses resulted 
in modest increase in permeability, described by a significant reduction in 
monolayer resistance with no significant changes in tracer leakage across 
treated monolayers, indicating that TEER is a more sensitive marker to changes 
in endothelial barrier functions. In addition, the greater changes in 
permeability, observed with larval ES products, might be due to the 
characteristic presence of proteolytic activities in ES compared to EF products, 
earlier described in chapter 2. This is in line with previous research in which 
bacteria such as Prophyromonas gingivalis and parasites such as Schistosoma 
mansoni were shown to adhere to endothelial cells in vitro which allowed them 
to modulate vascular permeability in response to parasitic triggers and gain 
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access to the host (Imamura et al, 1995; Timpl and Martin, 1997; Hansell et al, 
2008). 
 
Treatment of HUVEC monolayers with larval products in the apical or both 
chambers resulted in a significant increase in permeability compared to those 
treated in the basal chamber only. The direct interaction between endothelial 
cells and larval products applied to the apical chamber, resulted in a faster 
disruption of the endothelial barrier while the basal administration of larval 
products was associated with a delayed increase in permeability, possibly due 
to the need to cross multiple layers, both in vitro and in vivo, before reaching 
the cells. Negotiating the basement membrane, which is possibly facilitated by 
the ability of Necator americanus larval enzymes to digest its main 
components including collagen IV and laminin as described in chapter 3, may 
therefore account for this delayed increase in permeability following basal 
treatments. As argued in chapter 4, the apical-induced permeability is likely to 
mediate breaking out from the blood vessel during the lung-associated 
migration, while migrating from the skin into the dermal microcirculation, 
through the vascular basement membrane, may be mediated by larval-induced 
permeability similar to that observed following basal administration.  
 
Finally, treatment of HUVEC monolayers with larval products in the presence 
of protease inhibitors aimed at exploring which proteases are involved in this 
interaction and determining if protease inhibitors are able to prevent larval-
associated increase in endothelial permeability. The increase in monolayer 
permeability, in response to larval products, demonstrated a joint contribution 
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of serine, cysteinyl, aspartyl and metalloproteases, the inhibition of which 
resulted in a significant preservation of monolayer permeability. A total 
protection of endothelial barrier functions was never seen which suggests that 
additional enzymatic activity may also be involved and that treatment with 
larval products might also trigger the activation of matrix metalloproteinases 
(MMPs) from endothelial cells which in turn, can be partially responsible for 
inducing an additional increase in vascular permeability (Lafleur et al, 2001; 
Alexander, 2002; Johannsson et al, 2007). Inactivation of tissue-associated 
protease inhibitors, previously observed with Schistosoma mansoni species 
(Hansell et al, 2008), might also be triggered in the presence of Necator 
americanus larval enzymes leading to a further increase in vascular 
permeability.  
 
Parasites, such as Plasmodium falciparum, have been shown to induce 
apoptosis in endothelial cells as an important mechanism during host invasion 
(Pino et al, 2003). In this work, Necator americanus larvae induced no 
cytotoxicity against endothelial cells suggesting that larval migration into the 
microcirculation is not mediated by the activation of cell apoptosis and 
highlighting that, as proposed in the hypothesis, larvae are most likely to cause 
structural disturbance of the endothelial paracellular junctions, enough to allow 
larvae to enter the host. The transcellular routes of transport across the 
endothelium were not addressed in this thesis, primarily due to the large size of 
Necator americanus larvae which ranges between 550 and 580 µm in length 
(Adenusi and Ogunyomi, 2003).  
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The increase in monolayer permeability, described in chapter 4, was associated 
with a significant increase in cytokine production and loss of monolayer 
integrity. Larval ES products caused a dose related increase in IL-6 and IL-8 
release from HUVEC cells, but no significant increase in VEGF levels, 
possibly implicating these cytokines in modulating monolayer permeability and 
endothelial barrier properties in response to Necator americanus larval 
secretions (Ali et al, 1999; Dewi et al, 2004; Petreaca et al, 2007). At a cellular 
level, larval products also induced a dose related disruption of junctional 
integrity of HUVEC monolayer, described as a significant loss of VE-cadherin 
junctions, retraction of endothelial cells and the formation of intracellular gaps. 
Analysis of endothelial integrity suggested that, as described in chapter 5, 
larval enzymes might induce release of IL-6 and IL-8 from endothelial cells to 
trigger retraction of actin filaments and dissociation of VE-cadherin from other 
adhesion molecules (Blum et al, 1997; Yuan, 2002), eventually leading to 
rearrangement of actin cytoskeleton, increase in monolayer permeability and 
loss of barrier regulatory functions. However, the use of antibodies against IL-
6 and IL-8 to determine the importance of these cytokines in larval-induced 
permeability was not studied due to time limitations.  
 
Modulation of endothelial permeability in response to inflammatory agents 
such as thrombin, a serine protease primarily involved in the coagulation 
cascade, has been shown to involve the activation of multiple phosphorylation 
cascades including myosin light chain (MLC) phosphorylation (Garcia et al, 
1995; Verin et al, 2001) and protein kinase C (PKC) phosphorylation of VE-
cadherin complexes (Sandoval et al, 2001; Bogatcheva et al, 2002). In this 
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work, larval proteases were shown to trigger a series of intracellular signalling 
reactions by targeting endothelial junctional molecules including VE-cadherin 
and F-actin. The no change in VEGF levels indicated that larval enzymes 
activate endothelial cells, via cytokines, in a VEGF-independent mechanism, as 
has been shown for IL-8 (Petreaca et al, 2007). Therefore, alterations to 
endothelial barrier functions and paracellular permeability are most likely a 
result of cytokine-induced tyrosine phosphorylation of junctional molecules 
(Nwariaku et al, 2004) and modulation of the actin-myosin contractile system 
(Blum et al, 1997; Hordijk et al, 1999), which in theory, would allow Necator 
americanus larvae to enter the host.  
 
The significant increase in IL-6 and IL-8 production and the subsequent loss of 
VE-cadherin expression at cellular junctions was consistent with the increase in 
monolayer permeability following the apical treatment of HUVEC monolayers 
with larval products. The apical treatment was also shown to cause greater loss 
of junctional VE-cadherin while the basal treatment of HUVEC monolayers 
was associated with significant fragmentation of VE-cadherin molecules, 
emphasising that the modest increase in endothelial permeability upon basal 
treatment is primarily related to the delayed interaction with the monolayer due 
to multi-layered apparatus and, in reality, the complex structure of the skin and 
the underlying vasculature. Treatment of endothelial monolayers with larval 
products, pre-treated with protease inhibitors, resulted in significant reduction 
in IL-6 and IL-8 release and considerable preservation of junctional integrity, 
particularly when protease inhibitors were used as a cocktail. Results, 
therefore, highlighted the major role of larval proteases in the interaction of 
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Necator americanus larvae with the endothelial barrier and suggested that 
WDUJHWLQJ WKHVH SURWHDVHV ZRXOG SUHYHQW ODUYDO HQWU\ LQWR WKH KRVW¶V
bloodstream, hence providing an early protection against Necator americanus 
infection. 
 
Post-infection anti hookworm IgG, which was expected to prevent protease-
associated disruption of endothelial integrity, was used to probe larval products 
on Western blots, as described in chapter 2, and highlighted modest similarities 
between adult and larval ES antigens while no similarity, featured as no 
capturing of antigens, with EF products. These observations were confirmed 
using ELISA and are supported by the presence of certain antigens in adult and 
larval ES products such as calreticulin (Pritchard et al, 1999; Kasper et al, 
2001), aspartic Na-APR-1 (Williamson et al, 2002; Pearson et al, 2009) and 
cysteine Na-ASP-2 (Hawdon et al, 1999) proteases. Post-infection anti worm 
IgG was functional in that it binds parasitic analogues in a competitive manner. 
However, post-infection IgG did not inhibit the processes measured in this 
work including proteolysis of FITC-casein and digestion of ECM and skin 
macromolecules (chapter 3). Post-infection IgG antibodies were also shown to 
cause no significant protection of monolayer permeability and endothelial 
integrity, suggesting that these antibodies have no anti-larval activity and that 
enzyme-specific antibodies might be required to target specific larval EF and 
ES proteases for a pronounced inhibitory role and to provide protection against 
these species. 
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In conclusion, this study has demonstrated that Necator americanus larval 
products are capable of degrading skin macromolecules and interacting with 
the endothelial monolayer, causing increased IL-6 and IL-8 release and 
subsequent disruption in endothelial permeability. In addition, larval products 
also caused junctional disruption and gap formation, theoretically allowing 
Necator americanus larvae to enter the microcirculation and migrate from the 
bloodstream into the surrounding tissue. The characteristic contribution of a 
repertoire of larval enzymes to this process suggests that multiple enzymes 
may have to be targeted to prevent and treat the Necator americanus infection.  
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Future Work 
This thesis laid the groundwork for a good understanding of the interaction 
between Necator americanus larvae and the vascular endothelium. However, 
certain extensions to this work would help expand and strengthen the current 
knowledge to be able to provide protection against hookworm infections. 
 
In this thesis, the HUVEC model has been used to provide a general 
understanding of the interaction between Necator americanus larvae and the 
endothelium. The use of endothelial cells from vascular beds of significant 
relevance to hookworm infection, including the skin and lungs, would describe 
the specific mechanisms allowing larvae to migrate through the endothelial 
barrier in these organs. Using real time imaging to visualise live larvae 
migrating through an in vitro apparatus of endothelial cells grown on a matrix, 
also present an opportunity to study the penetration process and the interaction 
with the vascular endothelium. Unfortunately, the IgG used here was active 
against adult worms but barely active against larvae. The use of anti worm IgG 
of high specific activity against larval products is believed to inhibit their 
proteolytic activities and provide early protection against Necator americanus 
species and therefore should be investigated as an extension to this thesis.  
 
Alterations in endothelial permeability and barrier integrity, which were 
described in chapters 4 and 5, highlighted the need to study the signalling 
processes which are activated during Necator americanus larval invasion. 
Proteases, including thrombin and trypsin, have been reported to activate 
vascular endothelial cells through protease-activated receptors (PARs) as 
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previously described by Inomata et al (2007) and Day et al (2006). 
Investigations of the potential involvement of PARs in regulating larval-
induced increase in vascular permeability (Klarenbach et al, 2003) would 
therefore afford an understanding of the molecular mechanisms underlying 
hookworm-endothelium interactions and, probably, play a role in the 
prevention and treatment of Necator americanus infection. In addition, the 
interaction between larval calreticulin and the vascular endothelium is an 
interesting area for future work. Calreticulin, an antigen observed in Necator 
americanus larval and adult products, has been shown to interact with cell 
surface adhesion molecules, known as integrins (Reilly et al, 2004). The close 
co-operation between integrins and VE-cadherin is known to promote stability 
of the endothelium by connecting cells to the surrounding extracellular matrix 
molecules (Cheresh and Stupack, 2008), the disruption of which is likely to 
mediate larval-induced permeability and allow Necator americanus larvae to 
enter the body.   
 
Furthermore, there is an increased interest in understanding the potential 
therapeutic effects of Necator americanus infection on allergic disorders such 
as asthma, atopic dermatitis and eczema (Cooper et al, 2003; Falcone and 
Pritchard, 2005; Leonardi-Bee et al, 2006; Wordemann et al, 2008). Recent 
work by McLean and Hull (2007) demonstrated that both asthma and atopic 
dermatitis are related to genetic abnormalities in filament aggregation proteins 
(filaggrin), which under the normal conditions, are extensively cross-linked to 
epidermal proteins by tissue transglutaminases to form an impermeable barrier 
at the outer layer of the skin (McGrath and Uitto, 2008). Therefore, the effects 
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of larval EF and ES products in which transglutaminase activity was detected, 
as described in chapter 3, on filaggrin and other epidermal proteins present 
another bright area for future work which should be investigated in relation to 
the therapeutic importance of Necator americanus infection to different 
allergies. 
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A1.1 Sigma- Aldrich 
Acrylamide/Bis-acrylamide, 29:1 (A-2792) 
Agarose (A-9539) 
Albumin from Bovine Serum (A-7906) 
Albumin, tetramethyl-rhodamine isothiocyanate bovine (A-2289) 
2-amino-2-methyl-1,3-propanediol (A-9754) 
Ammonium Persulfate (A-3678) 
Anti Goat IgG (whole molecule)- Alkaline Phosphatase (A-4187) 
Anti Laminin (L-9393) 
Anti Mouse IgG (whole molecule)- Alkaline Phosphatase (A-3562)Anti  
Anti Rabbit IgG (whole molecule)- Alkaline Phosphatase (A-9919) 
Anti Rabbit IgG (whole molecule)- TRITC (T-6778) 
5' Biotinoyl- amino hexanoylamino-pentylamine trifluoroacetate salt 
(B-7306) 
Calcium Chloride, anhydrous (C-4901) 
Casein (C-5890) 
Citric acid, trisodium salt dehydrate (C-7254) 
Collagen from human placenta, type I (C-7774) 
Collagen from human placenta, type III (C-4407) 
Collagen from human placenta, type IV (C-7521) 
Collagen from human placenta, type V (C-3657) 
4-Chloro-1-Naphthol (C5,780-4) 
4-Chloro-1-Naphthol (C-8890) 
L-Cysteine (C-7755) 
Dimethyl Sulfoxide (D-8418) 
DL-Dithiothretol (D-9163) 
Endothelial Cell Growth Supplement from bovine neural tissue (E-
2759) 
Ethylenediaminetetraacetic acid, anhydrous (E-6758) 
E-TOXATE kit (ET0200) 
ExtrAvidin® Peroxidase conjugate (E-2886) 
Formaldehyde, 37% w/w solution (F-1268) 
Formamide, > 99% (F-7503) 
Gelatin, type A (G-8150) 
Gelatin, type B (G-9391) 
+DQN¶VEalanced salt solution (H-8264) 
Hemoglobin, human (H-7379) 
Heparin Sodium salt, grade 1-A (H-3149) 
Hyaluronic acid potassium salt from human umbilical cord (H-1504) 
Hyaluronidase from bovine testes, type I-S (H-3506) 
Hydrogen Peroxide, 30% w/w solution (H-1009) 
Magnesium Chloride, anhydrous (M-8266) 
Microtiter plate, poly 96-well (M-9685) 
Mouse IgG (whole molecule)- FITC (F-0257) 
Neutral Red solution (N-2889) 
Papain from papaya latex (P-4762) 
Paraformaldehyde (P-6148) 
Phalloidin- FITC (P-5282) 
1,10-Phenanthroline, monohydrate (P-9375) 
Phenylmethane Sulfonyl Fluoride (P-7626) 
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Phosphate Buffered Saline tablets (P-4417) 
RPMI-1640 Medium (R-7509) 
Silver Stain kit (AG-25) 
Sodium Acetate, trihydrate (S-7670) 
Sodium Bicarbonate (S-8875) 
Sodium Chloride (S-3160/63) 
Sodium Citrate, tribasic dehydrate (S-4641) 
Sodium Phosphate, dibasic (S-9390) 
Streptomycin Sulfate salt (S-9137) 
Stains-All (E-9379) 
3,3',5,5'-tetramethylbenidine dihydrochloride tablets (T-3405) 
N,N,N',N'-tetramethylethylene-diamine (T-9281) 
Triton, t-Octylphenoxypolythoxy ethanol (X-100) 
Trizma® base (T-1503) 
Trizma® hydrochloride (T-3253) 
Whatman Chromatography papers, 3 MM (Z-270849) 
 
A1.2 Fisher Scientific 
Acetone (A-0560/17) 
5-Bromo-4-Chloro-3-Indolyl Phosphate P- Toluidine salt, BCIP (B-
PE1610/100) 
Bromophenol Blue (B-P620/44) 
Citric Acid (C-6200/60) 
Glycine (B-P381/5) 
Silver Nitrate (S-1280/48) 
Sodium Dodecyl Sulfate (S-P530/53) 
Sodium Thiosulfate (S-7240/53) 
 
A1.3 BioRad 
Equilibration Buffer I (163-2107) 
Equilibration Buffer II (163-2108) 
Glycerol, 30% solution  
Mineral Oil (163-2129) 
Precision Plus ProteinTM Standards, Dual Color (161-0374) 
Protein Assay Dye Reagent Concentrate (500-0006) 
ReadyStripTM IPG strips, 7 cm, Ph 3-10 (163-2000) 
2-D Rehydration Sample Buffer I (163-2083) 
 
A1.4 Southern Biotech 
Goat Anti type III Collagen (1330-01) 
Goat Anti type IV Collagen (1340-01) 
 
A1.5 Calbiochem 
Casein, N, N-Dimethylated, Bovine (311511) 
E64 Protease Inhibitor (324890) 
Thrombin, Human Plasma (605190) 
 
A1.6 AbD Serotec 
Goat Anti Human Collagen I (131001) 
Goat Anti Human Collagen V (135001) 
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Native Human Laminin (5620-0604) 
Rabbit Anti Human Fibronectin (4470-2204) 
 
A1.7 BD Biosciences 
Biotin Mouse Anti Human IL-8 (554718) 
Fibronectin, Human (354008) 
Mouse Anti Human CD144 (555661)  
Mouse Anti Human IL-8 (554716) 
Recombinant Human IL-8 (554609) 
 
A1.8 Fluka 
Coomassie Brilliant Blue R-250 (14745) 
Pepstatin A (77170) 
3RO\HWK\OHQH*O\FRO¶ 
Sodium Chloride (71381) 
 
A1.9 Gibco (Invitrogen) 
Medium 199 X 1 (22340) 
Trypsin-EDTA, 0.05% (25300) 
 
A1.10 Biogenesis, UK 
Rabbit Anti Human Fibronectin (4470-2204) 
 
A1.11 The Binding Site, UK 
Anti Human IgG (AFF)-Perox (AP004) 
 
A1.12 Whatman PROTRAN 
NitroCellulose Transfer Membrane (0.1 µm) 
 
A1.13 Vector Laboratories, Inc 
Vectashield Mounting Medium for Fluorescence with Propidium Iodide 
(H-1300) 
 
A1.14 R&D Systems 
Human IL-6 DuoSet® ELISA Development System (DY206) 
Human VEGF DuoSet® ELISA Development System (DY293B) 
 
A1.15 MERCK 
Tert-Amyl-alcohol (8.06193) 
 
A1.16 HyClone 
Characterized Fetal Bovine Serum, heat inactivated (SH-30071) 
 
A1.17 Costar, Corning 
Transwell Permeable Supports, 12 mm inserts (3460) 
25 cm2 Tissue flasks (163371) 
 
A1.19 VYCON 
Lipid Resistant 3-way Stopcock (875.00) 
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A2.1 SDS-PAGE buffers 
 
A2.1.1  1.5 M Tris-HCl pH 8.8 
Tris      90.83 g 
Dissolved in distilled water, pH adjusted to 8.8 with concentrated HCl and 
made up to 500 mL. 
 
A2.1.2  0.5 M Tris-HCl pH 6.8 
Tris      30.30 g 
Dissolved in distilled water, pH adjusted to 6.8 with concentrated HCl and 
made up to 500 mL. 
 
A2.1.3  10% Sodium dodecyl sulphate (SDS) 
Sodium dodecyl sulphate   10 g 
Dissolved in distilled water to 100 mL. 
 
A2.1.4  10% Ammonium persulphate (APS) 
Ammonium persulphate   1 g 
Dissolved in distilled water to 10 mL, stored at -Û&LQ/DOLTXRWV 
 
A2.1.5  Resolving gel     6%     10%     12% 
Acrylamide/Bis-acrylamide (29:1)    2.4 mL    4 mL     4.8 mL 
1.5 M Tris-HCl, pH 8.8     3 mL        3 mL     3 mL 
10% SDS       120 µL    120 µL    120 µL 
Distilled water      6.48 mL    4.88 mL    4.08 mL 
To 12 mL of resolving gel, add: 
10% APS     60 µL 
TEMED     6 µL 
 
A2.1.6  4% Stacking gel  
Acrylamide/Bis-acrylamide (29:1)  6.25 mL     
0.5 M Tris-HCl, pH 6.8      12.5 mL 
10% SDS        0.5 mL 
Distilled water to 50 mL, and store at 4 Û&7RP/RIVWDFNLQJJHODGG 
10% APS     10 µL 
TEMED     4 µL 
 
A2.1.7  2 x Reducing sample buffer (RSB) 
0.5 M Tris-HCl, pH 6.8   2 mL 
Glycerol     2 mL 
10% SDS     4 mL 
1% Bromophenol Blue   20 µL 
Dithiothreitol (100 mM DTT)  154 g 
Distilled water    2 mL 
 
A2.1.8  2 x Non reducing sample buffer (NRSB) 
0.5 M Tris-HCl, pH 6.8   2 mL 
Glycerol     2 mL 
10% SDS     4 mL 
1% Bromophenol Blue   20 µL 
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Distilled water    2 mL 
 
A2.1.9  SDS-PAGE electrode buffer 
Tris      30 g 
Glycine     144 g 
SDS      10 g 
Distilled water to 10 L. 
 
A2.2 Staining and destaining buffers 
 
A2.2.1  Fixative and destain 
Methanol     250 mL 
Glacial Acetic acid    100 mL 
Distilled water    650 mL 
 
A2.2.2  1% Coomassie Brilliant Blue R250 stain 
Coomassie Brilliant Blue R250  0.5 g 
Methanol     125 mL 
Glacial Acetic acid    50 mL 
Distilled water to 500 mL, filtered before use and stored in the dark at room 
temperature. 
 
A2.2.3  0.1% Stains-All 
Stains-All     1 mg 
Formamide (50%)    1 mL 
 
0.25% Agarose 
Agarose     25 mg    
0.5 M Tris-HCl, pH 6.8   10 mL 
 
A2.2.4  0.02% Sodium thiosulphate 
Sodium thiosulphate    0.1 g 
Distilled water     500 mL 
Keep at 4 Û& 
 
A2.2.5  0.2% Silver nitrate 
Silver nitrate     1 g 
Distilled water    500 mL 
.HHSDWÛ& 
 
A2.2.6  Developing solution 
Sodium carbonate    15 g 
Sodium thiosulphate    2 mg 
Formaldehyde (37%)    0.25 mL 
'LVWLOOHGZDWHUWRP/VWRUHGDWÛ& 
 
A2.2.7  2% Ethylene-diaminetetraacetic acid (EDTA) 
EDTA      10 g 
Distilled water    500 mL 
6WRUHGDWÛ&       
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A2.3 Western blotting buffers 
 
A2.3.1  Tris buffered Saline (TBS) 
NaCl      90 g 
Tris      62.1 g 
Dissolved in approximately 200 mL of distilled water, pH adjusted to 7.4 and 
made up to 10 L. 
 
A2.3.2  Blocking buffer 
Skimmed milk powder   5 g 
TBS      100 mL 
 
A2.3.3  Washing buffer (TBS/0.05% Tween) 
Tween 20     250 µL 
TBS      500 mL 
 
A2.3.4  Transfer buffer 
Glycine     144.1 g 
Tris      30.25 g 
SDS      10 g 
Methanol     2 L 
Made up with distilled water to 10 L, and stored at room temperature. 
 
A2.3.5  Alkaline phosphatase substrate solution 
Substrate buffer 
Tris      45.41 g 
Dissolved in 330 mL of distilled water, pH adjusted to 9.6 with concentrated 
HCl and made up to 500 mL. 
 Nitro Blue Tetrazolium (NBT) 
Nitro blue tetrazolium    75 mg 
Dissolved in 1 mL of 70% dimethyl-sulfoxide, and stored at -Û&LQ/
aliquots. 
 5 Bromo-4-chloro-3-indolyl phosphate p-toluidine salt (BCIP) 
BCIP salt     50 mg 
Made up to 1 mL with 100% dimethyl-sulfoxide, and stored at -Û&LQ/
aliquots. 
Alkaline phosphatase substrate  
Substrate buffer    20 ml 
NBT      44 µL 
BCIP      33 µL 
 
A2.3.6  Horseradish peroxidase substrate solution 
Chlornaptol     50 mg 
Dissolved in 10 mL of ethanol, and made up to 50 mL with TBS. 
30 µL of hydrogen peroxide added before use. 
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A2.4 General buffers 
 
A2.4.1  Phosphate buffered saline (PBS) 
NaCl      80 g 
KCl      2 g 
Na2HPO4     14.4 g 
KH2PO4     2.4 g 
Dissolved in approximately 500 mL of distilled water, pH adjusted to 7.2 and 
made up to 10 L. 
 
A2.4.2  Washing buffer (PBS/0.05% Tween) 
Tween 20     250 µL 
PBS      500 mL 
 
A2.4.3  0.1 M Citrate/Sodium citrate buffer 
Sodium citrate     14.7 g 
Citric acid     10.52 g 
Each made up with distilled water to 500 mL, and titrated against each other to 
the required pH. 
 
A2.4.4  0.1 M Sodium phosphate buffer 
NaH2PO4.2H2O    7.8 g 
Na2HPO4     7.09 g   
Each made up with distilled water to 500 mL, and titrated against each other to 
the required pH. 
 
A2.4.5  0.05 M 2-amino-2-methyl-1:3-propanediol-HCl buffer 
2-amino-2-methyl-1:3-propanediol  2.6 g 
Made up with distilled water to 500 mL, pH adjusted as required with 
concentrated HCl. 
 
A2.4.6  0.5 M Tris-HCl pH 8.5 
Tris      30.30 g 
Dissolved in distilled water, pH adjusted to 8.5 with concentrated HCl and 
made up to 500 mL. 
 
A2.4.7  0.1 M Tris-HCl pH 8.5 
Tris      6.06 g 
Dissolved in distilled water, pH adjusted to 8.5 with concentrated HCl and 
made up to 500 mL. 
 
A2.4.8  0.05 M Carbonate/Bicarbonate buffer pH 9.6 
Na2CO3     0.8 g 
NaHCO3     1.47 g 
Dissolved in 100 mL distilled water, pH adjusted to 9.6 with 1 M HCl and 
made up to 500 mL.  
 
A2.4.9  0.1 M Sodium acetate pH 6 
Sodium acetate    8.2 g 
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Dissolved in 800 mL distilled water, pH adjusted to 6 with glacial acetic acid 
and made up to 1 L. 
 
A2.4.10 2.5 M Sulphuric acid 
Concentrated sulphuric acid   18 mL 
Distilled water    82 mL 
 
A2.4.11 Blocking buffer (for ELISA) 
Bovine albumin serum (BSA)  3 g 
PBS      100 mL 
 
A2.5 Cell culture materials 
 
A2.5.1  1% Gelatin 
Gelatin     1 g 
Milli Q water     100 ml 
Autoclaved to dissolve and sterilise, and stored at 4 Û& 
 
A2.5.2  0.9% Saline 
NaCl      4.5 g 
Distilled water    500 mL 
Autoclaved, and stored at room temperature.  
 
A2.5.3  Medium M0 
Medium 199     500 mL 
Penicillin     1000 U 
Streptomycin     1 g 
Fungizone     1 mg 
6WRUHGDWÛ& 
 
A2.5.4  M20 Growth medium 
M0      80 mL 
Fetal bovine serum (FBS)   20 mL  
 
A2.5.5  1% Collagenase  
Collagenase type II    100 mg 
+DQN¶VEDODQFHGVDOWVROXWLRQ+%66 10 mL 
Mixed, filter sterilized and stored at -Û& LQWR/DOLTXRWV ,Q+89(&
isolation, collagenase is used at 0.1% in M0. 
 
A2.5.6  50 mM Albumin-TRITC 
Albumin-TRITC    1 mg 
RPMI-1640 without phenol red  2 mL   
 
A2.5.7  0.1% BSA/PBS 
BSA      0.1 g 
PBS      100 mL 
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A3.1 Effect of protease inhibitors alone on endothelial integrity 
  
  
  
Figure A3.1.1    Effect of protease inhibitors on endothelial integrity as confluent 
HUVEC monolayers were treated with protease inhibitors, individually or in 
combination, and stained for VE-cadherin as described in section 4.2.5. Inhibitors alone 
induced no change in endothelial integrity as junctional VE-cadherin showed a 
continuous expression which is comparable to control, inhibitor-free monolayers. 
     1, 10 Phenanthroline 
        E64 Control 
  Pepstatin A 
     PMSF  All inhibitors 
